00013856132025FYfalsehttp://fasb.org/us-gaap/2025#OtherAssetshttp://fasb.org/us-gaap/2025#OtherAssetshttp://fasb.org/us-gaap/2025#OtherLiabilitieshttp://fasb.org/us-gaap/2025#OtherLiabilitiesiso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pureiso4217:GBPglre:segment00013856132025-01-012025-12-3100013856132025-06-3000013856132026-03-0900013856132025-10-012025-12-310001385613glre:SolasglasInvestmentsLPSILPMember2025-01-012025-12-3100013856132025-12-3100013856132024-12-3100013856132024-01-012024-12-3100013856132023-01-012023-12-310001385613us-gaap:CommonStockMember2024-12-310001385613us-gaap:CommonStockMember2023-12-310001385613us-gaap:CommonStockMember2022-12-310001385613us-gaap:CommonStockMember2025-01-012025-12-310001385613us-gaap:CommonStockMember2024-01-012024-12-310001385613us-gaap:CommonStockMember2023-01-012023-12-310001385613us-gaap:CommonStockMember2025-12-310001385613us-gaap:AdditionalPaidInCapitalMember2024-12-310001385613us-gaap:AdditionalPaidInCapitalMember2023-12-310001385613us-gaap:AdditionalPaidInCapitalMember2022-12-310001385613us-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310001385613us-gaap:AdditionalPaidInCapitalMember2024-01-012024-12-310001385613us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001385613us-gaap:AdditionalPaidInCapitalMember2025-12-310001385613us-gaap:RetainedEarningsMember2024-12-310001385613us-gaap:RetainedEarningsMember2023-12-310001385613us-gaap:RetainedEarningsMember2022-12-310001385613us-gaap:RetainedEarningsMember2025-01-012025-12-310001385613us-gaap:RetainedEarningsMember2024-01-012024-12-310001385613us-gaap:RetainedEarningsMember2023-01-012023-12-310001385613us-gaap:RetainedEarningsMember2025-12-3100013856132023-12-3100013856132022-12-310001385613srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2025-01-012025-12-310001385613glre:SolasglasInvestmentsLPSILPMember2023-01-012023-01-010001385613glre:SolasglasInvestmentsLPSILPMember2023-01-012023-12-310001385613glre:SolasglasInvestmentsLPSILPMember2024-08-012024-08-010001385613glre:SolasglasInvestmentsLPSILPMemberglre:GreenlightCapitalReLimitedPartnersMember2025-12-310001385613glre:SolasglasInvestmentsLPSILPMemberglre:GreenlightCapitalReLimitedPartnersMember2024-12-310001385613glre:SolasglasInvestmentsLPSILPMember2025-12-310001385613glre:SolasglasInvestmentsLPSILPMember2024-12-310001385613glre:SILPGeneralPartnerMember2025-12-310001385613glre:SILPGeneralPartnerMember2024-12-310001385613glre:LimitedPartnershipAgreementMember2025-01-012025-12-310001385613glre:SolasglasInvestmentsLPSILPMember2025-12-310001385613glre:SolasglasInvestmentsLPSILPMember2024-12-310001385613glre:SolasglasInvestmentsLPSILPMember2025-01-012025-12-310001385613glre:SolasglasInvestmentsLPSILPMember2024-01-012024-12-310001385613glre:SolasglasInvestmentsLPSILPMember2023-01-012023-12-310001385613glre:SolasglasInvestmentsLPSILPMember2024-01-012024-12-310001385613glre:SolasglasInvestmentsLPSILPMember2023-01-012023-12-310001385613us-gaap:USGovernmentAgenciesDebtSecuritiesMember2025-12-310001385613us-gaap:ResidentialMortgageBackedSecuritiesMember2025-12-310001385613us-gaap:CorporateBondSecuritiesMember2025-12-310001385613us-gaap:AssetBackedSecuritiesMember2025-12-310001385613glre:NonAgencyResidentialMortgageBackedSecuritiesMember2025-12-310001385613us-gaap:MunicipalBondsMember2025-12-310001385613us-gaap:PrivateEquityFundsMember2025-12-310001385613us-gaap:PrivateEquityFundsMember2025-01-012025-12-310001385613glre:PrivateConvertibleDebtSecuritiesMember2025-12-310001385613glre:PrivateConvertibleDebtSecuritiesMember2025-01-012025-12-310001385613us-gaap:PrivateEquityFundsMember2024-12-310001385613us-gaap:PrivateEquityFundsMember2024-01-012024-12-310001385613glre:PrivateConvertibleDebtSecuritiesMember2024-12-310001385613glre:PrivateConvertibleDebtSecuritiesMember2024-01-012024-12-310001385613glre:TrustAccountsMember2025-12-310001385613glre:TrustAccountsMember2024-12-310001385613glre:CashCollateralLettersofCreditIssuedMember2025-12-310001385613glre:CashCollateralLettersofCreditIssuedMember2024-12-310001385613glre:CashSecuringLoanFacilityMember2025-12-310001385613glre:CashSecuringLoanFacilityMember2024-12-310001385613glre:OtherCashAndCashEquivalentsMember2025-12-310001385613glre:OtherCashAndCashEquivalentsMember2024-12-310001385613us-gaap:FairValueMeasurementsNonrecurringMember2025-12-310001385613us-gaap:FairValueMeasurementsNonrecurringMember2024-12-310001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember2025-12-310001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember2024-12-310001385613glre:MeasurementPeriodOneMemberus-gaap:FairValueMeasurementsNonrecurringMember2025-12-310001385613glre:MeasurementPeriodTwoMemberus-gaap:FairValueMeasurementsNonrecurringMember2025-12-310001385613glre:MeasurementPeriodThreeMemberus-gaap:FairValueMeasurementsNonrecurringMember2025-12-310001385613us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001385613us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001385613us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001385613us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001385613us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001385613us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001385613us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001385613us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001385613us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001385613us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001385613us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001385613us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001385613us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001385613us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001385613us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001385613us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001385613glre:NonAgencyResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001385613glre:NonAgencyResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001385613glre:NonAgencyResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001385613glre:NonAgencyResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001385613us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001385613us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001385613us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001385613us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001385613us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310001385613us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310001385613us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310001385613us-gaap:FairValueMeasurementsRecurringMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:OpenMarketMember2025-01-012025-12-310001385613us-gaap:OperatingSegmentsMemberglre:InnovationsMember2025-01-012025-12-310001385613us-gaap:OperatingSegmentsMember2025-01-012025-12-310001385613us-gaap:CorporateNonSegmentMember2025-01-012025-12-310001385613us-gaap:OperatingSegmentsMemberglre:OpenMarketMember2024-01-012024-12-310001385613us-gaap:OperatingSegmentsMemberglre:InnovationsMember2024-01-012024-12-310001385613us-gaap:OperatingSegmentsMember2024-01-012024-12-310001385613us-gaap:CorporateNonSegmentMember2024-01-012024-12-310001385613us-gaap:OperatingSegmentsMemberglre:OpenMarketMember2023-01-012023-12-310001385613us-gaap:OperatingSegmentsMemberglre:InnovationsMember2023-01-012023-12-310001385613us-gaap:OperatingSegmentsMember2023-01-012023-12-310001385613us-gaap:CorporateNonSegmentMember2023-01-012023-12-310001385613us-gaap:OperatingSegmentsMemberAdverse Reserve Developmentglre:OpenMarketMember2025-01-012025-12-310001385613us-gaap:OperatingSegmentsMemberFavorable Reserve Developmentglre:OpenMarketMember2025-01-012025-12-310001385613us-gaap:OperatingSegmentsMemberAdverse Reserve Developmentglre:OpenMarketMember2024-01-012024-12-310001385613us-gaap:OperatingSegmentsMemberFavorable Reserve Developmentglre:OpenMarketMember2024-01-012024-12-310001385613us-gaap:OperatingSegmentsMemberAdverse Reserve Developmentglre:OpenMarketMember2023-01-012023-12-310001385613us-gaap:OperatingSegmentsMemberFavorable Reserve Developmentglre:OpenMarketMember2023-01-012023-12-310001385613us-gaap:OperatingSegmentsMemberAdverse Reserve Developmentglre:InnovationsMember2025-01-012025-12-310001385613us-gaap:OperatingSegmentsMemberFavorable Reserve Developmentglre:InnovationsMember2025-01-012025-12-310001385613us-gaap:OperatingSegmentsMemberFavorable Reserve Developmentglre:InnovationsMember2024-01-012024-12-310001385613us-gaap:OperatingSegmentsMemberAdverse Reserve Developmentglre:InnovationsMember2024-01-012024-12-310001385613us-gaap:OperatingSegmentsMemberAdverse Reserve Developmentglre:InnovationsMember2023-01-012023-12-310001385613us-gaap:OperatingSegmentsMemberFavorable Reserve Developmentglre:InnovationsMember2023-01-012023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2016-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2016-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2016-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2016-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2017-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2018-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2019-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2020-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2021-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2022-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2023-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2017-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2018-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2019-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2020-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2021-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2022-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2023-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2018-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2019-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2020-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2021-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2022-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2023-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2019-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2020-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2021-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2022-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2023-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2020-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2021-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2022-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2023-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2021-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2022-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2023-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2022-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2023-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2023-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2024-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:OpenMarketMember2025-12-310001385613glre:MultilineMemberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2016-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2017-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2018-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2019-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2020-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2021-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2022-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2023-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2017-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2018-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2019-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2020-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2021-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2022-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2023-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2018-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2019-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2020-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2021-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2022-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2023-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2019-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2020-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2021-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2022-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2023-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2020-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2021-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2022-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2023-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2021-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2022-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2023-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2022-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2023-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2023-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2024-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:OpenMarketMember2025-12-310001385613glre:PropertyMemberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:PropertyMemberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2016-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2017-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2018-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2019-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2020-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2021-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2022-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2023-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2017-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2018-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2019-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2020-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2021-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2022-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2023-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2018-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2019-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2020-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2021-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2022-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2023-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2019-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2020-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2021-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2022-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2023-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2020-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2021-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2022-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2023-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2021-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2022-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2023-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2022-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2023-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2023-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2024-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:OpenMarketMember2025-12-310001385613glre:SpecialtyMemberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberglre:OpenMarketMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2016-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2017-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2018-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2019-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2020-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2021-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2022-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2023-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2017-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2018-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2019-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2020-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2021-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2022-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2023-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2018-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2019-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2020-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2021-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2022-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2023-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2019-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2020-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2021-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2022-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2023-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2020-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2021-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2022-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2023-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2021-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2022-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2023-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2022-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2023-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2023-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2024-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:InnovationsMember2025-12-310001385613glre:CasualtyMemberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:CasualtyMemberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2016-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:FinancialMemberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2016-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:HealthMemberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2016-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:MultilineMemberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2016-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2017-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2018-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2019-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2020-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2021-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2022-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Memberglre:InnovationsMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:SpecialtyMemberglre:InnovationsMember2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2016-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2017-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2018-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2019-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2020-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2021-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2022-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2023-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2017-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2018-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2019-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2020-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2021-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2022-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2023-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2018-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2019-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2020-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2021-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2022-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2023-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2019-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2020-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2021-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2022-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2023-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2020-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2021-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2022-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2023-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2021-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2022-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2023-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Member2022-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Member2023-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Member2024-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2024Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMemberus-gaap:ShortDurationInsuranceContractAccidentYear2025Member2025-12-310001385613us-gaap:CorporateNonSegmentMemberglre:PropertyMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:OpenMarketMember2025-12-310001385613us-gaap:OperatingSegmentsMemberglre:InnovationsMember2025-12-310001385613us-gaap:CorporateNonSegmentMember2025-12-310001385613glre:RetrocessionPortfolioMemberglre:AOrBetterByA.M.BestMember2025-12-310001385613glre:RetrocessionPortfolioMemberglre:AOrBetterByA.M.BestMember2024-12-310001385613glre:RetrocessionPortfolioMemberglre:NotRatedMember2025-12-310001385613glre:RetrocessionPortfolioMemberglre:NotRatedMember2024-12-310001385613glre:RetrocessionPortfolioMember2025-12-310001385613glre:RetrocessionPortfolioMember2024-12-310001385613glre:ThreeReinsurersMemberglre:ReinsuranceConcentrationRiskMemberglre:TotalLossAndLossAdjustmentExpenseRecoverabilityMember2025-01-012025-12-310001385613glre:FourReinsurersMemberglre:ReinsuranceConcentrationRiskMemberglre:TotalLossAndLossAdjustmentExpenseRecoverabilityMember2024-01-012024-12-310001385613us-gaap:RevolvingCreditFacilityMemberglre:AmendedCreditAgreementMemberus-gaap:LineOfCreditMember2025-09-030001385613glre:TermLoanMember2025-09-030001385613us-gaap:RevolvingCreditFacilityMemberglre:AmendedCreditAgreementMemberus-gaap:LineOfCreditMember2025-09-032025-09-030001385613us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-01-012025-12-310001385613us-gaap:RevolvingCreditFacilityMemberglre:AmendedCreditAgreementMemberus-gaap:LineOfCreditMember2025-12-310001385613glre:NewTermLoanFacilityMember2023-06-162023-06-160001385613glre:NewTermLoanFacilityMember2023-06-160001385613glre:TermLoanMemberus-gaap:SeniorNotesMember2025-01-012025-12-310001385613glre:TermLoanMemberus-gaap:SeniorNotesMember2024-01-012024-12-310001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2025-01-012025-12-310001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2024-01-012024-12-310001385613glre:SeniorUnsecuredConvertibleNotesMemberus-gaap:SeniorNotesMember2023-01-012023-12-310001385613us-gaap:FinancialStandbyLetterOfCreditMemberexch:HSBC2025-12-310001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CitibankMember2025-12-310001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CIBCMember2025-12-310001385613us-gaap:FinancialStandbyLetterOfCreditMember2025-12-310001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CitibankFALMember2025-12-310001385613us-gaap:LetterOfCreditMemberexch:HSBC2024-12-170001385613glre:CitibankMember2024-12-190001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CIBCMember2023-12-220001385613glre:UnsecuredFinancialStandbyLetterOfCreditMemberglre:CIBCMember2023-12-220001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CIBCMember2025-01-012025-12-310001385613us-gaap:LetterOfCreditMemberglre:CitibankFALMember2025-12-310001385613us-gaap:LetterOfCreditMemberglre:CitibankFALMember2025-10-090001385613us-gaap:CommonClassAMember2022-12-310001385613us-gaap:CommonClassBMember2022-12-310001385613us-gaap:CommonClassAMember2023-01-012023-12-310001385613us-gaap:CommonClassBMember2023-01-012023-12-310001385613glre:EmployeesMember2025-01-012025-12-310001385613glre:EmployeesMember2024-01-012024-12-310001385613glre:EmployeesMember2023-01-012023-12-310001385613glre:EmployeesMemberus-gaap:CommonClassAMember2023-01-012023-12-310001385613glre:EmployeesMemberus-gaap:CommonClassBMember2023-01-012023-12-310001385613srt:DirectorMember2025-01-012025-12-310001385613srt:DirectorMember2024-01-012024-12-310001385613srt:DirectorMember2023-01-012023-12-310001385613srt:DirectorMemberus-gaap:CommonClassAMember2023-01-012023-12-310001385613srt:DirectorMemberus-gaap:CommonClassBMember2023-01-012023-12-310001385613us-gaap:CommonClassAMember2023-12-310001385613us-gaap:CommonClassBMember2023-12-3100013856132025-05-020001385613us-gaap:CommonClassAMember2025-12-310001385613glre:PerformanceRestrictedStockMember2023-12-310001385613glre:ServiceRestrictedStockMember2023-12-310001385613glre:PerformanceRestrictedStockMember2024-01-012024-12-310001385613glre:ServiceRestrictedStockMember2024-01-012024-12-310001385613glre:PerformanceRestrictedStockMember2024-12-310001385613glre:ServiceRestrictedStockMember2024-12-310001385613glre:PerformanceRestrictedStockMember2025-01-012025-12-310001385613glre:ServiceRestrictedStockMember2025-01-012025-12-310001385613glre:PerformanceRestrictedStockMember2025-12-310001385613glre:ServiceRestrictedStockMember2025-12-310001385613us-gaap:RestrictedStockMember2025-01-012025-12-310001385613us-gaap:RestrictedStockMember2024-01-012024-12-310001385613us-gaap:RestrictedStockMember2025-12-310001385613us-gaap:RestrictedStockMember2024-12-310001385613glre:PerformanceRestrictedStockUnitsMember2023-12-310001385613glre:ServiceRestrictedStockUnitsMember2023-12-310001385613glre:PerformanceRestrictedStockUnitsMember2024-01-012024-12-310001385613glre:ServiceRestrictedStockUnitsMember2024-01-012024-12-310001385613glre:PerformanceRestrictedStockUnitsMember2024-12-310001385613glre:ServiceRestrictedStockUnitsMember2024-12-310001385613glre:PerformanceRestrictedStockUnitsMember2025-01-012025-12-310001385613glre:ServiceRestrictedStockUnitsMember2025-01-012025-12-310001385613glre:PerformanceRestrictedStockUnitsMember2025-12-310001385613glre:ServiceRestrictedStockUnitsMember2025-12-310001385613us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-12-310001385613srt:MinimumMemberglre:PerformanceRestrictedStockUnitsMember2025-01-012025-12-310001385613srt:MaximumMemberglre:PerformanceRestrictedStockUnitsMember2025-01-012025-12-310001385613srt:MinimumMemberglre:PerformanceRestrictedStockUnitsMember2024-01-012024-12-310001385613srt:MaximumMemberglre:PerformanceRestrictedStockUnitsMember2024-01-012024-12-310001385613us-gaap:RestrictedStockUnitsRSUMember2025-12-310001385613us-gaap:RestrictedStockUnitsRSUMember2024-12-310001385613us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-12-310001385613srt:ChiefExecutiveOfficerMember2024-01-012024-12-310001385613srt:ChiefExecutiveOfficerMemberus-gaap:EmployeeStockOptionMember2024-12-310001385613srt:ChiefExecutiveOfficerMemberus-gaap:EmployeeStockOptionMember2024-01-012024-12-310001385613srt:ChiefExecutiveOfficerMember2025-01-012025-12-310001385613srt:ChiefExecutiveOfficerMember2025-12-310001385613us-gaap:EmployeeStockOptionMember2022-12-310001385613us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001385613us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001385613us-gaap:EmployeeStockOptionMember2023-12-310001385613us-gaap:EmployeeStockOptionMember2024-01-012024-12-310001385613us-gaap:EmployeeStockOptionMember2024-12-310001385613us-gaap:EmployeeStockOptionMember2025-01-012025-12-310001385613us-gaap:EmployeeStockOptionMember2025-12-310001385613us-gaap:EmployeeStockOptionMember2025-01-012025-12-310001385613us-gaap:EmployeeStockOptionMember2024-01-012024-12-310001385613us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001385613country:IE2025-01-012025-12-310001385613country:IE2024-01-012024-12-310001385613country:IE2023-01-012023-12-310001385613country:GB2025-01-012025-12-310001385613country:GB2024-01-012024-12-310001385613country:GB2023-01-012023-12-310001385613country:US2025-01-012025-12-310001385613country:US2024-01-012024-12-310001385613country:US2023-01-012023-12-310001385613glre:LimitedPartnershipAgreementMembersrt:BoardOfDirectorsChairmanMember2025-01-012025-12-310001385613glre:InvestmentAdvisoryAgreementMembersrt:BoardOfDirectorsChairmanMember2018-09-012018-09-010001385613glre:GreenBricksPartnersIncGRBKMemberglre:SolasglasInvestmentsLPSILPMembersrt:AffiliatedEntityMember2025-12-310001385613glre:ServiceAgreementMembersrt:BoardOfDirectorsChairmanMember2025-01-012025-12-310001385613glre:CollateralAssetsInvestementManagementAgreementMembersrt:BoardOfDirectorsChairmanMember2019-01-012019-01-010001385613srt:ChiefExecutiveOfficerMember2023-11-032023-11-030001385613srt:ChiefExecutiveOfficerMember2023-11-032023-12-310001385613srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockMember2023-11-032023-11-030001385613srt:ChiefExecutiveOfficerMemberus-gaap:PerformanceSharesMember2023-11-032023-11-030001385613srt:ChiefExecutiveOfficerMemberus-gaap:PerformanceSharesMember2024-03-012024-03-310001385613srt:ChiefExecutiveOfficerMember2023-01-012023-12-310001385613us-gaap:PerformanceSharesMember2025-01-012025-12-310001385613us-gaap:PerformanceSharesMember2024-01-012024-12-310001385613us-gaap:OperatingSegmentsMemberglre:OpenMarketMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:InnovationsMember2024-12-310001385613us-gaap:CorporateNonSegmentMember2024-12-310001385613us-gaap:OperatingSegmentsMemberglre:OpenMarketMember2023-12-310001385613us-gaap:OperatingSegmentsMemberglre:InnovationsMember2023-12-310001385613us-gaap:CorporateNonSegmentMember2023-12-310001385613country:IE2025-01-012025-12-310001385613country:IE2024-01-012024-12-310001385613country:IE2023-01-012023-12-310001385613country:GB2025-01-012025-12-310001385613country:GB2024-01-012024-12-310001385613country:GB2023-01-012023-12-310001385613country:KY2025-01-012025-12-310001385613country:KY2024-01-012024-12-310001385613country:KY2023-01-012023-12-310001385613glre:GreenlightReinsuranceLtd.Membercountry:KY2025-12-310001385613glre:GreenlightReinsuranceLtd.Membercountry:KY2024-12-310001385613glre:GreenlightReinsuranceIrelandDACMembercountry:IE2025-12-310001385613glre:GreenlightReinsuranceIrelandDACMembercountry:IE2024-12-310001385613glre:GreenlightReinsuranceLtd.Member2025-01-012025-12-310001385613glre:GreenlightReinsuranceIrelandDACMember2025-01-012025-12-310001385613glre:GreenlightReinsuranceLtd.Member2024-01-012024-12-310001385613glre:GreenlightReinsuranceIrelandDACMember2024-01-012024-12-310001385613glre:GreenlightReinsuranceLtd.Member2023-01-012023-12-310001385613glre:GreenlightReinsuranceIrelandDACMember2023-01-012023-12-310001385613us-gaap:OtherThanSecuritiesInvestmentMember2025-12-310001385613us-gaap:FixedIncomeSecuritiesMember2025-12-310001385613glre:LiquidityFundMember2025-12-310001385613us-gaap:FixedMaturitiesMember2025-12-310001385613srt:ParentCompanyMember2025-12-310001385613srt:ParentCompanyMember2024-12-310001385613srt:ParentCompanyMemberus-gaap:RelatedPartyMember2025-12-310001385613srt:ParentCompanyMemberus-gaap:RelatedPartyMember2024-12-310001385613srt:ParentCompanyMember2025-01-012025-12-310001385613srt:ParentCompanyMember2024-01-012024-12-310001385613srt:ParentCompanyMember2023-01-012023-12-310001385613srt:ParentCompanyMember2023-12-310001385613srt:ParentCompanyMember2022-12-310001385613us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember2025-01-012025-12-310001385613us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember2024-01-012024-12-310001385613us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember2023-01-012023-12-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K


☒			ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2025


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-33493

Greenlight Capital Re, Ltd.

(Exact Name of Registrant as Specified in Its Charter)


Cayman Islands			N/A
(State or other jurisdiction of incorporation or organization)			(I.R.S. employer identification no.)
65 Market Street
Suite 1207, Jasmine Court
P.O. Box 31110
Camana Bay
Grand Cayman
Cayman Islands			KY1-1205
(Address of principal executive offices)			(Zip code)

Registrant’s telephone number, including area code: 205-291-3440

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of exchange
Ordinary shares	GLRE	The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of ‘‘large accelerated filer,’’ ‘‘accelerated filer,’’ ‘‘smaller reporting company’’ and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Smaller reporting company ☐

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of voting and non-voting ordinary shares held by non-affiliates of the registrant at June 30, 2025, was $376.0 million.

At March 9, 2026, there were 33,983,603 ordinary shares outstanding, $0.10 par value per share, of the registrant.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the proxy statement for the registrant’s 2026 annual meeting of shareholders, to be filed subsequently with the Securities and Exchange Commission, or the SEC, pursuant to Regulation 14A, under the Securities Exchange Act of 1934, as amended, or the Exchange Act, relating to the registrant’s annual general meeting of shareholders scheduled to be held on July 28, 2026 are incorporated by reference in Part III of this Annual Report on Form 10-K.

GREENLIGHT CAPITAL RE, LTD.

TABLE OF CONTENTS


		Page
PART I		3
	NOTE ON FORWARD-LOOKING STATEMENTS
ITEM 1.	BUSINESS	5
	GLOSSARY OF SELECTED REINSURANCE TERMS	21
ITEM 1A.	RISK FACTORS	26
ITEM 1B.	UNRESOLVED STAFF COMMENTS	50
ITEM 1C.	CYBERSECURITY	50
ITEM 2.	PROPERTIES	51
ITEM 3.	LEGAL PROCEEDINGS	51
ITEM 4.	MINE SAFETY DISCLOSURES	51
PART II		51
ITEM 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS , AND ISSUER PURCHASES OF EQUITY SECURITIES	51
ITEM 6.	[RESERVED]	54
ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	54
ITEM 7A.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	77
ITEM 8.	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA	79
ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE	79
ITEM 9A.	CONTROLS AND PROCEDURES	79
ITEM 9B.	OTHER INFORMATION	82
ITEM 9C.	DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS	82
PART III		82
ITEM 10.	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE	82
ITEM 11.	EXECUTIVE COMPENSATION	82
ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	82
ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE	82
ITEM 14.	PRINCIPAL ACCOUNTING FEES AND SERVICES	82
PART IV		83
ITEM 15.	EXHIBITS AND FINANCIAL STATEMENT SCHEDULES	83
ITEM 16.	FORM 10-K SUMMARY	83
EXHIBIT INDEX		84
SIGNATURES		87

Return to table of contents

PART I

Note About Forward-Looking Statements

This Annual Report on Form 10-K (herein referred as “Form 10-K” or “Annual Report”) of Greenlight Capital Re, Ltd. (“Greenlight Capital Re,” “Company,” “us,” “we,” or “our”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements, other than statements of historical facts included in this report, including statements regarding estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements”. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the United States (“U.S.”) federal securities laws established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are not historical facts, and are based on current expectations, estimates and projections, and various assumptions, many of which, are inherently uncertain and beyond management’s control.

Forward-looking statements contained in this Form 10-K may include, but are not limited to, information regarding our estimates for net loss and loss adjustment expenses incurred (including catastrophes and weather-related losses), measurements of potential losses in the fair market value of our investments, our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, the outcome of our strategic initiatives, our expectations regarding pricing, and other market and economic conditions including inflation, our growth prospects, and valuations of the potential impact of movements in interest rates, equity securities’ prices, and foreign currency exchange rates.

Forward-looking statements only reflect our expectations and are not guarantees of performance. These statements involve risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual events or results to differ materially from those indicated in such statements. We believe that these factors include, but are not limited to:

•any suspension or revocation of any of our licenses;

•losses from catastrophes and other major events;

•the loss of significant brokers; and

•those described under “Item 1A, Risk Factors”of this Form 10-K, including the summary below, as those risk factors may be updated from time to time in our periodic and other filings with the Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

We undertake no obligation to publicly update or revise any forward-looking statements, whether due to new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only to the dates they were made.

We intend to communicate certain events that we believe may have a material adverse impact on our operations or financial position, including property and casualty catastrophic events and material losses in our investment portfolio, in a timely manner through a public announcement. Other than as required by the Exchange Act, we do not intend to make public announcements regarding underwriting or investment events that we do not believe, based on management’s estimates and current information, will have a material adverse impact on our operations or financial position.

Summary of Risk Factors

The following is a summary of the principal risks that we believe could adversely affect our business, operations, and financial results.

Risks Relating to Our Business

•Our results of operations fluctuate from period to period and may not be indicative of our long-term prospects.

•If our losses and loss adjustment expenses (“LAE”) greatly exceed our loss reserves, our financial condition may be materially and adversely affected.

Return to table of contents

•Our property and casualty reinsurance operations make us vulnerable to losses from catastrophes and may cause our results of operations to vary significantly from period to period.

•The loss of significant brokers or customers, could materially and adversely affect our business, financial condition and results of operations.

Risks Relating to Insurance and Other Regulations

•Any suspension or revocation of any of our licenses would materially and adversely affect our business, financial condition and results of operations.

•Our reinsurance subsidiaries are subject to minimum capital and surplus requirements, and our failure to meet these requirements could subject us to regulatory action.

Risks Relating to Our Solasglas Investment Strategy

•Our investment performance depends in part on the performance of Solaglas Investments, LP (“Solasglas”) and may suffer as a result of adverse financial market developments or other factors that impact Solasglas’ liquidity, which could materially and adversely affect our investment results, financial condition and results of operations.

•Solasglas may be concentrated in a few large positions, which could result in material adverse valuation movements.

•Under the Solasglas limited partnership agreement (“Solasglas LPA”), we are contractually obligated to invest substantially all our assets in Solasglas, with certain exceptions. Solasglas’ performance depends on the ability of its investment advisor, DME Advisors, LP (“DME Advisors”), to select and manage appropriate investments.

Risks Relating to Our Innovations Strategy

•The carrying values of our Innovations investments may differ significantly from those that would be used if we carried these investments at fair value. Additionally, we have a material concentration in our top five holdings at December 31, 2025.

•Our Innovations investments support our underwriting operations and the failure to identify and consummate investment opportunities may materially and adversely affect our ability to implement our business strategy.

•Investments in privately held early-stage companies (“private equities”) involve significant risks, and are highly illiquid.

Return to table of contents

Item 1. BUSINESS

Unless otherwise indicated or unless the context otherwise requires, all references in this Form 10-K to “the Company,” “we,” “us,” “our,” and similar expressions are references to Greenlight Capital Re, Ltd. and its consolidated subsidiaries. Unless otherwise indicated or unless the context otherwise requires, all references in this Annual Report to entity names are as set forth in the following table:


Reference			Entity’s legal name
Greenlight Capital Re or GLRE			Greenlight Capital Re, Ltd.
Greenlight Re			Greenlight Reinsurance, Ltd.
GRIL			Greenlight Reinsurance Ireland, Designated Activity Company
Verdant			Verdant Holding Company, Ltd.
Greenlight Re UK			Greenlight Re Marketing (UK) Limited
Syndicate 3456			Greenlight Innovation Syndicate 3456
GCM			Greenlight Re Corporate Member Ltd.
Viridis Re			Viridis Re SPC, Ltd.
GRIS			Greenlight Re Ireland Services Limited

We have included a Glossary of Selected Reinsurance Terms at the end of “Part I, Item 1. Business” of this Form 10-K.

All dollar amounts referred to in this Form 10-K are in U.S. dollars unless otherwise indicated. Tabular dollars are presented in thousands, with the exception of per share amounts or as otherwise noted. Due to rounding, numbers presented in the tables included in this Form 10-K may not add up precisely to the totals provided.

Additionally, we disclosed Non-GAAP financial measures in this Form 10-K. Refer to “Part II, Item 7, Management Discussion and Analysis - Key Financial Measures and Non-GAAP Measures” for further details.

Company Overview

Established in 2004, we are a global specialty property and casualty (“P&C”) reinsurer headquartered in the Cayman Islands and listed on NASDAQ (ticker: GLRE). We believe that our reinsurance and investment strategy differentiates us from most of our competitors. We conduct our operations principally through two wholly-owned licensed and regulated subsidiaries: Greenlight Re, based in Grand Cayman, Cayman Islands, and GRIL, based in Dublin, Ireland, in addition to our Lloyd’s platform, Syndicate 3456. Greenlight Re provides multi-line property and casualty reinsurance globally, while GRIL focuses mainly on specialty business. Further, since 2018, our Innovations business unit has supported innovative, technology-driven insurance partners, both in the form of seed capital and reinsurance capacity.

The London market specialty business is central to our underwriting portfolio. In 2020, we established a UK marketing Company, Greenlight Re UK, to increase our London market presence. On January 1, 2023, we acquired a Lloyd’s corporate member, GCM, that provides underwriting capacity for various syndicates (including Syndicate 3456) that underwrite general insurance and reinsurance business at Lloyd’s. Prior to acquiring GCM, we sourced our Funds at Lloyd’s (“FAL”) business through the same corporate member. The ownership of GCM complements our Syndicate 3456 and provides us more control over the FAL business.

Our goal is to build long-term shareholder value by providing risk management products and services to the insurance, reinsurance, and other risk marketplaces. We focus on delivering risk solutions to clients and brokers who value our expertise, analytics, and customer service offerings, while complementing our underwriting activities with a non-traditional investment approach designed to achieve higher rates of return over the long term than reinsurance companies that exclusively employ more traditional investment strategies.

Following the business growth momentum in 2024 and 2023, we grew our reinsurance business by 10.7% in gross premiums written during 2025 while maintaining a strong financial position and liquidity. Supported by strong net cash flows from operating activities, we made further stock buybacks and repaid most of our outstanding debt in 2025. In light of our strong balance sheet and steadily improved operating performance, A.M. Best Company, Inc. (“A.M. Best”) upgraded our Financial Strength Rating to A (Excellent) from A- (Excellent) with a stable outlook for

Return to table of contents

our principal operating subsidiaries in November 2025. At December 31, 2025, we had $2.2 billion of total assets and $0.7 billion of shareholders’ equity, and grew our fully diluted book value per share by 13.8% during 2025.

Company Capital Stock

We have one class of common stock, our ordinary shares. Each ordinary share is entitled to one vote per share. However, except upon unanimous consent of our Board pursuant to Section 11(1)(c) of our Fourth Amended and Restated Memorandum and Articles of Association (the “Articles”), no holder is permitted to acquire an amount of shares which would cause any person to own (directly, indirectly or constructively under applicable United States tax attribution and constructive ownership rules) 9.9% or more of the total voting power of the total issued and outstanding ordinary shares. In connection with certain proposals that passed at our 2023 AGM relating to the elimination of our former dual-class share structure, our Board consented to David Einhorn beneficially owning more than 9.9% of the total voting power of the total issued and outstanding ordinary shares, up to the amount of ordinary shares beneficially owned by Mr. Einhorn at the time of the consent (i.e., 6,254,715 ordinary shares, which represented 18.5% of the outstanding ordinary shares as of December 31, 2025). Mr. Einhorn is the Chairman of the Company’s Board of Directors and the President of Greenlight Capital, Inc. (see "Investments” in this Item 1).

Business Strategy

We continue to prioritize long-term growth in diluted book value per share as our primary financial metric in measuring the Company’s performance. The five-year compound annual growth for our diluted book value per share was 8.8% at December 31, 2025. We also measure our short and long-term underwriting performance based on our net underwriting income. We have incorporated these two key performance metrics in our incentive compensation plan to align employee and shareholder interests.

Our business is comprised of the following three strategic pillars:

Open Market Underwriting Strategy

We strive to grow our diverse book of business by responding timely to changing market conditions, prudently managing our lines of business, and driving sustainable shareholder returns.

We offer a diverse range of risk management products and services across market segments and geographies. Our small scale, relative to our global competitors, enables us to be more agile in allocating capacity to the most promising risks and classes. We write business on a non-proportional (or excess of loss) and proportional basis (also known as pro rata reinsurance, quota share reinsurance or participating reinsurance) across a range of classes in the property and casualty market. Our underwriting approach varies by class and type of opportunity:

•Where our expertise is sufficient to evaluate the risk thoroughly, we will generally seek to participate in syndicated placements negotiated and priced by another party that we judge to have market-leading expertise in the class or as a quota share retrocessionaire of a market-leading reinsurer; and

•Where we have domain-specific expertise and a high level of market access, we may seek to act as the lead underwriter to achieve greater influence in negotiating pricing, terms, and conditions.

Further, the size and diversification of our underwriting portfolio will vary based on our perception of the opportunities available in each line of business at any given point in time. As our focus on certain lines fluctuates based on market conditions, we may only offer or underwrite a limited number of lines in any given period. We seek to:

•mitigate underwriting volatility over the long term by focusing on short and medium tail risk;

•target markets and lines of business where we believe an appropriate risk/reward profile exists;

•attract and retain clients with expertise in their respective lines of business;

•employ strict underwriting discipline; and

•select reinsurance opportunities with anticipated favorable returns on capital.

Innovations Investments and Underwriting Strategy

Since 2018, we have been making strategic capital investments in startup companies and managing general agents (“MGAs”). In addition to the potential for higher investment returns over the long term, this strategically positions us for long-term access to a stream of attractive underwriting opportunities directly with our investees, coupled with

Return to table of contents

new sources of fee income through our insurance and reinsurance platforms. For many of our strategic investments, we have observer rights with the investee’s Board of Directors, providing us with high-level transparency into the investee’s business performance.

To capitalize on global opportunities, in 2022 we created Syndicate 3456, a Lloyd’s syndicate-in-a-box, with a Lloyd’s A+ financial strength rating (see Ratings below). Until the end of 2025, Greenlight Re was the sole capital provider for Syndicate 3456. Starting in 2026, we have secured 22.5% of third party capital to support Syndicate 3456’s projected business growth. We believe that this arrangement also enables us to generate fee income. Furthermore, in late 2023, we incorporated Viridis Re as an exempted segregated portfolio company (“SPC”) in the Cayman Islands. Through segregated portfolios of Viridis Re, we offer a turn-key “captive-as-a-service” alternative for current and future strategic partners, which we believe provides a more cost-effective insurance and reinsurance solution, quicker “go to market” alternative, and shared risk taking and resources opportunities.

During 2025, we have expanded our Innovations business, with gross premiums written increasing 28% to $121.6 million (see “Reportable Segments" within this Item 1. Business). As a result of building a strong reputation and brand in the insurtech industry in recent years, we continued to grow our pipeline opportunities in 2025, positioning us for further growth in the foreseeable future, including scaling our Syndicate 3456. In response to this recent growth, we established a whole-account retrocession program with a group of reputable reinsurers, in which we agreed to cede 28.5% of Innovations-related contracts in 2025 in return for an override commission income. We have increased this retrocession program for 2026 to 33%. This strategic initiative enables us to grow our share in promising businesses while efficiently deploying our capital. As result, we can provide greater reinsurance capacity to the startup companies and MGAs (mainly in the insurtech industry) and be meaningful supporters of our partners. This also positions us favorably for further portfolio diversification, fee income, and sustained profitability in the Innovations segment over the long term.

Value-Oriented Investment Strategy

Our value-oriented investment strategy, managed through Solasglas, is designed to maximize returns over the long term while minimizing the risk of capital loss. Unlike the investment strategies of many of our competitors, which invest primarily in fixed-income securities either directly or through fixed-fee arrangements with one or more investment managers, our investment strategy is focused mainly on long and short positions, primarily in publicly-traded equity and corporate debt instruments. See “Investments” within this Item 1. Business for further information.

In late 2025, we began investing restricted cash and cash equivalents held in certain regulatory trusts for the benefit of our U.S. cedents in a fixed maturity investment portfolio to improve the yield on the restricted assets that we are unable to invest in Solasglas. The fixed maturity investment portfolio is managed by a third-party investment manager.

Reportable Segments

We have two reportable segments: Open Market and Innovations.

Refer to “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” (herein referred as “MD&A”) for additional information relating to our reportable segments and related underwriting performance and “Part II, Item 8. Note 18 “Segment Reporting” to the consolidated financial statements for further details on our reportable segments and a breakdown of our gross premiums written by geographic area of risks insured.

The following table presents the gross premiums written for the most recent three years:


Year ended December 31,	2025				2024				2023
Open Market	$	652,229	84.3	%	$	603,798	86.5	%	$	504,435	79.2	%
Innovations	121,598		15.7	%	94,725		13.6	%	88,602		13.9	%
Total Segments	773,827		100.1	%	698,523		100.0	%	593,037		93.1	%
Corporate (1)	(566)		(0.1)	%	(188)		—	%	43,773		6.9	%
Total consolidated gross premiums written	$	773,261	100.0	%	$	698,335	100.0	%	$	636,810	100.0	%

(1) Corporate includes gross premiums written from Innovations’ related property runoff business. Negative gross premiums written reflect adjustments to original premium estimate.

Return to table of contents

Open Market Segment

Our Open Market segment is led by our Group CUO, with over 25 years of P&C reinsurance experience. Our Group CUO also oversees the underwriting activities of our Innovations segment (see below).

We provide treaty reinsurance to insurance companies on a global basis, written on a proportional or non-proportional (also known as excess of loss) basis. The Open Market segment has the following lines of business:

•Casualty: includes primarily general liability, umbrella, multiline casualty, and workers’ compensation coverage.

•Financial: includes primarily mortgage, trade credit, surety, transactional liability, and financial multiline coverage.

•Health: includes primarily accident and critical illness coverage.

•Multiline: includes predominantly FAL business, coupled with multiline commercial and personal auto liability, BOP, and multiline commercial coverage.

•Property: includes mainly commercial property and property catastrophe coverage.

•Specialty: includes primarily agriculture, cyber, marine and energy, aviation and space, specialty multiline, and WPVT coverage.

The majority of our Open Market business is produced through reinsurance brokers worldwide. Brokerage distribution channels provide us with access to an efficient, variable cost and global distribution system. In some cases, intermediaries also provide other services, including risk analytics, processing, and clearing.

We aim to build and strengthen long-term relationships with global reinsurance brokers. Our underwriting team has relationships with most primary and specialty broker intermediaries in the reinsurance marketplace. By maintaining close relationships with brokers, we believe that we will continue to obtain access to a broad range of reinsurance clients and opportunities.

We seek to strengthen our broker relationships and become the preferred choice of brokers and clients by providing, where applicable:


			●			demonstrated expertise in the underlying reinsured exposures and the operation of the contracts;
			●			rapid responses to risk submissions;
			●			timely claims payments;
			●			customized solutions that address the specific business needs of our clients;
			●			financial security; and
			●			a clear indication of risks we will and will not underwrite.

We focus on the quality and financial strength of any brokerage firm we conduct business with. Brokers do not have the authority to bind us to any reinsurance contract. Their commissions are generally determined based on a percentage of gross premiums written.

The following table shows the percentage of our Open Market’s gross premiums written by broker, shown individually where a broker accounted for 10% or more of the total, in any of the last three years:


	2025		2024		2023
Aon plc	21.5	%	22.0	%	15.7	%
Marsh & McLennan	20.9	%	19.2	%	24.1	%
Howden Group Holdings	18.1	%	15.3	%	13.4	%
Arthur J. Gallagher & Co	10.0	%	16.8	%	17.6	%
All others and MGAs	29.5	%	26.7	%	29.2	%
Total	100.0	%	100.0	%	100.0	%

Return to table of contents

We frequently meet in the Cayman Islands, Ireland, U.K. and elsewhere with brokers and senior representatives of clients and prospective clients. We review and (when we deem appropriate) approve all contract submissions in the Cayman Islands or Ireland. Due to our dependence on brokers, the inability to obtain business from them could adversely affect our business strategy. See “Item 1A. Risk Factors — Risks Related to Our Business — The loss of significant brokers or customers, could materially and adversely affect our business, financial condition and results of operations.” We may assume a degree of the credit risk of our reinsurance brokers. See “Item 1A. Risk Factors — Risks Related to Our Business — We are subject to the credit risk of our brokers, cedents, agents and other counterparties.”

Our FAL business is generated through our Lloyd’s corporate member (GCM), which represented approximately 36%, 26%, and 35% of our Open Market gross premiums written for the years ended December 31, 2025, 2024, and 2023, respectively.

Innovations Segment

Our Innovations segment is led by our Head of Innovations since 2020, with over 15 years of P&C experience, with the underwriting led by our Innovations Chief Underwriting Officer, with over 22 years of P&C experience.

Innovation-related Investments

We make strategic investments in promising startup companies and MGAs, subject to investment guidelines as approved by our Board of Directors, in addition to providing reinsurance capacity on a case by case basis. These private investments consist primarily of unlisted equities (mostly preferred shares) and debt instruments.

In evaluating Innovations opportunities, we generally ensure that each investment meets at least one of the following criteria:


			●			The value we add to a partnership is derived primarily from the application of our risk expertise, not solely capital or reinsurance support;
			●			The investment provides value to our company in specific risk areas, technology, product innovation, or other areas;
			●			The partnership approach provides access to a pool of capital, products, or distribution;
			●			Overall, the partnership approach creates a combined effort that generates a durable strategic or competitive position in one or more markets and increases our opportunities to achieve revenue growth and margin expansion.

Given the higher-risk nature of early / seed-stage investments, we limit our initial investment to between a range of $0.25-$2.0 million for each investee. See “Item 1A. Risk Factors - Risks Relating to Our Innovations Strategy”

Innovation-related Underwriting

We provide underwriting capacity to our program partners through insurance and reinsurance structures on a global basis, written on a proportional or non-proportional basis. The Innovations segment has the following lines of business:

•Casualty: includes primarily general liability and multiline casualty coverage.

•Financial: includes predominantly miscellaneous financial coverage.

•Health: includes primarily travel and other miscellaneous health coverage.

•Multiline: includes mostly BOP and multiline commercial coverage, in addition to business written via Syndicate 3456 (multiple lines of business).

•Specialty: includes primarily contingency liability and travel-related (e.g. trip cancellation / interruption, baggage and personal effects, and medical insurance) coverage.

Our Innovations underwriting business is sourced from our strategic partners in startup companies and MGAs. Concurrently with our initial investment, in most cases, we enter into a right of first offer to provide underwriting capacity based on a minimum percentage of the business written by the direct client. In some cases, we may not invest capital in the strategic partner but rather provide reinsurance capacity. We also work closely with our strategic partners who wish to attain Lloyd’s coverholder status, which allows them to conduct business with Syndicate 3456. Starting in 2024, as an alternative to the Lloyd’s platform, we also offer to clients the ability to create segregated cells within Viridis Re based in the Cayman Islands, providing them more flexible and cost effective reinsurance solutions.

Return to table of contents

The following table shows the percentage of our Innovations’ gross premiums written by customer, shown individually where a customer accounted for 10% or more of the total, in any of the last three years:


	2025		2024		2023
Customer A	20.0	%	4.8	%	4.5	%
Customer B	10.4	%	—	%	—	%
Customer C	10.2	%	15.1	%	8.9	%
Customer D	5.7	%	22.7	%	15.5	%
Customer E	3.8	%	4.5	%	14.8	%
Customer F	3.5	%	9.6	%	30.4	%
All others	46.4	%	43.3	%	25.9	%
Total	100	%	100	%	100	%

Underwriting and Risk Management

We have established an underwriting platform composed of experienced underwriters and actuaries. We have underwriting operations in three locations: the Cayman Islands, Dublin, Ireland, and London, U.K. These platforms provide access to key markets in the U.S., Europe, Middle East, and Asia. Our experienced team allows us to deploy our capital in various lines of business and capitalize on opportunities that we believe offer favorable returns on equity over the long term. Our underwriters and actuaries have expertise in multiple lines of business. We generally apply the following underwriting and risk management principles:

Economics of Results

Our primary underwriting goal is to build a (re)insurance portfolio that maximizes profitability, subject to risk and volatility constraints.

Underwriting Analysis

Our approach to underwriting analysis begins at the class-of-business level. This analysis includes identifying and assessing the structural drivers of risk and emerging loss trends and understanding the market participants and results, capacity conditions for supply and demand, and other factors. Our underwriting professionals specialize in business lines, and our quantitative professionals (pricing actuaries) assist in evaluating all risks we underwrite. Combined with cross-line management, we believe this approach enables us to build and deploy expertise and insight into the business line’s risk dynamics and external factors that will affect each transaction.

We assign a deal team composed of underwriting and quantitative professionals to evaluate each potential transaction’s pricing and structure. Before committing capital to any transaction, the deal team and the regional Chief Underwriting Officer must obtain approval from at least one of, the CEO, Group CUO, or GRIL’s CUO (except for deals led by the GRIL’s CUO). In seeking this approval, the deal team presents the key components of the proposed transaction, including assumptions and threats, market and individual deal risk factors, market capacity dynamics, transaction structure and pricing, maximum downside, and other factors.

We collaborate with our current and prospective clients and brokers to understand the risks associated with each potential transaction. For most of our business, we follow terms set by recognized market leads. We consider the remainder of our underwriting portfolio, including contracts linked to our Innovations partners or in areas where we have significant market expertise, to be “lead business.” When underwriting lead business, we generally structure the reinsurance agreements to ensure that our cedents’ interests and ours are aligned. Where appropriate, we conduct or contract for on-site audits or reviews of the clients’ underwriting files, systems, and operations. We usually obtain substantial data from our clients to conduct a thorough actuarial modeling analysis. As part of our pricing and underwriting process, we assess, among other factors:

Return to table of contents


			●			the client’s and industry’s historical loss data;
			●			the expected duration for claims to fully develop;
			●			the client’s pricing and underwriting strategies;
			●			the geographic areas in which the client is doing business and its market share;
			●			the reputation and financial strength of the client and its management and underwriting teams;
			●			the reputation and expertise of the broker; and
			●			reports provided by independent industry specialists.

We develop proprietary quantitative models and use several commercially available tools to price our business. Our models consider conventional underwriting and risk metrics and incorporate various class-specific and market-specific aspects from our line-of-business analyses. We use models to evaluate the quantitative work’s quality and predictive power and undertake a detailed assessment of the data quality.

Underwriting Authorities

The Underwriting Committee of our Board of Directors (the “Underwriting Committee”) sets parameters for aggregate property catastrophic caps and limits for maximum loss potential under any individual contract. The Underwriting Committee must approve any exceptions to the established limits. The Underwriting Committee may amend the maximum underwriting authorities periodically to align with our capital base. The Underwriting Committee designs our underwriting authorities to ensure the underwriting portfolio is appropriate on a risk-adjusted basis.

Refer to “Part II, Item 5. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Financial Condition” for a summary of our catastrophe loss exposure in terms of our probable maximum loss (“PML”), net of retrocession and reinstatement premiums, as at January 1, 2026.

Retrocessional Coverage

We opportunistically purchase retrocessional coverage for one or more of the following reasons: to manage our overall catastrophe events or aggregate exposure, reduce our net liability on individual risks, obtain additional underwriting capacity, and balance our underwriting portfolio.

The retrocessional coverage we purchase varies based on numerous factors, including the inherent volatility and risk accumulation of our underwriting portfolio and capital base. Our portfolio, and by extension our gross risk position, will change in size from year to year depending on market opportunities, so it is difficult to predict the level of retrocessional coverage that we will purchase in any future year.

We generally purchase uncollateralized retrocessional coverage from reinsurers with a minimum financial strength rating of “A- (Excellent)” from A.M. Best or an equivalent rating from a recognized rating service. For lower-rated or non-rated reinsurers, we endeavor to obtain and monitor collateral in the form of cash, funds withheld, letters of credit, regulatory trusts, or other collateral in the form of guarantees. At December 31, 2025, the aggregate amount due from reinsurers from retrocessional coverages represented 8.4% (2024: 10.0%) of our gross loss reserves. For further details, please see Note 9 “Retrocession” to the consolidated financial statements.

Claims Management

Our claims management process begins upon receiving claims notifications from our clients or third-party administrators. We review reserving and settlement authority under the individual contract requirements and, as necessary, discuss with the contract’s underwriter. Our in-house claims team oversees claims reviews and approves all claim settlements. Claims above the claims manager’s authority are referred to the General Counsel, Chief Financial Officer (“CFO”), CEO, Chief Actuary, Chief Operating Officer or Group CUO together with the claims officer’s recommendations, for secondary approval. We believe that this process ensures that we pay claims in accordance with each contract's terms and conditions.

Where appropriate, we conduct or contract for on-site claims audits at cedents and third-party administrators, particularly for large accounts, Innovations partners, and those whose performance differs from our expectations. Through these audits, we evaluate and monitor the third-party administrators’ and the ceding companies’ organization and claims-handling practices. These practices include:

Return to table of contents

•fact-finding and investigation techniques;

•loss notifications;

•reserving;

•claims negotiation and settlement;

•adherence to claims-handling guidelines.

The results of these claim reserves are shared with the underwriters and actuaries to assist them in pricing products and establishing loss reserves.

We recognize that the fair interpretation of our reinsurance agreements and timely payment of covered claims are essential components of the service we provide to our clients.

Reserves

Our reserving philosophy is to set reserves at the level representing our best estimate of the amount we will ultimately be required to pay in connection with risks we have underwritten. Our actuarial staff performs quarterly reviews of our portfolio and provides reserving estimates according to our stated reserving philosophy. In doing so, our team groups our portfolio into reserving analysis segments based primarily on homogeneity considerations. Currently, this process involves analysis at the line of business, individual client or transaction level.

We engage an independent actuarial firm who reviews and provides opinions on these reserve estimates at least once a year. Due to the use of different assumptions and loss experience, the amount we establish as reserves with respect to individual risks, clients, transactions, or business lines may be greater or less than those set by our clients or ceding companies. Reserves include claims reported but not yet paid (referred as “case reserves”), additional case reserves (“ACR”), claims incurred but not reported, and claims in the process of settlement. Additional underwriting liabilities include unearned premiums, premium deposits, and profit commissions earned but not yet paid.

Reserves represent an estimate rather than an exact quantification. Although the methods for establishing reserves are well established, many assumptions about anticipated loss emergence patterns are subject to unanticipated fluctuation. We base our estimates on our assessment of facts and circumstances, future trends in claim severity and frequency, judicial theories of liability, and other factors, including inflation, interest rate changes, political risks and the actions of third parties, which are beyond our control.

Another significant component of reserving risk relates to the estimation of losses in the aftermath of a major catastrophe event. Accordingly, we believe the most significant accounting judgment made by management is our estimate of loss and loss adjustment expense reserves. For more information on our reserving process and methodology, refer to the “Critical Accounting Policies and Estimates - Loss and Loss Adjustment Expense Reserves” under “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

See Note 8 “Loss and Loss Adjustment Expense Reserves” of the consolidated financial statements for a reconciliation of claims reserves, loss development tables by accident year, and explanations of significant prior period loss development movements. For a discussion on risk factors relating to loss reserves, see “Item 1A. Risk Factors — Risks Relating to Our Business — If our losses and LAE greatly exceed our loss reserves, our financial condition may be materially and adversely affected.”

Collateral Arrangements and Letter of Credit Facilities

We are primarily licensed and admitted as a reinsurer only in the Cayman Islands and the European Economic Area (the “EEA”). Many jurisdictions, including the United States, do not permit clients to take credit for reinsurance on their statutory financial statements if they obtain such reinsurance from unlicensed or non-admitted insurers without appropriate collateral. As a result, our U.S. clients and some non-U.S. clients require us to provide collateral for the contracts we bind with them. We provide collateral as funds withheld, trust arrangements, or letters of credit (“LOC”). For further information, see Note 10 - “Debt and Credit Facilities” of the consolidated financial statements in “Item 8. Financial Statements and Supplementary Data”.

Return to table of contents

Competition

We compete for reinsurance business in the Cayman Islands and European markets. The global reinsurance market is highly competitive. Competition is generally influenced by a variety of factors, including available capacity, service, financial strength ratings, prior history and relationships, and price. We compete with major global reinsurers, most of which are well-established and have significant operating histories, strong financial strength ratings, and long-standing client relationships. Competitors also provide protection in the form of catastrophe bonds, industry loss warranties, and other risk-linked products that are outside of the traditional reinsurance treaty market. This may lead to reduced pricing and/or reduced participation levels in certain reinsurance products.

Our competitors vary according to the individual market and situation. Generally, they include Arch Capital, Sampo Re, AXIS Capital, Conduit, Everest Re, Fidelis, Hamilton Re, Hannover Re, RenaissanceRe, SiriusPoint, and smaller companies, other niche reinsurers, alternative risk providers (such as captives, catastrophe bonds and other forms of insurance linked securities), and Lloyd’s syndicates and their related entities. Although we seek to provide coverage where capacity and alternatives are limited, we directly compete with these and other larger companies due to the breadth of their coverage across the property and casualty market in substantially all lines of business. See “Item 1A — Risk Factors — Risks Relating to Our Business – Competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit.”

Ratings

On November 13, 2025, A.M. Best upgraded our Financial Strength Rating to “A (Excellent)” and the Long-Term Issuer Credit Ratings of “a” (Excellent) for our principal operating subsidiaries and revised the outlook to stable from positive. We believe a strong rating is important to compete and market reinsurance products to clients and brokers. These ratings reflect the rating agency’s opinion of our reinsurance subsidiaries’ financial strength, operating performance, and ability to meet obligations. It is not an evaluation directed toward the investors’ protection or a recommendation to buy, sell or hold our ordinary shares.

Additionally, A.M. Best assessed our Enterprise Risk Management (“ERM”) practices as appropriate for the Company’s business complexity and overall risk profile.

A.M. Best periodically reviews the financial positions of our operating subsidiaries and therefore our rating may be subsequently revised or revoked by the agency. The failure to maintain at least an “A-” A.M. Best rating may significantly and negatively affect our ability to implement our business strategy. See “Item 1A. Risk Factors — Risks Relating to Our Business — A downgrade or withdrawal of our A.M. Best ratings would materially and adversely affect our ability to implement our business strategy.”

Further, by being part of the Lloyd’s market, Syndicate 3456 benefits from the following four Lloyd’s financial strength ratings: “A+” (Superior) from A.M. Best; AA- (Very Strong) from Fitch Ratings; AA- (Very Strong) from Kroll Bond Rating Agency; and AA- (Very Strong) from Standard & Poor’s.

Regulations

Cayman Islands Insurance Regulation

The legislative framework for conducting insurance and reinsurance business in and from within the Cayman Islands is composed of The Insurance Act, 2010 (as amended) and underlying regulations thereto (the “Act”), which became effective in the Cayman Islands on November 1, 2012.

Greenlight Re holds a Class D insurer license issued in accordance with the terms of the Act and is subject to regulation and supervision by the Cayman Islands Monetary Authority (“CIMA”). Viridis Re holds a Class B insurer license issued in accordance with the terms of the Act and is subject to regulation and supervision by CIMA.

As the holder of an insurer license, each of Greenlight Re and Viridis Re is permitted to carry on reinsurance business from the Cayman Islands but, except with the prior written approval of CIMA, may not carry on any insurance or reinsurance business where the underlying risk originates and resides in the Cayman Islands.

Greenlight Re and Viridis Re are required to comply with the following principal requirements under the Act:

•to maintain capital and a margin of solvency in accordance with the capital and solvency requirements prescribed by the Act;

Return to table of contents

•to carry on its business in accordance with its business plan and the laws of the Cayman Islands, including the regulatory laws, regulations, rules, and statements of guidance, where applicable;

•to maintain a minimum of at least two directors and to seek the prior approval of CIMA in respect of the appointment of directors and officers and to provide CIMA with information in connection therewith and notification of any changes thereto;

•to have a place of business in the Cayman Islands and to maintain such resources, including staff and facilities, books and records as CIMA considers appropriate, having regard for the nature and scale of the business of Greenlight Re;

•to submit to CIMA an annual return in the prescribed form together with:

◦financial statements prepared in accordance with internationally recognized accounting standards, audited by an independent auditor approved by CIMA;

◦an actuarial valuation of its assets and liabilities, certified by an actuary approved by CIMA;

◦certification of solvency prepared by a person approved by CIMA in accordance with the prescribed requirements;

◦confirmation that the information contained in its license application, as modified by any subsequent changes, remains correct and up to date;

◦such other information as may be prescribed by CIMA; and

•to pay an annual license fee.

It is the duty of CIMA:

•to maintain a general review of insurance practices in the Cayman Islands;

•to examine the affairs or business of any licensee or other person carrying on, or who has carried on, insurance business to ensure that the Act has been complied with and that the licensee is in a sound financial position and is carrying on its business in a fit and proper manner;

•to examine and report on the annual returns delivered to CIMA in terms of the Act; and

•to examine and make recommendations with respect to, among other things, proposals for the revocation of licenses and cases of suspected insolvency of licensed entities.

Greenlight Re and Viridis Re are also required to comply with, amongst other standards, the Rule on Corporate Governance for Insurers, the Rule on Risk Management for Insurers, and the Rule on Investment Activities for Insurers and the associated Statement of Guidance, and the Rule and Statement of Guidance on Internal Controls for Regulated Entities. Respectively, these rules require regulated insurers to establish and maintain (a) a corporate governance framework that provides for the sound and prudent management and oversight of the insurer's business, including outsourcing and internal controls, and which adequately recognizes and protects the interests of its policyholders, and (b) a risk management framework that is capable of promptly identifying, measuring, assessing, reporting, monitoring and controlling all sources of risks that could have a material impact on its operations, and (c) implement investment activities that consider all of Greenlight Re’s and Viridis Re’s risks and solvency requirements, and (d) an internal control framework covering: control environment, risk assessment, control activities, information flow, and monitoring.

The Act provides that where CIMA believes a licensee is committing, or is about to commit or pursue, an act that is an unsafe or unsound business practice, CIMA may direct the licensee to cease or refrain from committing the act or pursuing the offending course of conduct. Failure to comply with such a CIMA direction may be punishable on summary conviction by a fine of up to 100,000 Cayman Islands dollars (US$120,000) or to imprisonment for a term of five years or to both, and on conviction on indictment to a fine of 500,000 Cayman Islands dollars (US$600,000) or to imprisonment for a term of ten years or to both and to an additional 10,000 Cayman Islands dollars ( US$12,000) for every day after conviction that the breach continues.

The Monetary Authority Act (“MAA”) also provides CIMA with the authority to impose administrative fines on licensees. The recent Monetary Authority (Administrative Fines) (Amendment) Regulations, 2020 (the “Amendment Regulations”) came into force on 26 June 2020. They extended the scope of the fines CIMA may impose for breaches of a range of regulatory laws, including the Act. Breaches are categorized as minor, serious, or very serious, and, depending on the category of the breach, fines range from $6,100 to $1,220,000 per breach for very serious breaches. Where a breach is committed by a corporate entity and is shown to have been committed with the consent, connivance, knowledge, or neglect of an individual, that individual may also be subject to an administrative fine.

Whenever CIMA believes that a licensee is or may become unable to meet its obligations as they fall due, is carrying on business in a manner likely to be detrimental to the public interest or the interests of its creditors or

Return to table of contents

policyholders, has contravened the terms of the Act or has otherwise behaved in such a manner to cause CIMA to call into question the licensee’s fitness, CIMA may take one of several steps. The steps include requiring the licensee to rectify the matter, suspending the license of the licensee, revoking the license, imposing conditions upon the license and amending or revoking any such condition, requiring the substitution of any director, manager, or officer of the licensee, at the expense of the licensee, appointing a person to advise the licensee on the proper conduct of its affairs and to report to CIMA thereon, at the expense of the licensee, appointing a person to assume control of the licensee’s affairs or otherwise requiring such action to be taken by the licensee as CIMA considers necessary. We have not been subject to any such actions from CIMA to date.

Other Regulations in the Cayman Islands

As Cayman Islands exempted companies, Greenlight Capital Re, Greenlight Re and Viridis Re may not carry on business or trade locally in the Cayman Islands except in furtherance of their business outside the Cayman Islands and are prohibited from soliciting the public of the Cayman Islands to subscribe for any of their securities or debt. These companies are further required to file a return with the Registrar of Companies in January of each year (“Annual Return”) and to pay an annual registration fee at that time. Additionally, these companies must comply with the Proceeds of Crime Act (as revised) and the Anti-Money Laundering Regulations and the Guidance Notes on the Prevention and Detection of Anti-Money Laundering, Terrorist Financing and Proliferation Financing in the Cayman Islands, together the “Anti-Money Laundering Regulations (as revised)” in the Cayman Islands.

Economic substance law requiring a “relevant entity” conducting “relevant activity” to file notifications and, unless exempt, to report to the Tax Information Authority (“TIA”) and maintain economic substance.

The International Tax Co-operation (Economic Substance) Act (as revised) and International Tax Co-operation (Economic Substance) Regulations, 2020, were published on February 5, 2021, and August 11, 2020, respectively, and subsequently amended (together, the “ES Act”). The latest version of the Guidance on Economic Substance for Geographically Mobile Activities (“ES Guidance”) was published in July 2022.

Greenlight Capital Re, Greenlight Re and Viridis Re must confirm their economic substance classification on an annual basis and submit this classification to the TIA as a prerequisite to the Annual Return filing.

The Cayman Islands has no exchange controls restricting dealings in currencies or securities.

Cayman Islands Status with the European Union (“EU”) and Financial Action Task Force (“FATF”) Compliance

The Cayman Islands is a member of the Financial Action Task Force (“FATF”) and, like all member countries, it will from time to time be subject to mutual evaluation reviews which may in turn prompt regulatory changes. The Cayman Islands has completed and satisfied all required action items arising from its 4th round FATF mutual evaluation process. The FATF has commenced the 5th round mutual evaluation process for member countries, and the Cayman Islands will be assessed as part of the 5th round in due course.

Ireland Insurance Regulations

Our Irish subsidiary, GRIL, is authorized as a non-life reinsurance undertaking by the Central Bank of Ireland “CBI” in accordance with the European Union (Insurance and Reinsurance) Regulations 2015 (the "Irish Regulations"). The Irish Regulations give effect in Ireland to EU Directive 2009/138/EC (known as "Solvency II"), which introduced a new European regulatory regime for insurers and reinsurers with effect from January 1, 2016. Solvency II is supplemented by the European Commission Delegated Regulation (EU) 2015/35, other European Commission “delegated acts” and binding technical standards, and guidelines issued by the European Insurance and Occupational Pensions Authority (“Delegated Acts and Guidelines”). GRIL is required to comply at all times with the Irish Regulations, the Irish Insurance Acts 1909 to 2022, regulations relating to insurance business or reinsurance business promulgated under the European Communities Act 1972, the Irish Central Bank Acts 1942 to 2023 as amended, regulations promulgated thereunder and directions, guidelines and codes of conduct issued by the CBI (collectively the “Irish Insurance Acts and Regulations”). In addition, GRIL is required to comply with the Delegated Acts and Guidelines and must meet risk-based solvency requirements imposed under Solvency II on insurers and reinsurers that are authorized in EU/EEA member states to undertake business. Solvency II and the Delegated Acts and Guidelines set out classification and eligibility requirements, including the characteristics that capital, including any capital contribution, must display to qualify as regulatory capital.

Return to table of contents

GRIL is also required to comply with the European Union (Insurance Distribution) Regulations 2018 (the "2018 Regulations"), which apply to distributors of insurance and reinsurance products (including insurers and reinsurers). The 2018 Regulations give effect in Ireland to Directive (EU) 2016/97 (known as the "IDD") and strengthen the regulatory regime applicable to distribution activities through increased transparency, information, and conduct requirements. On May 25, 2018, the General Data Protection Regulation (the "GDPR") came into force across the EU. The GDPR is supplemented and given further effect in Ireland by the Data Protection Acts 1988 to 2018 and by regulations relating to privacy promulgated under the European Communities Act 1972. The GDPR significantly increases organizations’ obligations and responsibilities in collecting, using, storing, and protecting personal data. Organizations in breach of the GDPR may incur sizable financial penalties up to, the higher of €20 million or 4% of annual global turnover.

UK Regulations

Lloyd’s Oversight

Syndicate 3456 is subject to oversight by Lloyd’s, substantially effected through the Lloyd’s Council. Our business plan for Syndicate 3456, including maximum underwriting capacity, requires annual approval by Lloyd’s. Lloyd’s may require changes to any business plan presented to it or additional capital to be provided to support the underwriting plan. We have deposited certain assets and an unsecured LOC with Lloyd’s to support GCM’s underwriting business at Lloyd’s.

By entering into a membership agreement with Lloyd’s, GCM has undertaken to comply with all Lloyd’s by-laws and regulations as well as the provisions of the Lloyd’s Acts 1871 to 1982 and the Financial Services and Markets Act 2000, as amended by the Financial Services Act 2012 and the Financial Services and Markets Act 2023. This arrangement subjects us to the following:


			●			Capital Requirements. The underwriting capacity of a member of Lloyd’s must be supported by providing a deposit, referred to as FAL, in an amount determined on the basis of such entity’s solvency and capital requirements. The amount of such deposit is calculated for each member through the completion of an annual capital adequacy exercise. In addition, if the FAL are not sufficient to cover all losses, the Lloyd’s Central Fund provides an additional level of security for policyholders. Dividends from a Lloyd’s managing agent and a Lloyd’s corporate member can be declared and paid provided the relevant company has sufficient profits available for distribution.
			●			Ratings. The financial security of the Lloyd’s market as a whole is regularly assessed by four independent rating agencies (A.M. Best, S&P, Kroll Bond and Fitch). Syndicates at Lloyd’s take their financial security rating from the rating of the Lloyd’s market. A satisfactory credit rating issued by an accredited rating agency is necessary for Lloyd’s syndicates to be able to trade in certain classes of business at current levels.
			●			Intervention Powers. The Lloyd’s Council has wide discretionary powers to regulate members’ underwriting at Lloyd’s, including, the power to withdraw a member’s permission to underwrite business or to underwrite a particular class of business and to change the basis on which syndicate expenses are allocated.
			●			Assessments. If Lloyd’s determines that the Central Fund needs to be increased, it has the power to assess premium levies on current Lloyd’s members up to 5% of a member’s underwriting capacity in any one year.

Prudential Regulation Authority (“PRA”) and Financial Conduct Authority (“FCA”) Regulation

The PRA is part of the Bank of England and responsible for the prudential regulation and supervision of banks, building societies, credit unions, insurers, and major investment firms authorized in the UK. The FCA has responsibility for market conduct regulation. Lloyd’s as a whole is authorized by the PRA and regulated by both the FCA and the PRA, which both have substantial powers of intervention in relation to regulated firms. Lloyd’s is required to implement certain rules prescribed by the PRA and the FCA. If it appears to either the PRA or the FCA that either Lloyd’s is not fulfilling its delegated regulatory responsibilities or that managing agents are not complying with the applicable regulatory rules and guidance, the PRA or the FCA may intervene at their discretion. To minimize duplication, both regulators have arrangements with Lloyd’s for co-operation on supervision and enforcement.

Return to table of contents

Lloyd’s is subject to an annual PRA solvency test which measures whether Lloyd’s has sufficient assets in the aggregate to meet all outstanding liabilities of its members, both current and run-off. If Lloyd’s fails this test, the PRA may require the entire Lloyd’s market to cease underwriting or individual Lloyd’s members may be required to cease or reduce their underwriting.

Investments

Our Board of Directors reviews our investment portfolio activities and oversees our investment guidelines to meet our investment objectives. These investment guidelines, which may be amended, modified, or waived from time to time, take into account restrictions imposed on us by regulators, our liability mix, requirements to maintain an appropriate claims-paying rating by ratings agencies and requirements of lenders. We believe our predominantly equities-based value-oriented investment approach, while generating returns less predictable than those of a traditional fixed-income portfolios, complements our reinsurance business and will achieve higher rates of return over the long term than reinsurance companies that invest predominantly in fixed-income securities. We have designed our investment guidelines to maintain adequate liquidity to fund our reinsurance operations.

At December 31, 2025, our total investments were $633.1 million, of which 79.7% (2024 - 84.1%) was invested in Solasglas, 10.4% (2024 - nil%) in fixed maturity investments, and 9.9% (2024 - 15.9%) in Innovation-related investments.

Investment in Solasglas

Our investment portfolio is managed by DME Advisors, LP (“DME Advisors”), a value-oriented investment advisor that analyzes companies’ available financial data, business strategies, and prospects to identify undervalued and overvalued securities. DME Advisors is a related party as it is controlled by David Einhorn. Refer to Note 16 “Related Party Transactions” of the consolidated financial statements.

Effective September 1, 2018, we have entered into an amended and restated exempted limited partnership agreement of Solasglas (the “Solasglas LPA”), as amended from time to time, with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, GRIL and the initial limited partner (each, a “Partner”). Effective January 1, 2021, we reduced the maximum Investment Portfolio, as defined in the Solasglas LPA, from 100% to 50% of GLRE Surplus. Subsequently, this cap was raised to 60% effective January 1, 2023, and increased further to 70% on August 1, 2024. We present our investment in Solasglas under the caption “Investment in related party investment fund” in our consolidated balance sheets.

On September 1, 2018, Solasglas entered into an investment advisory agreement (the “IAA”) with DME Advisors, with an initial term ending on August 31, 2023, subject to automatic extensions for successive three-year terms. DME Advisors has the contractual right to manage substantially all of our investable assets and is required to follow our investment guidelines and act in a fair and equitable manner in allocating investment opportunities to Solasglas. However, DME Advisors is not otherwise restricted with respect to the nature or timing of making investments for Solasglas.

DME Advisors receives a monthly management fee at an annual rate of 1.5% of each limited partner’s Investment Portfolio, as provided in the Solasglas LPA. DME II receives a performance allocation based on the positive performance change of each limited partner’s capital account equal to 20% of net profits calculated per annum, subject to a loss carryforward provision.

The loss carryforward provision allows DME II to earn a reduced performance allocation of 10% on net profits in any year after the year in which a limited partner’s capital account incurs a loss until the limited partner has recouped all losses and has earned an additional amount equal to 150% of the loss. DME II is not entitled to a performance allocation in a year in which a capital account incurs a loss. At December 31, 2025, we estimate the reduced performance allocation of 10% to continue to be applied until Solasglas achieves additional investment returns of 66.6%, at which point the performance allocation will revert to 20%.

Return to table of contents

DME Advisors is required to follow our investment guidelines and act in a manner that it considers fair and equitable in allocating investment opportunities to us and Solasglas. However, the IAA does not otherwise impose any specific obligations or requirements concerning the allocation of time, effort, or investment opportunities to us and Solasglas or any restrictions on the nature or timing of investments for our or Solasglas’ account or other accounts that DME Advisors or its affiliates may manage. DME Advisors can outsource to sub-advisors without our consent or approval. If DME Advisors and any of its affiliates attempt to invest in the same opportunity simultaneously, DME Advisors and its affiliates may allocate the opportunity as they determine reasonably. Affiliates of DME Advisors presently serve as the general partner or the investment advisor of Greenlight Capital LP, Greenlight Capital Offshore, Ltd., GCOI Intermediate, LP, Greenlight Capital Offshore Master, Ltd., Greenlight Masters, LP, Greenlight Masters Qualified, LP, Greenlight Masters Offshore, Ltd., Greenlight Masters Offshore I, Ltd., Greenlight Masters Offshore Partners, Greenlight Masters Partners and several separately managed accounts (collectively, the “Greenlight Funds”).

We have agreed to use commercially reasonable efforts to cause all our current and future subsidiaries to enter into the Solasglas LPA. Under the Solasglas LPA, we are contractually obligated to use commercially reasonable efforts to cause substantially all investable assets of Greenlight Re and GRIL, with limited exceptions, to be contributed to Solasglas.

We have agreed to release DME II and DME Advisors and their affiliates from any liability arising out of the IAA or the Solasglas LPA, subject to certain exceptions. Furthermore, DME II has agreed to indemnify us against any liability incurred in connection with certain actions.

Under the Solasglas LPA, either GLRE Limited Partner may voluntarily withdraw all or part of its capital account for its operating needs by giving DME II at least three business days’ notice. Either of the GLRE Limited Partners may withdraw as a partner and fully withdraw all of its capital account from Solasglas on three business days’ notice if the limited partner’s board declares that a cause for withdrawal exists as per the Solasglas LPA.

Investment Strategy

DME Advisors implements a value-oriented investment strategy by taking long positions in perceived undervalued securities and short positions in perceived overvalued securities. DME Advisors aims to achieve high absolute returns while minimizing the risk of capital loss. DME Advisors attempts to determine the risk/return characteristics of potential investments by analyzing factors such as the risk that expected cash flows would not be achieved, the volatility of the cash flows, the leverage of the underlying business, and the security’s liquidity, among others.

DME Advisors is contractually obligated to adhere to our investment guidelines and make investment decisions on our behalf. These decisions may include buying publicly listed equity securities and corporate debt, selling securities short, and investing in private placements, futures, currencies, commodities, swaps, sovereign debt, derivatives, and other instruments.

Investment returns for Solasglas

In accordance with the Solasglas LPA, DME Advisors constructs a levered investment portfolio as agreed with the Company (the “Investment Portfolio” as defined in the Solasglas LPA). Investment returns, net of all fees and expenses, by quarter for the last five years are as follows:


Quarter	2025		2024		2023		2022		2021
1st	7.2	%	5.2	%	(1.1)	%	1.7	%	1.5%
2nd	(4.0)		1.2		10.9		4.9		(0.9)
3rd	(3.2)		5.2		(0.6)		3.6		(2.7)
4th	7.9		(1.9)		0.3		13.4		9.9
Full Year	7.5	%	9.8	%	9.4	%	25.3	%	7.5	%

The above investment returns are calculated monthly and compounded to calculate the quarterly and annual returns generated by our Investment Portfolio. Past performance is not necessarily indicative of future results. The monthly investment return is calculated by dividing the investment income/loss (net of fees and expenses) by the Investment Portfolio.

Return to table of contents

Fixed Maturity Investments

Our fixed maturity investments consist of the following:


	2025
Third-party managed portfolio	$	53,029	81%
Liquidity fund	12,580		19%
Total fixed maturity investments	$	65,609	100%

Third-Party Managed Portfolio

Starting in the fourth quarter (“Q4”) 2025, we began investing a portion of our restricted cash and cash equivalents held in regulatory trusts to a fixed maturity investment portfolio managed by a third party investment manager. These asset are held for the benefit of our U.S. cedents in connection with reinsurance agreements and are therefore restricted.

The funds are invested in fixed maturity securities subject to the investment guidelines of the respective trusts and the Company’s fixed-income investment guidelines as established by our Board of Directors. This enables us to leverage the expertise of a reputable investment manager specializing in fixed maturity investments to generate higher risk-adjusted returns relative to maintaining funds as restricted cash and cash equivalents.

Liquidity Fund

Starting in Q4 2025, we also transferred the cash held by Syndicate 3456 into a liquidity fund approved by Lloyd’s (“Liquidity fund”), to generate higher yields on liquid assets.

Innovation-related Investments

See “Innovations Segment” within this Item 1. Business for further information.

For further information about our total investments and related investment income, refer to “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Financial Condition” and “Note 3 - Investments in Related Party Investments Fund and Note 5 - Other Investments” of the consolidated financial statements.

Enterprise Risk Management

Enterprise risk management (“ERM”) is at the core of our corporate culture and is a shared responsibility across all business functions. Our ERM processes are in place to accurately identify, assess, manage, and monitor risks in line with our strategic objectives and risk appetite.

We maintain an Executive Risk Committee (ERC) which oversees the ERM function and is responsible for the design and review of risk management framework (RMF), comprised of various members of our executive team. The Board of Directors approves the RMF on an annual basis or as appropriate.

The RMF sets out the risk management roles and responsibilities for all stakeholders across the organization, and sets the quantitative and qualitative metrics of our risk appetite, risk monitoring, and risk mitigation measures. Risk metrics from risk owners are gathered and collated on at least a quarterly basis and a risk grid is presented to the ERC and the Audit Committee of the Board of Directors.

One of the key objectives of our ERM function is to ensure that our underwriting efforts comply with explicitly stated underwriting appetite. We establish limits to balance our risk position size with our expertise while containing the cost of incorrectly assessing risks and rewards. We believe that an informed, disciplined risk selection approach ties directly into our business strategy. To achieve this, we encourage a collaborative, open work environment and group decision making. We closely monitor our accumulations of exposure and frequently review our investment and underwriting portfolios to assess the impact on capital under stressed scenarios. With the assistance of DME

Return to table of contents

Advisors, we analyze our investment assets and liabilities, including the numerous risk components in our portfolio, such as concentration and liquidity risks.

We strive to encourage a culture of operational risk management, providing training and resources to all staff, maintaining robust business continuity protocols, and establishing HR practices to motivate and retain talent. We maintain and closely monitor our outsourcing, regulatory, and anti-money laundering policies and procedures.

Information Technology (“IT”)

We employ a cloud-centric IT strategy, which allow us to scale our infrastructure dynamically based on demand. The strategy prioritizes the use of cloud services for hosting applications, data storage, and other IT resources. With the use of cloud-based services, our security and systems reliability have proven cost-effective and have provided the required levels of service and redundancy.

We have implemented backup procedures to ensure that key services are saved daily and can be restored as needed.

We have a disaster recovery plan for our IT infrastructure that includes data and system snapshots with restore points. We conduct regular disaster recovery testing, and can access our core systems with minor outages and restore our primary systems within our mean time to restore (MTTR).

We are also monitoring use and potential uses of artificial intelligence (AI) tools across our business, and recently implemented an AI Usage Policy in order to establish guidelines for the ethical, secure, and compliant use of AI platforms by our employees in connection with our business.

We protect our information systems with physical, electronic, and software safeguards considered appropriate by our management. We employ a specialist vendor to continuously monitor our systems for security events and risks within our network. We regularly provide security risk awareness education and training to our staff and to the Board of Directors. Despite these efforts, computer viruses, hackers, employee misuse or misconduct, and other internal or external hazards could expose our data systems to security breaches, cyber-attacks, or other disruptions. Refer to “Item 1C. Cybersecurity” for more information on our cybersecurity risk management.

See “Part I, Item 1A. Risk Factors — Risks Related to Our Business — Modeling risks are inherent in our business.” and “— Technology breaches or failures, including those resulting from a malicious ransomware or cyber-attack on us or our business partners and service providers, could disrupt or otherwise negatively impact our business.”

Human Capital Management

Human Capital & Company Core Values

Our employees are our most valuable asset and are core to our success. We are focused on building a performance and results-driven culture, which strives to get the best out of all employees and to help them to maximize their full potential. We believe in fostering an open and collaborative culture that encourages employees to take ownership of their performance and development. Our executive management team and Board of Directors are committed to creating an environment where every employee can succeed. In late 2024 we formalized the following set of core values that reflect how our colleagues should strive to operate and behave across the Company, regardless of location, level, or function: Nimble, Innovative, Excellence, Accountable, and Collaborative. We took steps throughout 2025 to embed these core values into all aspects of our culture through such areas as employee onboarding, reviews and recognition programs.

Diversity

As of December 31, 2025, 42% of our total global employees were female. In January 2025, we conducted a survey completed by 83% of our employees, with approximately 33% of employees self-identifying as racially or ethnically diverse.

Return to table of contents

Employees

At December 31, 2025, we had 84 total employees worldwide, including internship and part-time employees, 41 of whom were based in Grand Cayman, Cayman Islands, 25 in Dublin, Ireland, and 18 in London, United Kingdom. From time to time, we also engage consultants and contract with third parties, as needed, to provide additional resources to support our business activities.

Talent Development

We recognize that our strength lies in our people and therefore we strive to hire talented people and invest significantly in our employees’ professional development and personal growth. We have implemented an employee training and development policy to encourage our employees to take advantage of training and development opportunities.

We also invest in the professional growth of our leaders through customized executive training to build advanced skills and capabilities.

Compensation Practices

We have designed our performance-driven compensation policy to attract, motivate, reward and retain the best people. We use short-term compensation composed of base salary and annual cash bonuses and long-term compensation composed of stock options, restricted share units, and restricted shares, as applicable, to align our employees’ and executive officers’ interests with those of our shareholders. In addition, from time to time and under certain circumstances, we award sign-on bonuses, retention bonuses, and other bonus opportunities. We also offer welfare benefits and other perquisites, including a defined contribution pension plan and medical insurance coverage for our employees. As part of our commitment to supporting our employees, we match certain contributions made by our employees to charities and not-for-profit organizations.

We believe our employees are fairly compensated without regard to gender, race, and ethnicity.

Work Environment

We are committed to the health, safety and wellness of our workforce, including maintaining a workplace free from discrimination and harassment. Each of our employees annually acknowledges complying with our Code of Business Conduct and Ethics, which provides employees with access to an anonymous whistleblower hotline to report any violations. Our Code of Business Conduct and Ethics is available on our website.

Additional Information

Our website address is www.greenlightre.com, and we make available, free of charge, on or through our website, links to our Annual Reports, quarterly reports on Form 10-Q, current reports on Form 8-K, and other documents we file with or furnish to the SEC, as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. Information contained on our website is not incorporated by reference into this Annual Report.

Glossary of Selected Reinsurance Terms


Accident & Health insurance						Insurance against loss by illness or bodily injury. Health insurance provides coverage for medicine, visits to the doctor or emergency room, hospital stays, and other medical expenses.
Acquisition costs						Ceding commissions, profit commissions, brokerage fees, premium taxes, and other direct expenses relating directly to premium production.
Acquisition cost ratio						The acquisition cost ratio is calculated by dividing net acquisition costs by net premiums earned.
Actuary						A person professionally trained in the mathematical and technical aspects of insurance and related fields, particularly in calculating premiums, loss reserves, and other values.

Return to table of contents


Aviation and space coverage						Aviation covers loss of or damage to an aircraft and the aircraft operations’ liability to passengers, cargo and hull as well as to third parties. Space covers damage to a satellite during launch and in orbit.
BOP coverage						Business owners’ policy (BOP) coverage is designed for small to mid-size businesses and generally combines several key coverages into one policy, including general liability, commercial property, and business interruption.
Broker						An intermediary who negotiates contracts of insurance or reinsurance, receiving a commission for placement and other services rendered, between (1) a policyholder and a primary insurer, on behalf of the policyholder, (2) a primary insurer and a reinsurer, on behalf of the primary insurer, or (3) a reinsurer and a retrocessionaire, on behalf of the reinsurer.
Capacity						Capacity is the percentage of surplus that an insurer or reinsurer is willing or able to place at risk or the dollar amount of exposure it is willing to assume. Capacity may apply to a single risk, a program, a business line, or an entire book of business. Capacity may be constrained by legal restrictions, corporate restrictions, or indirect financial restrictions such as capital adequacy requirements.
Casualty reinsurance						Casualty reinsurance is primarily concerned with the losses caused by injuries to third persons (persons other than the policyholder) and the legal liability imposed on the policyholder resulting therefrom. Casualty reinsurance includes but is not limited to workers’ compensation, automobile liability, and general liability. A greater degree of unpredictability is generally associated with casualty risks known as ‘‘long-tail risks,’’ where losses take time to become known, and a claim may be separated from the circumstances that caused it by several years. An example of a long-tail casualty risk includes the use of certain drugs that may cause cancer or birth defects. There tends to be a greater delay in the reporting and settlement of casualty reinsurance claims due to the long-tail nature of the underlying casualty risks and their greater potential for litigation.
Catastrophe						A severe loss of at least $5 million, typically involving multiple claimants. Common perils include earthquakes, hurricanes, tsunamis, hailstorms, tornados, derechos, severe winter weather, floods, fires, explosions, volcanic eruptions, and other natural or human-made disasters. Catastrophe losses may also arise from acts of war, acts of terrorism, and geopolitical instability.
Cede; cedent						When a party reinsures its liability to another party, it ‘‘cedes’’ business to the reinsurer and is referred to as the ‘‘client.’’
Claim						Request by an insured or reinsured for indemnification by an insurance or reinsurance company for loss incurred from an insured peril or event.
Client						A party whose liability is reinsured by a reinsurer, also known as a cedent.
Combined ratio						The combined ratio is the sum of the loss ratio, acquisition cost ratio, and underwriting expense ratio.
Composite ratio						The composite ratio is the ratio of underwriting losses incurred, loss adjustment expenses, and acquisition costs, excluding underwriting-related general and administrative expenses, to net premiums earned, or equivalently, the sum of the loss ratio and acquisition cost ratio.
Contingency liability coverage						Covers event cancellation and non-appearance.
Corporate expenses						Corporate expenses include those costs associated with operating as a publicly listed entity and an allocation of other general and administrative expenses.
Delegated authority						A contractual arrangement between an insurer or reinsurer or an agent whereby the agent is authorized to bind insurance or reinsurance on behalf of the insurer or reinsurer. The authority is generally limited to a particular class or classes of business and a particular territory. The exercise of the authority to bind insurance or reinsurance is generally subject to underwriting guidelines and other restrictions such as maximum premium income. Under the delegated authority, the agent is responsible for issuing policy documentation, the collection of premium and may also be responsible for the settlement of claims.
Deposit assets and liabilities						Assets (or liabilities) representing the consideration paid (or received) in connection with contracts that do not incorporate sufficient risk transfer to merit reinsurance accounting.

Return to table of contents


Development						The difference between the amount of reserves for losses and loss adjustment expenses initially estimated by an insurer or reinsurer and the amount re-estimated in an evaluation at a later date.
Excess of loss reinsurance						Reinsurance that indemnifies the reinsured against all or a specified portion of losses above a specified dollar or percentage loss ratio amount.
Financial strength rating						The opinion of rating agencies regarding an insurance or reinsurance company’s financial ability to meet its financial obligations under its policies.
Funds at Lloyd’s (FAL)						Funds of an approved form that are lodged and held in trust at Lloyd's as security for a member’s underwriting activities. They comprise the member’s deposit, personal reserve fund, and special reserve fund. They may be drawn down if the member’s syndicate-level premium trust funds are insufficient to cover its liabilities. The amount of the deposit is related to the member's premium income limit and also the nature of the underwriting account.
Gross premiums written						Total premiums for assumed reinsurance during a given period.
Health insurance						Insurance against loss by illness or bodily injury. Health insurance covers medicine, visits to the doctor or emergency room, hospital stays, and other medical expenses.
Incurred but not reported (IBNR)						Reserves for estimated loss and loss adjustment expenses incurred by insureds and reinsureds but not yet reported to the insurer or reinsurer, including unknown future developments on loss and loss adjustment expenses known to the insurer or reinsurer.
Large event loss						A significant event loss of at least $1 million but less than $5 million.
Lloyd’s						Depending on the context, this term may refer to - (a) the society of individual and corporate underwriting members that insure and reinsure risks as members of one or more syndicates. Lloyd’s is not an insurance company; (b) the underwriting room in the Lloyd’s Building in which managing agents underwrite insurance and reinsurance on behalf of their syndicate members. In this sense, Lloyd’s should be understood as a marketplace; or (c) the Corporation of Lloyd’s, which regulates and provides support services to the Lloyd’s market.
Loss adjustment expenses (LAE)						The expenses of settling claims, including legal and other fees, and the portion of general expenses allocated to claim settlement costs. Also known as claim adjustment expenses.
Loss ratio						The loss ratio is calculated by dividing net loss and loss adjustment expenses incurred by net premiums earned.
Loss reserves and loss adjustment expense reserves						Liabilities established by insurers and reinsurers to reflect the estimated cost of claims payments and the related expenses that the insurer or reinsurer will ultimately be required to pay in respect of insurance or reinsurance contracts it has written. Reserves are established for losses and loss adjustment expenses and consist of reserves established for individual reported claims and incurred but not reported losses.
Marine & energy coverage						Covers damage to ships and goods in transit, marine liability lines and yacht-owned perils. Energy includes offshore energy industry insurance. Offshore energy covers losses relating to offshore oil, gas, and renewable energy operations.
Multi-line						Contracts that cover more than one line of business.
Mortgage coverage						Covers credit risks that compensates insureds for losses arising from mortgage loan defaults.
Net financial impact						The net impact of prior period loss development after taking into account net losses and loss expenses incurred, earned reinstatement premiums assumed and ceded, and adjustments to assumed and ceded acquisition costs and profit commissions.
Net premiums written						An insurer’s gross premiums written, less premiums ceded to reinsurers.
Non-admitted insurers						An insurer not licensed to do business in the jurisdiction in question. Also known as an unauthorized insurer and unlicensed insurer.
Premiums; written, earned, and unearned						Premiums represent the cost of insurance paid by the cedent or insured to the insurer or reinsurer. Written represents the total amount of premiums received, and earned represents the amount recognized as income over a period of time. Unearned is the difference between written and earned premiums.

Return to table of contents


Probable maximum loss (PML)						PML is the anticipated loss, taking into account contract terms and limits, caused by a natural catastrophe affecting a broad geographic area, such as that caused by an earthquake or hurricane.
Professional liability insurance						Professional liability insurance protects a company and its representatives against legal claims arising from error or misconduct in providing or failing to provide professional services. This coverage includes errors and omissions policies, directors and officers coverage, and specialty coverage like employment practices liability insurance.
Profit commission						A commission paid by a reinsurer to a ceding insurer based on a predetermined percentage of the profit realized by the reinsurer on the ceded business.
Property insurance						Property insurance covers a business’s building and its contents—money and securities, records, inventory, furniture, machinery, supplies, and even intangible assets such as trademarks—when damage, theft, or loss occurs.
Property catastrophe reinsurance						Property catastrophe reinsurance contracts are typically ‘‘all risk’’ in nature, protecting against losses from natural and human-made catastrophes. Losses on these contracts typically stem from direct property damage and business interruption.
Proportional reinsurance						All forms of reinsurance in which the reinsurer shares a proportional part of the original premiums and losses of the reinsured. In proportional reinsurance, the reinsurer generally pays the client a ceding commission. The ceding commission is generally based on the client’s cost of acquiring the business being reinsured (including commissions, premium taxes, assessments, and miscellaneous administrative expenses) and may include a profit component. Frequently referred to as quota-share reinsurance.
Quota-share reinsurance						A form of proportional reinsurance in which the reinsurer assumes an agreed percentage of each underlying insurance contract being reinsured.
Reinstatement premium						Premium charged for the reinstatement of the amount of reinsurance coverage to its full amount otherwise reduced as a result of a reinsurance loss payment.
Reinsurance						An arrangement in which a reinsurer agrees to indemnify an insurance company, the client, against all or a portion of the insurance risks underwritten by the client under one or more policies. Reinsurance can provide a client with several benefits, including reducing net liability on individual risks and catastrophe protection from large or multiple losses. Reinsurance also provides a client with additional underwriting capacity by permitting it to accept larger risks and write more business than would be possible without a related increase in capital and surplus, and facilitates the maintenance of acceptable financial ratios by the client. Reinsurance does not legally discharge the client from its liability with respect to its obligations to the insured.
Reinsurer						An insurance company that assumes part of the risk in exchange for part of the premium to a primary insurer.
Retrocession; retrocessional coverage						A transaction whereby a reinsurer cedes to another reinsurer, commonly referred to as the retrocessionaire, all or part of the reinsurance that the first reinsurer has assumed. Retrocessional reinsurance does not legally discharge the ceding reinsurer from its liability with respect to its obligations to the reinsured.
Risks						A term used to denote the physical units of property at risk or the object of insurance protection that are not perils or hazards. Also defined as chance of loss or uncertainty of loss.
Risk-free rate						The interest rate on a riskless or safe asset, usually taken to be a short-term U.S. government security.
Risk transfer						The shifting of all or a part of a risk to another party.
Severity business						Insurance/reinsurance characterized by contracts containing the potential for significant losses emanating from one event.
Surety and fidelity insurance						Surety and fidelity insurance includes (1) insurance guaranteeing the fidelity of persons holding positions of public or private trust; (2) insurance guaranteeing the performance of contracts other than insurance policies and guaranteeing and executing bonds, undertakings, and contracts of suretyship; and (3) insurance indemnifying banks, bankers, brokers, financial or moneyed corporations or associations against loss.

Return to table of contents


System and Organizational Controls (SOC) 2 Type II Report (“SOC 2 Report”)						It is a reporting framework developed by the American Institute of Certified Public Accountants (“AICPA”) for independent audits of controls over information and systems relevant to security, availability, processing integrity, confidentiality, and privacy.
Syndicate						A member or group of members underwriting (re)insurance business at Lloyd’s through the agency of a managing agent or substitute agent to which a syndicate number is assigned.
Trade credit coverage						Covers short-term commercial credit insurance, including pre-agreed domestic and export sales of goods and services with typical coverage periods of 60 to 120 days.
Transactional liability coverage						Covers financial losses relating to mergers and acquisitions arising from unforeseen risks, including potential breaches, misrepresentations, or undisclosed liabilities.
Treaty						A reinsurance agreement covering a book or class of business that is automatically accepted on a bulk basis by a reinsurer. A treaty contains common contract terms along with a specific risk definition, data on limit and retention, and provisions for premium and duration.
Underwriter						An insurance or reinsurance company employee who examines, accepts, or rejects risks and classifies risks to charge an appropriate premium for each accepted risk.
Underwriting						The process of evaluating, defining, and pricing reinsurance risks including, where appropriate, the rejection of such risks, and the acceptance of the obligation to pay the reinsured under the terms of the contract.
Underwriting expense						Underwriting expenses include those expenses directly related to underwriting activities that are not eligible to be capitalized and an allocation of other general and administrative expenses.
Underwriting expense ratio						The underwriting expense ratio includes those expenses directly related to underwriting activities and an allocation of other general and administrative expenses. Therefore, the underwriting expense ratio is the ratio of underwriting expenses to net premiums earned. The underwriting expense ratio also incorporates interest income and expenses from deposit-accounted contracts.
Workers’ compensation insurance						Workers’ compensation insurance provides medical, disability, and lost-wage benefits to employees for injuries and illness sustained in the course of their employment.
WPVT coverage						Covers losses relating to war, political violence, and terrorism.

Return to table of contents

ITEM 1A. RISK FACTORS

The following risk factors could result in a significant or material adverse effect on our results of operations or financial condition.

Risks Relating to Our Business

Our results of operations fluctuate from period to period and may not be indicative of our long-term prospects.

Our results of operations fluctuate from period to period due to a variety of factors, including:


			●			our assessment of the quality of available reinsurance and renewal opportunities;
			●			loss experience on our reinsurance contracts;
			●			reinsurance contract pricing;
			●			the volume and mix of reinsurance products we underwrite; and
			●			our ability to assess and integrate our risk management strategy.

Accordingly, our short-term results of operations may not be indicative of our long-term prospects.

If our losses and LAE greatly exceed our loss reserves, our financial condition may be materially and adversely affected.

Our results of operations and financial condition depend upon our ability to accurately assess the potential losses and loss adjustment expenses associated with the risks we reinsure. Reserves are liabilities established by insurers and reinsurers to reflect the estimated cost of claims payments and the related expenses that the insurer or reinsurer will ultimately be required to pay in respect of insurance or reinsurance contracts it has written. We estimate these reserves based upon facts and circumstances then known, estimates of future trends in claim severity, and other variable factors. The inherent uncertainties associated with estimating loss reserves are generally greater for reinsurance companies than for primary insurance companies due primarily to:


			●			the lapse of time from the occurrence of an event to the reporting of the claim and the ultimate resolution or settlement of the claim;
			●			the settlement delays associated with the reporting delays;
			●			the diversity of development patterns among different types of reinsurance treaties;
			●			the necessary reliance on clients for information regarding claims; and
			●			other macro-economic changes which may impact reserves generally.

Our reserve estimates may be less reliable than the reserve estimations of a reinsurer with a greater volume of business and more established loss history. Actual losses and loss adjustment expenses paid may deviate substantially from the estimates of our loss reserves contained in our financial statements and could negatively affect our results of operations. If we determine our loss reserves to be inadequate, we will increase our loss reserves with a corresponding reduction in our net income and capital in the period in which we identify the deficiency. If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be materially and adversely affected. For a summary of the effects of reserve re-estimation on prior year reserves and net income, see “Part II. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates, Loss and Loss Adjustment Expense Reserves”.

Our property and casualty reinsurance operations make us vulnerable to losses from catastrophes and may cause our results of operations to vary significantly from period to period.

Certain of our reinsurance operations expose us to claims arising out of unpredictable catastrophic events, including losses from severe weather and other natural catastrophes and man-made disasters such as acts of war or terrorism. The incidence and severity of catastrophes are inherently unpredictable, with climate change continuing to add to such unpredictability as well as increasing the frequency and severity of events. To the extent climate

Return to table of contents

change produces extreme changes in temperatures and weather patterns, it could impact the frequency or severity of weather including, but not limited to, hurricanes, tornadoes, freezes, droughts, other storms, and wildfires. These changes in weather patterns could also affect the frequency and severity of other natural catastrophe events to which we may be exposed. Further, such catastrophes could impact the affordability and availability of homeowners insurance, which could impact pricing. Additionally, increases in the value and geographic concentration of insured property, particularly along coastal regions, could cause the cost of such losses to increase.

Catastrophic losses are a function of the insured exposure in the affected area and the event’s severity. Claims from catastrophic events could cause substantial volatility in our financial results for any fiscal quarter or year and could materially and adversely affect our business, financial condition and results of operations.

Finally, given the scientific uncertainty of predicting the effect of climate cycles and global climate change on the frequency and severity of natural catastrophes and the lack of adequate predictive tools, we may not be able to adequately model the associated exposures and potential losses in connection with such catastrophes which could have a material adverse effect on our business, financial condition or operating results.

We may need additional capital in the future in order to operate our business, and such capital may not be available to us or may not be available to us on favorable terms.

We may need to raise additional capital in the future through public or private equity or debt offerings or otherwise in order to:



			●			fund liquidity needs or replace lost capital resulting from underwriting or investment losses;
			●			meet rating agency capital requirements;
			●			satisfy collateral requirements that may be imposed by our clients or by regulators;
			●			meet applicable statutory jurisdiction requirements; or
			●			respond to competitive pressures.

Additional capital may not be available on terms favorable to us, or at all. Increases in interest rates could result in higher interest expense on debt. Further, any additional capital raised through the sale of equity could dilute existing ownership interest in our company and may cause the market price of our ordinary shares to decline. Additional capital raised through the issuance of debt may result in creditors having rights, preferences, and privileges senior or otherwise superior to those of our ordinary shares.

Competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit.

The reinsurance industry is highly competitive. We compete with major reinsurers, many of which have substantially greater financial, marketing, and management resources than we do, as well as smaller companies, other niche reinsurers, alternative risk providers (such as captives, catastrophe bonds and other forms of insurance linked securities), and Lloyd’s syndicates and their related entities. Competition in the types of business that we underwrite is based on many factors, including:


			●			the perceived financial strength and general reputation of the reinsurer, including its level of service, trustworthiness, business practices, and other subjective matters;
			●			ratings assigned by independent rating agencies;
			●			relationships with reinsurance brokers;
			●			pricing (for instance, significant capacity continues to enter into the market in the form of insurance linked securities, which may have the potential to impact and/or reduce reinsurance pricing and rates);
			●			terms and conditions of products offered;
			●			speed of claims payment; and
			●			the experience and reputation of the members of our underwriting team in the particular lines of reinsurance we seek to underwrite.

We cannot assure you that we will be able to continue to compete successfully in the reinsurance market. Our failure to continue to compete effectively could materially and adversely affect our financial condition and results of

Return to table of contents

operations, and may increase the likelihood that we will be deemed a passive foreign investment company or an investment company. See “— Risks Relating to Taxation — United States persons who own ordinary shares may be subject to United States federal income taxation on our undistributed earnings and may recognize ordinary income upon disposition of ordinary shares.” and “—Risks Relating to Insurance and Other Regulations — We are subject to the risk of possibly becoming an investment company under U.S. federal securities law.”

Consolidation in the reinsurance industry could adversely affect us.

The reinsurance industry, including our competitors, customers, and insurance and reinsurance brokers, has experienced significant consolidation over the last several years. Consolidated entities may try to use their enhanced market power to negotiate price reductions for our products and services. If competitive pressures reduce our prices, we would expect to write less business. If the insurance industry further consolidates, competition for customers may intensify, and the importance of acquiring and servicing each customer may become greater. We could incur greater expenses relating to customer acquisition and retention, further reducing our operating margins. In addition, insurance companies that merge may be able to spread their risks across a larger capital base so that they require less reinsurance. The number of companies offering retrocessional reinsurance may decline. Reinsurance intermediaries could also consolidate, potentially adversely impacting our ability to access business and distribute our products. We could also experience more robust competition from larger, better-capitalized competitors. Any of the foregoing could materially and adversely affect our business, financial condition and results of operations.

Challenging economic or political conditions may adversely impact our results of operations or financial condition.

Our results of operations and financial condition may be materially adversely affected by a challenging economic market, such as a highly inflationary environment. Inflation can be caused by any number of factors including, but not limited to, expansionary monetary policy and deficit spending by the government, a growing economy, rising wages, an imbalance of the supply and demand for goods, supply chain disruptions and the imposition of tariffs. Recently, for instance, the U.S. administration imposed and/or announced (and in some cases postponed or changed) tariffs on imports from various countries and on certain products, which may lead to unpredictable economic consequences including inflation or trade wars. Our operations are susceptible to inflation, and underestimating inflation levels could result in underpricing the risks we reinsure because premiums are established before the ultimate amounts of losses and LAE are known. While we consider the potential effects of inflation when setting premium rates, our premiums may not fully offset the ultimate effects of inflation. Additionally, our reserving models include assumptions about future payments for the settlement of claims and claims-handling expenses, such as the value of replacing property, associated labor costs for the property business we write, and litigation costs. The global inflationary environment in the last few years has resulted in an increase in our projected future claim costs, resulting in adverse loss reserve development. While the global inflationary pressures have abated from their recent highs, any subsequent increase in inflation may lead to an increase in our loss reserves with a corresponding reduction in net income in the period the deficiency is identified, which may have a material adverse effect on our results of operations and financial condition. Unanticipated higher inflation could also lead to higher interest rates, potentially negatively impacting the value of any rate-sensitive financial instruments held by Solasglas and could also impact our Innovations investments and cause us to incur higher interest expense on our debt. See “—Risks Related to Our Solasglas Investment Strategy” and “—Risks Related to Our Innovations Strategy.”

Further, our results of operations and financial condition may also be materially adversely affected by a challenging political climate, including events such as military actions, invasions, wars, civil unrest and terrorist activities and the imposition of sanctions and importation limitations. For example, the ongoing conflict between Russia and Ukraine and the resulting responses have led to disruption, instability and volatility in global markets and industries. Although the severity and duration of the ongoing Ukraine conflict is impossible to predict, the continuing active conflict could lead to further economic uncertainty, represented by significant and prolonged volatility in commodity prices, credit and capital markets, as well as supply chain interruptions. Due to the widespread impact of the ongoing conflict, it is likely to indirectly impact the markets in which we operate.

Return to table of contents

Emerging claim and coverage issues have had and may continue to adversely impact our business and results.

As industry practices and social, political, legal, judicial, and regulatory conditions change, unexpected issues related to claims and coverage have emerged and adversely affected our results. Examples of emerging claims and coverage issues include, but are not limited to:


			●			new theories of liability and disputes regarding medical causation with respect to certain diseases;
			●			assignment-of-benefits agreements, where rights of insurance claims and benefits of the insurance policy are transferred to third parties, which can result in inflated repair costs and legal expenses to insurers and reinsurers;
			●			claims related to political unrest, geopolitical instability, or other politically driven events, such as the conflict in the Middle East, and the military conflict between Russia and Ukraine, including loss claims relating to expropriation, forced abandonment, license cancellation, trade embargo, contract frustration, non-payment, war on land or political violence (including terrorism, revolution, insurrection, and civil unrest);
			●			claims related to data security breaches, information system failures, or cyber-attacks; and
			●			claims related to business interruption including protocols enlisted by governments in connection with pandemics, and ransomware and cyber-attacks.

For instance, our specialty line of business is exposed to aviation losses emanating from the conflict between Russia and Ukraine and the impact of sanctions imposed on Russia that left a number of leased aircraft stranded in Russia. Given the uniqueness of the situation, it is impossible to determine whether and how potential losses may ultimately occur, which will depend on such factors as judicial rulings interpreting applicable coverages and contracts in place and the future behavior of the Russian government and airlines.

Additionally, various provisions of our contracts, such as limitations or exclusions from coverage or choice of forum, may be difficult to enforce in the manner we intend due to, among other things, disputes relating to coverage and choice of legal forum. These issues may adversely affect our business by either extending coverage beyond the period that we intended or by increasing the number or size of claims. In some instances, these changes may not manifest themselves until many years after we have issued reinsurance contracts that are affected by these changes. As a result, we may not be able to ascertain the full extent of our liabilities under our reinsurance contracts for many years following the issuance of our contracts.

The property and casualty reinsurance market is affected by cyclical trends.

We write reinsurance in the property and casualty markets, which are subject to pricing cycles. These cycles, as well as other factors that influence aggregate supply and demand for property and casualty reinsurance products, are outside our control. Primary insurers’ underwriting results, prevailing general economic and market conditions, liability retention decisions of companies, and primary insurers and reinsurance premium rates influence the demand for property and casualty reinsurance. Prevailing prices and available surplus to support assumed business influence reinsurance supply. Supply may fluctuate in response to changes in return on capital realized in the reinsurance industry, the frequency and severity of losses, and prevailing general economic and market conditions.

As a result, the reinsurance business historically has been a cyclical industry characterized by periods of intense price competition due to high levels of available underwriting capacity and periods when shortages of capacity have permitted favorable premium levels and changes in terms and conditions. The supply of available reinsurance capital could increase in future years, either due to capital provided by new entrants or by the commitment of additional capital by existing insurers or reinsurers.

Continued increases in the supply of reinsurance may have consequences for the reinsurance industry generally and for us, including fewer contracts written, lower premium rates, increased expenses for customer acquisition and retention, less favorable policy terms and conditions, and/or lower premium volume. The effects of cyclicality could materially and adversely affect our financial condition and results of operations.

Return to table of contents

A downgrade or withdrawal of our A.M. Best ratings would materially and adversely affect our ability to implement our business strategy.

If A.M. Best downgrades or withdraws either of our ratings, we could be severely limited or prevented from writing any new reinsurance contracts, which would materially and adversely affect our ability to implement our business strategy. Additionally, if A.M. Best downgrades or withdraws our ratings, we cannot provide assurance that our regulators, CIMA and the Central Bank of Ireland, would continue to authorize our current business strategy and investment strategy. See “—Risks Relating to Insurance and Other Regulations – Any suspension or revocation of our reinsurance licenses would materially and adversely impact our ability to do business and implement our business strategy.”

A.M. Best’s current rating for Greenlight Re is “A (Excellent”) and the outlook is stable. A.M. Best periodically reviews our ratings and may revise one or more of our ratings downward or revoke them at its sole discretion based primarily on its analysis of our balance sheet strength, operating performance, and business profile. Potential developments that may affect such an analysis include:


			●			if A.M. Best alters its capital adequacy assessment methodology in a manner that would adversely affect the rating of our reinsurance entities;
			●			if A.M. Best alters its approach regarding our Solasglas investment strategy or our Innovations investments;
			●			if our actual losses significantly exceed our loss reserves;
			●			if unfavorable financial or market trends impact us;
			●			if we change our business practices from our organizational business plan in a manner that no longer supports our A.M. Best ratings;
			●			if we are unable to retain our senior management and other key personnel or implement succession plans; or
			●			if our investments incur significant losses.

Substantially all of our assumed reinsurance contracts contain provisions that permit our clients to cancel the contract or require additional collateral in the event of a downgrade in our A.M. Best ratings below specified levels (generally below “A-”) or a reduction of our capital or surplus below specified levels over the course of the agreement.

We expect that similar provisions will also be included in future contracts. Whether a client would exercise such cancellation rights would likely depend on, among other things, the prevailing market conditions, the degree of unexpired coverage, and the pricing and availability of replacement reinsurance coverage. We cannot predict how many of our clients would ultimately exercise such rights. The exercise of such rights in the aggregate could significantly affect our financial condition, results of operations, and our underwriting capacity.

Modeling risks are inherent in our business.

We believe that our modeling is critical to our business. We utilize modeling tools to facilitate the pricing, reserving, and risk management of our reinsurance portfolio. These models help us to control risk accumulation, inform management and other stakeholders of capital requirements and to improve the risk/return profile or minimize the amount of capital required to cover the risks in each reinsurance contract. However, given the inherent uncertainty of modeling techniques and the application of such techniques, these models and databases may not accurately address the emergence of a variety of matters that might be deemed to impact certain of our coverages. These models have been developed internally, and in some cases, they make use of third-party software. The construction of these models and the selection of assumptions require significant actuarial judgment. Furthermore, these models typically rely on either cedent or industry data, which may be incomplete or may be subject to errors. Accordingly, these models, and the assumptions and judgments made in connection therewith, may understate the exposures we are assuming, and our financial results may be materially and adversely impacted.

Technology breaches or failures, including those resulting from a malicious ransomware or cyber-attack on us or our business partners and service providers, could disrupt or otherwise negatively impact our business.

Our information technology and application systems have been an important part of our underwriting process and our ability to compete successfully. We have also licensed certain systems and data from third parties. We cannot

Return to table of contents

be certain that we will have access to these service providers or that our information technology or application systems will continue to operate as intended. In addition, we cannot be certain that we would be able to replace these systems without slowing our underwriting response time. Like all companies, we have information technology and application systems that are vulnerable to data breaches, interruptions or failures due to events that may be beyond our control, including, but not limited to, natural disasters, theft, terrorist attacks, malicious ransomware cyber-attacks, computer viruses, hackers and general technology failures. In addition, artificial intelligence technologies are evolving at a fast pace and being adopted, which may increase potential cybersecurity risks.

A major defect or failure in our internal controls or information technology and application systems could result in management distraction, a violation of applicable privacy or other laws, harm our reputation, a loss of customers, or monetary fines or penalties or otherwise increased expenses. We believe appropriate controls and mitigation procedures are in place to prevent significant data breaches, interruptions, or failures in, information technology and application systems. However, internal controls provide only a reasonable, not absolute, assurance as to the absence of errors or irregularities, and the ineffectiveness of such controls and procedures could have a material adverse effect on our business.

The cybersecurity regulatory environment is evolving, and we expect the costs of complying with new or developing regulatory requirements to increase. These laws and regulations vary country to country and state to state, but they generally require the establishment of programs to detect and prevent unauthorized access to personal data and to mitigate theft of personal data. For example, the General Data Protection Regulation (“GDPR”), which establishes uniform data privacy laws across the European Union (“EU”) is effective for all EU member states. The GDPR anticipates the processing of data for reinsurance and other purposes and applies standards and rules that covered entities must establish and monitor with respect to such processing and use. As our operations expand to other jurisdictions, we will be required to comply with cybersecurity laws in those jurisdictions, which will further increase our cost of compliance. See “Part 1, Item 1. Business - Regulations” and “Part 1C. Cybersecurity.”

The loss of significant brokers or customers, could materially and adversely affect our business, financial condition and results of operations.

A significant portion of our business is placed through brokered transactions (for Open Market segment) or direct placements (for Innovations segment). For the Open Market segment, our four largest brokers each accounted for more than 10% of our gross written premiums, and in the aggregate, they accounted for approximately 70.5% of the segment’s gross premiums written in 2025. For the Innovations segment, we had six customers that accounted for 53.6% of the segment’s gross premiums written in 2025. Accordingly, we are exposed to concentration risk for both Open Market and Innovations segments. To lose or fail to expand all or a substantial portion of the business provided through brokers or direct customers could materially and adversely affect our business, financial condition and results of operations.

We depend on our clients’ evaluations of the risks associated with their insurance underwriting, which may subject us to reinsurance losses.

In our proportional reinsurance business, we do not expect to separately evaluate each of the original individual risks assumed under these reinsurance contracts. Therefore, we are largely dependent on the original underwriting decisions made by ceding companies. We are subject to the risk that the clients may not have adequately evaluated the insured risks and that the premiums ceded may not adequately compensate us for the risks we assume. We also do not separately evaluate each of the individual claims made on the underlying insurance contracts under quota share contracts, rendering us dependent on the claims decisions our clients make.

We are subject to the credit risk of our brokers, cedents, agents and other counterparties.

In accordance with industry practice, we frequently pay amounts owed on claims under our policies to reinsurance brokers, and these brokers, in turn, remit these amounts to the ceding companies that have reinsured a portion of their liabilities with us. In some jurisdictions, if a broker fails to make such a payment, we might remain liable to the client for the deficiency, notwithstanding the broker’s obligation to make such payment. Conversely, in certain jurisdictions, when the client pays premiums for policies to reinsurance brokers for payment to us, these premiums are considered to have been paid, and the client will no longer be liable to us for these premiums, whether or not we have actually received them. Consequently, we assume a degree of credit risk associated with brokers.

We are also exposed to the credit risk of our cedents and agents, who, pursuant to their contracts with us, may be required to pay us profit commission, additional premiums, reinstatement premiums, and adjustments to ceding

Return to table of contents

commissions over a period of time, which in some cases may extend beyond the initial period of risk coverage. Insolvency, liquidity problems, distressed financial condition, or the general effects of an economic recession may increase the risk that our cedents or agents may not pay some or all of their obligations to us. To the extent our cedents or agents become unable to pay us, we would be required to recognize a downward adjustment to our reinsurance balances receivable or loss and loss expenses recoverable, as applicable, in our financial statements. While we generally seek to mitigate this risk through, among other things, collateral agreements, funds withheld, corporate guarantees, and the right to offset receivables against any losses payable, an increased inability of customers to fulfill their obligations to us could have an adverse effect on our financial condition and results of operations.

Our reinsurance balances receivable from brokers and cedents at December 31, 2025 totaled $664.4 million, which included premiums, funds withheld balances (including FAL), and profit commission receivable, a majority of which are not collateralized (see Part II, Item 8. Note 17. “Commitments and Contingencies” to the consolidated financial statements). We cannot provide assurance that such receivables will be collected or that valuation allowances or write-downs for uncollectible balances will not be required in future periods.

We may not successfully alleviate risk through reinsurance arrangements. Additionally, we may be unable to collect, which could adversely affect our business, financial condition, and results of operations.

As part of our risk management, from time to time, we seek to purchase reinsurance for certain liabilities we reinsure to mitigate the effect of a potential concentration of losses upon our financial condition. At December 31, 2025, total loss recoverables were $81.4 million, a majority of which were from highly-rated reinsurers and not collateralized (see Part II, Item 8. Note 9 “Retrocession” to the consolidated financial statements). The insolvency or inability or refusal of a retrocessionaire to make payments under the terms of its agreement with us could have an adverse effect on us because our obligations to our clients would remain.

At certain times, market conditions have limited, and in some cases have prevented, reinsurers from obtaining the types and amounts of retrocessional coverage they consider necessary for their business needs. Accordingly, we may not be able to obtain our desired amounts of retrocessional coverage, negotiate terms that we deem appropriate or acceptable, or obtain retrocessional coverage from entities with satisfactory creditworthiness. Our inability to establish adequate retrocessional arrangements or the failure of our retrocessional arrangements to protect us from overly concentrated risk exposure could materially and adversely affect our business, financial condition, and results of operations.

Our failure to comply with restrictive covenants contained in our current or future credit facilities could trigger prepayment obligations, which could adversely affect our business, financial condition, and results of operations.

Our credit facilities require us and/or certain of our subsidiaries to comply with certain covenants, including restrictions on our ability to place a lien or charge on pledged assets, issue debt, and in certain circumstances, on the payment of dividends. For more details, see “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity”. Our failure to comply with these or other covenants could result in an event of default under the respective credit facilities or any credit facility we may enter into in the future, which, if not cured or waived, could result in us being required to repay the amounts outstanding under these facilities prior to maturity. As a result, our business, financial condition, and results of operations could be materially and adversely affected.

We may not successfully obtain the necessary credit facilities to support our business strategy.

As noted in “Part 1, Item 1. Business - Regulations”, we are required to provide letters of credit or collateral to jurisdictions in which we are not licensed or admitted as a reinsurer. In addition to the CIBC LC facility entered in late 2023, we expanded the available letters of credit facilities by adding the Uncommitted HSBC LC Facility and the Uncommitted Citibank LC Facility in late 2024 and the Citibank FAL Facility in 2025 (see Note 10 “Debt and Credit Facilities” of the consolidated financial statements). The Uncommitted Citibank LC Facility, Uncommitted HSBC LC Facility and Citibank FAL Facility are not committed facilities, which means Citibank and HSBC can decide not to issue the LC under the respective facility when we attempt to draw upon it. In addition, we cannot assure you that we will be able to increase existing credit facilities or add additional credit facilities in the future on favorable terms or at all.

Return to table of contents

If we lose or are unable to retain or implement succession plans for our senior management and other key personnel, our ability to implement our business strategy could be delayed or hindered, which, in turn, could materially and adversely affect our business, financial condition and results of operations.

Our success depends, to a significant extent, on the efforts of our senior management and other key personnel to implement our business strategy. We believe there are only a limited number of available qualified executives with substantial experience in our industry and we currently do not maintain key life insurance with respect to any of our senior management. We could face challenges and incur expenses in attracting and retaining personnel in the Cayman Islands, U.K., and Ireland. Accordingly, the loss of the services of one or more of the members of our senior management or other key personnel, or our inability to implement succession plans or hire and retain other key personnel, could prevent us from continuing to implement our business strategy and, consequently, materially and adversely affect our business.

Our ability to implement our business strategy could be adversely affected by Cayman Islands employment restrictions.

Compliance with Cayman Islands’ immigration requirements may adversely impact a company’s ability to meet its business goals. Under Cayman Islands law, specifically the Immigration (Transition) Act (as amended), no person may work in the Islands unless they are Caymanian, a permanent resident with the right to work (including a person married to, or in a civil partnership with, a Caymanian), the holder of a 25-year Residency Certificate that affords the right to work, or a work permit. It is a criminal offence to work or to employ someone without such authorisation.

Work permits are the most common form of employment authorisation for non-Caymanian workers. They are generally granted for periods of one to three years at a time, though the maximum length of time a worker may be granted work permits is nine years, after which they must leave the Islands for at least one year. All work permit holders who have resided legally in Cayman Islands for a continuous period of eight years have however the right to apply for permanent residence with the right to work, though if unsuccessful, must leave the Islands for at least one year.

Approval of work permits cannot be guaranteed: the employing company must first demonstrate before applying for a work permit, and before each subsequent renewal application, by way of advertising the position on a government jobs portal for fourteen days, that there is no qualified Caymanian or permanent resident available to fill the position. If it is considered that there is such a person available, the application will be refused. Further uncertainty is created by processing times for full work permit applications.

Reforms to immigration policy approved by Parliament in December 2025, and which are expected to come into effect later in 2026, aim to prioritize Caymanian employment, tighten employment mobility for foreign workers, and restructure aspects of the work permit system to enhance oversight and accountability. For businesses, this could mean higher compliance obligations, increased work permit-related costs, reduced flexibility in hiring and transferring employees from other jurisdictions, and longer processing times, all of which impacts strategic planning and business certainty.

We may face risks arising from future strategic transactions such as acquisitions, dispositions, mergers, or joint ventures.

We may pursue strategic transactions from time to time, which could involve acquisitions or dispositions of businesses or assets. Any strategic transactions could have an adverse impact on our reputation, business, results of operation, or financial condition. Sources of risk arising from these types of transactions include financial, accounting, tax, and regulatory challenges; difficulties with integration, business retention, execution of strategy, unforeseen liabilities or market conditions; and other managerial or operating risks and challenges. Any future transactions could also subject us to risks such as failure to obtain appropriate value, post-closing claims being levied against us, and disruption to our other businesses during the negotiation or execution process or thereafter. Accordingly, these risks and difficulties may prevent us from realizing the expected benefits from such strategic transactions. For example, businesses that we acquire or our strategic alliances or joint ventures may underperform relative to the price paid or resources committed by us; we may not achieve anticipated cost savings; we may otherwise be adversely affected by transaction-related charges; we may assume unknown or undisclosed business, operational, tax, regulatory and other liabilities; fail to accurately assess known contingent liabilities; or assume businesses with internal control deficiencies. Risk-mitigating provisions that we put in place in the course of

Return to table of contents

negotiating and executing these transactions, such as due diligence efforts and indemnification provisions, may not be sufficient to fully address these risks and contingencies.

Non-compliance with laws, regulations, and taxation regarding transactions with international counterparties may adversely affect our business.

As we provide reinsurance on a worldwide basis, we are subject to an expanding legal, regulatory, and tax environment intended to help detect and prevent anti-trust activity, money laundering, terrorist financing, proliferation financing, fraud, tax avoidance, and other illicit activity. These requirements include, among others, regulations promulgated and administered by CIMA, the U.S. Department of the Treasury's Office of Foreign Assets Control, The Foreign Corrupt Practices Act of 1977, the Iran Freedom and Counter-Proliferation Act of 2012, and the Foreign Account Tax Compliance Act. These and other programs prohibit or restrict dealings with certain persons, entities, countries, governments and, in certain circumstances, their nationals and may require detailed reporting to various administrative parties. Non-compliance with any of these regulations could have a material adverse effect on our ability to conduct our business.

Currency fluctuations could result in exchange rate losses and negatively impact our business.

Our functional currency is the U.S. dollar. However, we expect to write a portion of our business in currencies other than the U.S. dollar. We may incur foreign currency exchange gains or losses as we ultimately receive premiums and settle claims in foreign currencies. In addition, Solasglas may invest in securities or cash denominated in currencies other than the U.S. dollar. Consequently, we may experience exchange rate losses to the extent that our foreign currency exposure is not hedged, which could materially and adversely affect our business. If we or Solasglas hedge our foreign currency exposure through forward foreign currency exchange contracts or currency swaps, we will be subject to the risk that the hedging counterparties to such arrangements may fail to perform.

Natural disasters and other catastrophic events may adversely affect our operations and disrupt our business.

Our corporate headquarters are located in the Cayman Islands, a geographic region which is susceptible to natural disasters such as hurricanes and earthquakes as well as other potentially catastrophic events. If the Cayman Islands were to experience a major hurricane, earthquake or other catastrophic event, our corporate headquarters could be severely damaged and our operations could suffer significant disruption. There can be no assurance that our disaster recovery and business continuity plans will perform as expected and, if they don’t, our business could be materially adversely effected.

Risks Relating to Insurance and Other Regulations

Any suspension or revocation of any of our licenses would materially and adversely affect our business, financial condition and results of operations.

Greenlight Re is licensed as a reinsurer in both the Cayman Islands and the EEA. We are also licensed to write insurance business in the U.K. and the EEA through our Syndicate 3456. Viridis Re is also licensed as a reinsurer in the Cayman Islands. The suspension or revocation of any of our licenses to do business in either of these jurisdictions for any reason would mean that we would not be able to enter into any new reinsurance contracts in that jurisdiction until the suspension ended or we became licensed in another jurisdiction. The process of obtaining licenses is time-consuming and costly, and we may not be able to become licensed in another jurisdiction in the event we choose to. Any such suspension or revocation of our license would negatively impact our reputation in the (re)insurance marketplace, could have a material adverse effect on any potential license application and would materially and adversely affect our business, financial condition and results of operations.

CIMA and the CBI may take a number of actions, including suspending or revoking a reinsurance license whenever the regulatory body believes that a licensee is or may become unable to meet its financial obligations, is carrying on business in a manner likely to be detrimental to the public interest or the interest of its creditors or policyholders, has contravened the terms of the Act, or has otherwise behaved in such a manner so as to cause such regulatory body to call into question the licensee’s fitness to conduct regulated activity.

Further, based on statutes, regulations, and policies in their respective jurisdictions, CIMA and CBI may suspend or revoke our licenses if certain events occur, including without limitation:

Return to table of contents


			●			we cease to carry on reinsurance business;
			●			the direction and management of our reinsurance business have not been conducted in accordance with laws and regulations;
			●			we cease to meet certain capital and surplus requirements;
			●			a person holding a position as a director, manager or officer is not deemed to be a fit or proper person to hold the respective position; or
			●			we become bankrupt, go into liquidation, or are wound up or otherwise dissolved.

Similarly, if either CIMA or the CBI suspended or revoked our licenses, we could lose our exemption under the Investment Company Act of 1940, as amended (the “Investment Company Act”) (See “— We are subject to the risk of possibly becoming an investment company under U.S. federal securities law.”)

Our reinsurance subsidiaries are subject to minimum capital and surplus requirements, and our failure to meet these requirements could subject us to regulatory action.

The Insurance (Capital and Solvency) (Classes B, C, and D Insurers) Regulations (2018 Revision) (the “Capital and Solvency Regulations”) impose on Greenlight Re as a Class D reinsurer to maintain minimum statutory capital and surplus equal to the greater of: a) the minimum capital requirement of $50 million and b) the prescribed capital requirement and impose on Viridis Re a requirement to maintain minimum statutory capital of $0.2 million for a Class B(iii) general reinsurer and the prescribed capital requirement (the “Capital Requirements”). At December 31, 2025, both Greenlight Re and Viridis Re were in compliance with their respective Capital Requirements - see Note 19 “Statutory Requirements” of the consolidated financial statements.

GRIL, our Irish subsidiary, is required to comply with risk-based solvency requirements under the European legislation known as “Solvency II,” including calculating and maintaining a minimum capital requirement and solvency capital requirement. At December 31, 2025, GRIL’s minimum capital requirement and solvency capital requirement was approximately $10.3 million and $41.0 million, respectively. At December 31, 2025, GRIL was in compliance with the capital requirements required under the Irish Insurance Acts and Regulations.

Any failure to meet applicable requirements or minimum statutory capital requirements could subject us to further examination or action by regulators, including restrictions on dividend payments, limitations on our writing of additional business or engaging in financial or other activities, enhanced supervision, financial or other penalties, or liquidation. Further, any changes in existing risk-based capital requirements or minimum statutory capital requirements may require us to increase our statutory capital levels, which we might be unable to do.

We are a holding company that depends on the ability of our subsidiaries to pay dividends.

We are a holding company and do not have any significant operations or assets other than our ownership of the shares of our subsidiaries. Dividends and other permitted distributions from our subsidiaries are our primary source of funds to meet ongoing cash requirements, including future debt service payments, if any, and other corporate expenses, and to repurchase shares or pay dividends to our shareholders if we choose to do so. Some of our subsidiaries are subject to significant regulatory restrictions limiting their ability to declare and pay dividends. The inability of our subsidiaries to pay dividends in an amount sufficient to enable us to meet our cash requirements at the holding company level could have an adverse effect on our operations and our ability to repurchase shares or pay dividends to our shareholders if we choose to do so and/or meet our debt service obligations, if any.

To the extent any of our subsidiaries located in jurisdictions other than the Cayman Islands consider declaring dividends, such subsidiaries are required to comply with restrictions set forth under applicable law and regulations in such other jurisdictions. These restrictions could adversely impact the Company.

We are subject to the risk of possibly becoming an investment company under U.S. federal securities law.

In the United States, the Investment Company Act regulates certain companies that invest in or trade securities. We rely on an exemption under the Investment Company Act for an entity organized and regulated as a foreign insurance company which is engaged primarily and predominantly in the reinsurance of risks on insurance agreements. As we hold ourselves out as a global specialty property and casualty reinsurer and we do not propose to engage primarily in the business of investing or trading in securities, we believe the exemption applies.

Return to table of contents

Accordingly, we do not believe that we are, or are likely to become in the future, an investment company under the Investment Company Act.

Nonetheless, the law in this area is not well developed, and there is a lack of definitive guidance as to the meaning of “primarily and predominantly” under the relevant exemption to the Investment Company Act. If this exemption were deemed inapplicable, we would have to register under the Investment Company Act as an investment company. Registered investment companies are subject to extensive, restrictive, and potentially adverse regulation relating to, among other things, operating methods, management, capital structure, leverage, dividends, and transactions with affiliates. Registered investment companies are not permitted to operate their business in the manner in which we operate our business, nor are registered investment companies permitted to have many of the relationships that we have with our affiliated companies. Any changes to our investment strategy necessitated by being labeled a registered investment company could materially and adversely impact our investment results, financial condition, and ability to implement our business strategy.

If at any time it were established that we had been operating as an investment company in violation of the registration requirements of the Investment Company Act, there would be a risk, among other material adverse consequences, that we could become subject to monetary penalties or injunctive relief, or both, or that we would be unable to enforce contracts with third parties or that third parties could seek to obtain rescission of transactions with us undertaken during the period in which it was established that we were an unregistered investment company.

To the extent that the laws and regulations change in the future so that contracts we write are deemed not to be reinsurance contracts, we will be at greater risk of not qualifying for the Investment Company Act exception. Additionally, it is possible that our classification as an investment company would result in the suspension or revocation of our reinsurance license.

Insurance regulations to which we are, or may become, subject, and potential changes thereto, could have a significant and negative effect on our business.

We currently are admitted to do reinsurance business in the Cayman Islands and the EEA. We are also licensed to write insurance business in the U.K. and the EEA through our Syndicate 3456. Our operations in these jurisdictions are subject to varying degrees of regulation and supervision. The laws and regulations of the jurisdictions in which our subsidiaries are domiciled require that, among other things, these subsidiaries maintain minimum levels of statutory or regulatory capital, surplus, and liquidity, meet solvency standards, submit to periodic examinations of their financial condition, and restrict payments of dividends and reductions of capital. Statutes, regulations, and policies that our subsidiaries are subject to may also restrict the ability of these subsidiaries to write insurance and reinsurance policies, make certain investments, and distribute funds.

More specifically, with respect to GRIL, Solvency II governs the prudential regulation of insurers and reinsurers, and requires insurers and reinsurers in Europe to meet risk-based solvency requirements. It also imposes group solvency and governance requirements on groups with insurers and/or reinsurers operating in the EEA. A number of European Commission delegated acts and technical standards have been adopted, which set out more detailed requirements based on the overarching provisions of the Solvency II Directive. However, further delegated acts, technical standards, and guidance are likely to be published on an ongoing basis.

Although we presently are admitted to do business in the Cayman Islands, U.K. and the EEA, we cannot provide assurance that insurance regulators in the United States or elsewhere will not review our activities and claim that we are subject to such jurisdiction’s licensing requirements. In addition, we are subject to indirect regulatory requirements imposed by jurisdictions that may limit our ability to provide reinsurance. For example, our ability to write reinsurance may be subject, in certain cases, to arrangements satisfactory to applicable regulatory bodies, and proposed legislation and regulations may have the effect of imposing additional requirements upon, or restricting the market for, non-U.S. reinsurers such as Greenlight Re and GRIL, with whom domestic companies may place business. We do not know of any such proposed legislation pending at this time.

We may not be able to comply fully with, or obtain desired exemptions from, revised statutes, regulations, and policies that currently, or may in the future, govern the conduct of our business. Failure to comply with, or to obtain desired authorizations and/or exemptions under, any applicable laws could result in restrictions on our ability to do business or undertake activities that are regulated in one or more of the jurisdictions in which we operate and could subject us to fines and other sanctions. The MAA includes amendments that provide for a specific administrative fines framework whereby CIMA has been granted the power to issue monetary penalties of up to 1 million Cayman Islands Dollars for a very serious breach.

Return to table of contents

In addition, governmental authorities worldwide have become increasingly interested in potential risks posed by the insurance industry as a whole, and to the commercial and financial systems in general. While we cannot predict the exact nature, timing, or scope of possible governmental initiatives, there may be increased regulatory intervention in our industry in the future. Changes in the laws or regulations to which our subsidiaries are subject or may become subject, or in the interpretations thereof by enforcement or regulatory agencies, could have a material adverse effect on our business.

There are differences between Cayman Islands corporate law and Delaware corporate law with respect to interested party transactions, which may benefit certain of our shareholders at the expense of other shareholders.

As a matter of Cayman Islands law, a director of a Cayman Islands company is in the position of a fiduciary with respect to the company and therefore they owe certain duties to the company, including the following: a duty to act in good faith and in what they consider to be in the best interests of the company; a duty not to make a profit out of their position as director (unless the company permits them to do so); a duty to exercise their powers for the purposes for which they are conferred; and a duty not to put themselves in a position where the interests of the company conflict with their personal interest or their duty to a third party. A director of a Cayman Islands company owes to the company a duty to act with skill and care. A director will need to exhibit in the performance of their duties both the degree of skill that may reasonably be expected from a subjective perspective determined by reference to their knowledge and experience and the skill and care objectively to be expected from a person occupying office as a director of the company.

Under Cayman Islands corporate law and pursuant to our Articles, a director may vote on a contract or transaction where the director has an interest as a shareholder, director, officer, or employee, provided such interest is duly disclosed to the Board. In exercising any such vote, such director's duties remain as described above. Pursuant to our Articles none of our contracts will be deemed to be void purely because any director is an interested party in such transaction and in such circumstances, interested parties will generally not be held liable for monies owed to the Company. Under Delaware law, interested party transactions are voidable.

A failure by our Syndicate 3456 to comply with rules and regulations could materially and adversely interfere with our business strategy.

Syndicate 3456 is subject to Lloyd’s oversight. The PRA and the FCA regulate all financial services firms in the U.K., including Lloyd’s and Syndicate 3456. Both the PRA and the FCA have substantial powers of intervention in relation to Lloyd’s Syndicates, including the power to remove Lloyd’s authorization to manage such Syndicates. See “— Item 1. Business — Regulations — UK Regulations” for further discussion of such regulations.

Failure to comply with, or any future regulatory changes or rulings to, the regulations of the PRA and/or the FCA could interfere with the business strategy of Syndicate 3456, which could materially and adversely affect our business, financial condition and results of operations.

Risks Relating to Our Solasglas Investment Strategy

Our investment performance depends in part on the performance of Solasglas and may suffer as a result of adverse in financial markets or other factors that impact Solasglas’ liquidity.

Our operating results depend in part on the performance of Solasglas. We cannot provide assurance that DME Advisors, on behalf of Solasglas, will successfully structure investments in relation to our liquidity needs or liabilities. Failure to do so could force us to make redemptions from Solasglas that cause DME Advisors to liquidate investments at a significant loss or at prices that are not optimal, which could materially and adversely affect our financial results.

The risks associated with Solaglas’ value-oriented investment strategy may be substantially greater than the risks associated with traditional fixed-income investment strategies. In addition, long equity investments may generate losses if the market declines. Similarly, short equity investments may generate losses in a rising market. The success of the Solasglas investment strategy may also be affected by general economic conditions. Unexpected market volatility and illiquidity associated with our investment in Solasglas could materially and adversely affect our investment results, financial condition, or results of operations.

Return to table of contents

Solasglas may be concentrated in a few large positions, which could result in material adverse valuation movements.

Our Board of Directors has adopted our investment guidelines, which provide that Solasglas may not commit more than, 10% of Greenlight Re Surplus (as defined in the Solasglas LPA) and 10% of GRIL Surplus (as defined in the Solasglas LPA) to any single investment, unless a waiver has been obtained by the Board of Directors of Greenlight Re or GRIL, as applicable. At December 31, 2025, we were in compliance with these investment guidelines.

In addition, GRIL’s investment guidelines require that the ten largest investments shall not constitute more than 50% of the GRIL Surplus, and GRIL’s investment portfolio shall at all times, unless waived by the GRIL board of directors, be composed of a minimum of 50 debt or equity securities of publicly traded companies. From time to time, Solasglas may hold a small number of relatively large security positions in relation to our capital accounts. Since Solasglas may not be widely diversified by security or by industry, it may be subject to more rapid changes in value than would be the case if our investment portfolio were required to maintain a wide diversification among companies, securities industries, and types of securities.

Under the Solasglas LPA, we are contractually obligated to invest substantially all our assets in Solasglas with certain exceptions. Solasglas’ performance depends on the ability of DME Advisors to select and manage appropriate investments.

DME Advisors acts as the exclusive investment advisor for Solasglas. Apart from funds required for collateral purposes, funds allocated to our Innovations investment strategy, risk management, and other operational needs, we are contractually obligated to use commercially reasonable efforts to cause substantially all investable assets of Greenlight Re and GRIL to be contributed to Solasglas. Although DME Advisors is contractually obligated to follow the investment guidelines of both Greenlight Re and GRIL, we cannot provide assurance as to how DME Advisors will allocate our investable assets to different investment opportunities.

The performance of the Solasglas investment portfolio depends to a great extent on the ability of DME Advisors to select and manage appropriate investments for Solasglas. We cannot assure you that DME Advisors will successfully meet our investment objectives and the failure of DME Advisors to perform adequately could materially and adversely affect our business, results of operations, and financial condition.

We have limited control over Solasglas and Solasglas LPA limits our ability to use another investment manager.

Under the Solasglas LPA, subject to our investment guidelines and certain other conditions, DME II, as the general partner of Solasglas, has complete and exclusive power and responsibility for all investment and investment management decisions to be undertaken on behalf of Solasglas and for managing and administering the affairs of Solasglas. As a result, we have limited control over Solasglas and there can be no assurance that the interests of DME II in managing Solasglas will always be aligned with our interests. In addition, the Solasglas LPA contains exclusivity and limited termination provisions which severely restricts our ability to use other investment managers for so long as Greenlight Re and GRIL are limited partners in Solasglas. Greenlight Re and GRIL, as limited partners of Solasglas may withdraw upon notice only on the Greenlight Re Relevant Date or the GRIL Relevant Date or “for cause” (each as defined in the Solasglas LPA). Additionally, while GRIL has the right to withdraw as a limited partner in Solasglas due to unsatisfactory long-term performance of DME II or DME Advisors, as determined solely by the Board of Directors of GRIL at the end of each fiscal year during the term of the Solasglas LPA, Greenlight Re does not have this right.

The historical performance of DME Advisors and its affiliates should not be considered indicative of the future results of the Solasglas investment portfolio, our future results, or any returns expected on our ordinary shares.

The historical returns of Solasglas and other funds managed by DME Advisors and its affiliates are not directly linked to our ordinary shares. Results for the Solasglas investment portfolio could differ from those of other funds managed by DME Advisors and its affiliates due to restrictions imposed by our investment guidelines and other factors.

Return to table of contents

Potential conflicts of interest with DME Advisors and its affiliates may exist that could adversely affect us.

DME Advisors and its affiliates, in addition to managing Solasglas, may engage in investment and trading activities for their own accounts and/or for the accounts of third parties. None of DME Advisors or its affiliates, including David Einhorn, Chairman of our Board of Directors and the President of Greenlight Capital, Inc., is obligated to devote any specific amount of time, effort or allocation, or prioritize any investment opportunity, to Solasglas or to address possible or actual conflicts among the accounts they may manage, which may adversely affect Solasglas’ investment returns, and, correspondingly, our investment returns.

In addition, under Cayman Islands laws, Mr. Einhorn is not legally restricted from making decisions with respect to Greenlight Re’s investment guidelines. Accordingly, his involvement as a member of the Boards of Directors of Greenlight Capital Re and Greenlight Re may lead to a conflict of interest.

DME Advisors and its affiliates may also manage accounts whose advisory fee schedules, investment objectives, and policies differ from those of Solasglas, which may cause DME Advisors and its affiliates to effect trading in one account that may have an adverse effect on another account, including Solasglas.

Certain investments made by Solasglas may have limited liquidity and lack valuation data which could create a conflict of interest.

Our investment guidelines allow Solasglas to invest in certain securities with limited liquidity or no public market. This lack of liquidity may adversely affect the ability of Solasglas to execute trade orders at desired prices and may impact our ability to fulfill our underwriting payment obligations. To the extent that Solasglas invests in securities or instruments for which market quotations are not readily available, the valuation of such securities and instruments for purposes of compensation will be determined by DME Advisors, whose determination, subject to audit verification, will be conclusive and binding in the absence of bad faith or manifest error.

If DME Advisor’s risk management methodologies are ineffective, we may be exposed to material unanticipated losses.

DME Advisors and its affiliates continually refine its risk management techniques, strategies, and assessment methods. However, its risk management techniques and strategies do not fully mitigate the risk exposure of its funds and managed accounts, including Solasglas, in all economic or market environments or against all types of risk, including risks that it might fail to identify or anticipate. Any failures in DME Advisors’ risk management techniques and strategies to accurately quantify risk exposure could affect the risk-adjusted returns of Solasglas. In addition, any risk management failures could cause losses to be significantly greater than historical measures predict. DME Advisors’ approach to managing those risks could prove insufficient, exposing Solasglas, and correspondingly our Solasglas investment portfolio, to material unanticipated or material losses.

The compensation arrangements of Solasglas may create an incentive to effect transactions that are risky or speculative.

Pursuant to the Solasglas LPA, each of Greenlight Re and GRIL is obligated to pay a performance allocation of 20% to DME II at the end of each performance period based on its positive performance change to its capital account, subject to a modified loss carry forward provision.

The loss carry forward provision contained in the Solasglas LPA allows DME II to earn a reduced performance allocation of 10% of profits in any year subsequent to the year in which Solasglas has incurred a loss until all losses are recouped and an additional amount equal to 150% of the loss is earned.

While the performance compensation arrangement contained in the Solasglas LPA provides that losses will be carried forward as an offset against net profits in subsequent periods, DME II and DME Advisors generally will not otherwise be penalized for losses or decreases in the value of our portfolio under the Solasglas LPA. These performance compensation arrangements may incentivize DME Advisors to engage in transactions that focus on the potential for short-term gains rather than long-term growth or that are particularly risky or speculative.

Return to table of contents

DME Advisors’ representatives’ service on boards and committees may place trading restrictions on our investments and may subject us to indemnification liability.

DME Advisors may, from time to time, place its or its affiliates’ representatives on creditors’ committees and/or boards of certain companies in which Solasglas has invested. While such representation may enable DME Advisors to enhance the sale value of Solasglas’ investments, it may also prevent Solasglas from freely disposing of investments. The IAA provides for the indemnification of DME Advisors or any other person designated by DME Advisors for claims arising from such board representation.

We and Solasglas are exposed to credit risk from counterparties that may default on their obligations to us.

We and Solasglas are exposed to credit risk from counterparties that may default on their obligations to us or it. The amount of the maximum exposure to credit risk is indicated by the carrying value of our and Solasglas’ financial assets. In addition, Solasglas holds the securities of our investment portfolio with prime brokers and has credit risk from the possibility that one or more of them may default on their obligations to Solasglas.

Issuers or borrowers whose securities or debt Solasglas holds, customers, reinsurers, clearing agents, exchanges, clearing houses, and other financial intermediaries and guarantors may default on their obligations to us and/or Solasglas due to bankruptcy, insolvency, lack of liquidity, adverse economic conditions, operational failure, fraud or other reasons. Such defaults could have a significant and negative effect on us and/or Solasglas and, correspondingly, our investment portfolio and our results of operations, financial condition, and cash flows.

Solasglas effectuates short sales that subject our capital accounts to material and adverse loss potential.

Solasglas enters into transactions in which it sells a security it does not own, which we refer to as a short sale, in anticipation of a decline in the market value of the security. Short sales subject our capital accounts in Solasglas to material and adverse loss potential since the market price of securities sold short may continuously increase. Short sales may result in a substantial loss and may expose us to a loss exceeding the original amount invested.

Short-sale transactions have been subject to increased regulatory scrutiny and Solasglas’ ability to execute a short selling strategy may be materially and adversely impacted by new rules, interpretations, prohibitions, and restrictions adopted in response to adverse market events.

As a result, Solasglas may be unable to effectively pursue a short-selling strategy which may adversely affect Solasglas’ investment returns, and correspondingly, our investment returns.

Solasglas may trade on margin and use other forms of financial leverage, which may increase the risk of our investment portfolio.

Our investment guidelines allow Solasglas to trade on margin and use other forms of financial leverage. Solasglas relies on prime brokers to extend leverage and such prime brokers may elect not to provide leverage to Solasglas. Fluctuations in the market value of our investment in Solasglas could have a disproportionately large effect in relation to our capital. Any event which may adversely affect the value of positions Solasglas holds could materially and adversely affect the net asset value of our investment portfolio and our results of operations.

Solasglas may transact in derivatives trading, which may increase the risks associated with our investment portfolio.

Derivative instruments, or derivatives, include futures, options, swaps, structured securities, and other instruments and contracts that derive their value from one or more underlying securities, financial benchmarks, currencies, commodities, or indices. There are a number of risks associated with derivatives trading. Because many derivatives are leveraged, a relatively small adverse market movement may result in a substantial loss and may expose us to a loss exceeding the original amount invested. Derivatives may also expose Solasglas, and correspondingly, our investment portfolio, to liquidity risk as there may not be a liquid market within which to close or dispose of outstanding derivative contracts. The counterparty risk lies with each party with whom Solasglas contracts for the purpose of making derivative investments. In the event of the counterparty’s default, Solasglas will generally only rank as an unsecured creditor and risk the loss of all or a portion of the amounts Solasglas is contractually entitled to receive.

Return to table of contents

Risks Relating to Our Innovations Strategy

The carrying values of our Innovations investments may differ significantly from those that would be used if we carried these investments at fair value. Additionally, we have a material concentration in our top five holdings at December 31, 2025.

Our Innovations investments include investments in private equities for which no active market may exist. We carry these investments on our consolidated balance sheets at cost, less impairment, plus or minus observable price changes (see “Critical Accounting Estimates - “Investments” under “Part II, Item 8. Management Discussion and Analysis of Financial Condition and Results of Operations”). These carrying values may differ significantly from those that would be used if we carried them at fair value. If we were required to liquidate all or a portion of these investments quickly, we could realize significantly less than the carrying value. The carrying value of our Innovations investments may become concentrated in a limited number of entities as a result of subsequent remeasurement and/or have significant exposure to certain geographic areas or economic sectors. The concentration of investments can increase investment risk and volatility. At December 31, 2025, our top five holdings accounted for 53% of the total carrying value. Any of the foregoing could result in a decline in our investment performance and capital resources and, accordingly, could materially and adversely affect our financial results and results of operations. Refer to “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Innovations Segment” for total impairment charge in 2025.

Our Innovations investments carry higher risks due to illiquidity.

We invest in illiquid equity and debt instruments of early-stage companies in our Innovations investments portfolio. Furthermore, our Innovations investments are generally subject to restrictions on redemptions and sales that limit our ability to liquidate these investments in the short term. As such, there is a high liquidity risk due to the lack of active markets. We may not be able to sell timely, or at all, illiquid holdings of early-stage companies facing significant challenges operationally and financially subsequent to our initial investment (see below “Investments in privately held early-stage companies involve significant risks”). Accordingly, this could materially and adversely affect our business, financial condition and results of operations.

Our Innovations investments support our underwriting operations and the failure to identify and consummate investment opportunities may materially and adversely affect our ability to implement our business strategy.

We operate in a competitive market for Innovations investment opportunities. Many of our competitors have considerably greater resources than we do. If we fail to compete for or otherwise lose the opportunity to make Innovations investments, which support our underwriting strategy, our ability to implement our business strategy may be materially and adversely impacted.

Investments in privately held early-stage companies involve significant risks.

Our Innovations unit primarily invests in privately held early-stage companies. Investments in privately held early-stage companies involve a number of significant risks, including the following:

Return to table of contents


			●			these companies may have limited financial resources and may be unable to meet their operating obligations;
			●			they typically have limited operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;
			●			they typically depend on the management talents and efforts of a small group of persons. Therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse effect on such investment and, in turn, on us;
			●			they may not have adequate internal controls which would make them susceptible to fraud or mismanagement;
			●			there is generally little public information about these companies. These companies and their financial information are generally not subject to the Exchange Act and other regulations that govern public companies, and we may be unable to uncover all material information about these companies, which may prevent us from making a fully informed investment decision and cause us to lose money on our investments;
			●			they generally have less predictable operating results and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position;
			●			changes in laws and regulations (including applicable tax laws), as well as their interpretations, may adversely affect their business, financial structure or prospects; and
			●			they may have difficulty accessing the capital markets to meet future capital needs.

Economic recessions or downturns could impair our Innovations investment and harm our operating results.

The current macroeconomic environment is characterized by high inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility, volatility in global capital markets and growing recession risk. The risks associated with our Innovations investments and the businesses of the entities in which we have invested are more severe during periods of economic slowdown or recession.

Many of our Innovations investments may be susceptible to economic downturns or recessions. Therefore, during these periods the carry values of our Innovations portfolio may decrease if we are required to write down the values of our investments. Adverse economic conditions may also decrease the value of our investments. Economic slowdowns or recessions could lead to financial losses in our Innovations portfolio and a decrease in revenues, net income and assets.

Our Innovations investments are made in entities that may incur debt or issue equity securities that rank equally with, or senior to, our investments in such companies.

Our Innovations investments are made in entities that have, or may be permitted to incur, other debt, or issue other equity securities, that rank equally with, or senior to, our investments. By their terms, such instruments may provide that the holders are entitled to receive payment of dividends, interest or principal on or before the dates on which we are entitled to receive payments in respect of our investments. These debt instruments would usually prohibit the investments from paying interest on or repaying our investments in the event and during the continuance of a default under such debt. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of an entity, holders of securities ranking senior to our investment typically are entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such holders, the entity may not have any remaining assets for repaying its obligation to us. In the case of securities ranking equally with our investments, we would have to share on an equal basis any distributions with other security holders in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant entity.

As a minority equity investor, we are often not in a position to influence the entity, and other equity holders and management of such entity may make decisions that could decrease the value of our investment in such entity.

When we make a minority equity investment through our Innovations segment, we are subject to the risk that an entity may make business decisions with which we disagree. The other equity holders and management of the entity may take risks or otherwise act in ways that do not serve our interests. As a result, an entity may make decisions that could decrease the value of our investment.

Return to table of contents

Our Innovations investments are in entities that may be highly leveraged.

Some of our Innovations investments are made in entities that may be highly leveraged, which may have adverse consequences for those companies and for us as a shareholder. The entity may be subject to restrictive financial and operating covenants and their leverage may impair the ability to finance their future operations and capital needs. As a result, such entity’s flexibility to respond to changing business and economic conditions and to take advantage of business opportunities may be limited.

Our failure to make follow-on investments in our existing Innovations investments could impair the value of our portfolio.

Following an initial investment in an entity, we may make additional investments in the entity as “follow-on” investments to: (1) increase or maintain in whole or in part our equity ownership percentage; (2) exercise warrants, options or convertible securities that we acquired in the original or subsequent financing; (3) protect our liquidation preference rights or (4) attempt to preserve or enhance the value of our investment.

We may elect not to make follow-on investments, be constrained in our ability to employ available funds, or otherwise lack sufficient funds to make those investments. We have the discretion to make any follow-on investments, subject to the availability of capital resources. The failure to make follow-on investments may, in some circumstances, jeopardize the continued viability of an entity, dilute our investment, or result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make a follow-on investment, we may elect not to make it because we may not want to increase our concentration of risk, we prefer other opportunities, or we are constrained under the Investment Company Act. See “–Risks Relating to Insurance and Other Regulations – We are subject to the risk of possibly becoming and investment company under U.S. federal securities laws.”

Risks Relating to Our Ordinary Shares

Our ability to achieve our business objectives depends on our ability to manage and deploy capital.

Our ability to achieve our business objectives depends on our ability to manage and deploy capital, which depends, in turn, on our management’s ability, with oversight from our Board of Directors, to identity, evaluate and monitor our underwriting and investment results, our liquidity and competing needs for capital. We cannot assure you that our management and deployment of capital will enable us to achieve our business objectives, and our failure to effectively manage and deploy our capital could materially and adversely affect our financial condition and results of operations.

Our level of debt may have an adverse impact on our liquidity, restrict our current and future operations, particularly our ability to respond to business opportunities, and increase our vulnerability to adverse economic and industry conditions.

While we had $4.7 million of debt outstanding at December 31, 2025, we have the ability to borrow up to $50 million under the Revolving Credit Facility (see Note 10 “Debt and Credit Facilities” of our consolidated financial statements). The level of debt and the provisions of such debt could have significant consequences, which include, but are not limited to, the following:


			●			limit our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, or other general corporate purposes;
			●			require a substantial portion of our cash flows to be dedicated to debt service payments instead of other purposes, thereby reducing the amount of cash flows available for working capital, capital expenditures, acquisitions, and other general corporate purposes;
			●			discourage an acquisition of us by a third party;
			●			place us at a competitive disadvantage to competitors carrying less debt; and
			●			make us more vulnerable to economic downturns and limit our ability to withstand competitive pressures or take advantage of new opportunities to grow our business.

We cannot assure you that we will be able to refinance our indebtedness debt upon maturity on acceptable terms or at all.

Return to table of contents

A shareholder may be required to sell its ordinary shares.

Our Articles provide that we have the option, but not the obligation, to require a shareholder to sell its ordinary shares for their fair market value to us, to other shareholders or to third parties if our Board of Directors determines that ownership of our ordinary shares by such shareholder may result in adverse tax, regulatory or legal consequences to us, any of our subsidiaries or any of our shareholders and that such sale is necessary to avoid or cure such adverse consequences.

Provisions of our Articles, the Companies Act of the Cayman Islands (the “Companies Act”) and our corporate structure may each impede a takeover, which could adversely affect the value of our ordinary shares.

Our Articles contain certain provisions that could make it difficult for a third party to acquire us, even if doing so would be beneficial to our shareholders. Our Articles provide that a director may only be removed for “cause” as defined in the Articles, upon the affirmative vote of not less than 50% of the votes cast at a meeting at which more than 50% of our issued and outstanding ordinary shares are represented. Further, under the Amended and Restated Memorandum and Articles of Association of Greenlight Re, a director may only be removed without cause upon the affirmative vote of not less than 80% of the votes cast at a meeting at which more than 50% of our issued and outstanding ordinary shares are represented.

Our Articles permit our Board of Directors to issue preferred shares from time to time, with such rights and preferences as they consider appropriate. Our Board of Directors may authorize the issuance of preferred shares with terms and conditions and under circumstances that could have an effect of discouraging a takeover or other transaction, deny shareholders the receipt of a premium on their ordinary shares in the event of a tender or other offer for ordinary shares and have a depressive effect on the market price of the ordinary shares.

As compared to mergers under corporate law in the United States, it may be more difficult to consummate a merger of two or more companies in the Cayman Islands or the merger of one or more Cayman Islands companies with one or more overseas companies, even if such transaction would be beneficial to our shareholders. For example, a merger or consolidation generally requires the consent of each holder of a fixed or floating security interest, unless the court waives such requirement, and a formal declaration must be made, meeting enumerated requirements, if the transaction involves a foreign company or where the surviving company is the Cayman Islands exempted company.

The Companies Act also includes statutory provisions that facilitate the reconstruction and amalgamation of companies, provided that such a scheme of arrangement is approved by (i) in respect of shareholders, 75% in value of the shareholders or each class of shareholder who attend and vote, either in person or by proxy, at a meeting or meetings convened for that purpose; or (ii) in respect of creditors, a majority in number representing 75% in value of creditors or each class of creditors who attend and vote, either in person or by proxy, at a meeting or meetings convened for that purpose.

The convening of the scheme meetings and subsequently the terms of the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that:


			●			the company is not proposing to act illegally or beyond the scope of its corporate authority and the statutory provisions as to majority vote have been complied with;
			●			the shareholders have been fairly represented at the meeting in question and the classes properly delineated;
			●			the scheme of arrangement is such as a businessperson would reasonably approve; and
			●			the scheme of arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act or that would amount to a “fraud on the minority”.

If a scheme of arrangement is thus approved, the dissenting shareholders would have no rights comparable to appraisal

rights, which would otherwise ordinarily be available to dissenting shareholders of a Delaware corporation.

Return to table of contents

Holders of ordinary shares may have difficulty obtaining or enforcing a judgment against us, and they may face difficulties in protecting their interests because we are incorporated under Cayman Islands law.

We are an exempted company limited by shares incorporated under the laws of the Cayman Islands and conduct a majority of our operations outside the United States. A significant amount of our assets are located outside the United States. A majority of our officers and directors reside outside the United States and substantial portion of the assets of those persons are located outside of the United States. As a result, it could be difficult or impossible for you to bring an action against us or against these individuals outside of the United States in the event that you believe that your rights have been infringed upon under the applicable securities laws or otherwise. Even if you are successful in bringing an action of this kind, the laws of the Cayman Islands could render you unable to enforce a judgment against our assets or the assets of our directors and officers.

Our corporate affairs are governed by our Articles, the Companies Act and the common law of the Cayman Islands. The rights of shareholders to take legal action against our directors and us, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from judicial precedent in the Cayman Islands as well as from English common law, which has persuasive, but not binding, authority on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under the laws of the Cayman Islands are not as clearly defined as under statutes or judicial precedent in existence in jurisdictions in the United States. Therefore, you may have more difficulty protecting your interests than would shareholders of a corporation incorporated in a jurisdiction in the United States, due to the comparatively less well developed Cayman Islands law in this area.

Shareholders of Cayman Islands exempted companies such as ours have no general rights under Cayman Islands law to inspect corporate records and accounts or to obtain copies of lists of shareholders. Our directors have discretion under our Articles to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders, but are not obliged to make them available to our shareholders. This may make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest.

The courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature. Although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, the judgment must be obtained in a court of law which had jurisdiction over the judgment debtor, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings, including if concurrent proceedings are being brought elsewhere.

We are not aware nor have we been advised of any reported class action having been brought in a Cayman Islands court. Derivative actions have been brought in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability for such actions. Generally, we will be the proper plaintiff in any claim based on a breach of duty owed to us, and a claim against (for example) our officers or directors usually may not be brought by a shareholder. However, based both on Cayman Islands authorities and on English authorities, which would in all likelihood be of persuasive authority and be applied by a court in the Cayman Islands, exceptions to the foregoing principle apply including, for example, in circumstances in which those who control the company are perpetrating a “fraud on the minority.”

A shareholder may have a direct right of action against us where the individual rights of that shareholder have been infringed or are about to be infringed, and may have a direct right of action against us in circumstances where our Board of Directors exercise their powers for an improper purpose (or are about to exercise their powers for an improper purpose).

Return to table of contents

Subject to limited exceptions, under Cayman Islands law, a minority shareholder may not bring a derivative action against our Board of Directors.

We do not intend to pay dividends on our ordinary shares and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common shares.

We do not intend to declare and pay dividends on our ordinary shares for the foreseeable future. Therefore, you are not likely to receive any dividends on your ordinary shares for the foreseeable future. The success of an investment in our ordinary shares will depend upon any future appreciation in their value. There is no guarantee that our ordinary shares will appreciate in value or even maintain the price at which our shareholders have purchased their shares.

In the event that we did declare a dividend, such dividends and other distributions on issued and outstanding ordinary shares may only be paid out of the funds of the Company lawfully available for such purpose. Dividends and other distributions will be distributed among the holders of our ordinary shares on a pro rata basis.

Risks Relating to Taxation

We may be subject to United States federal income taxation.

Greenlight Capital Re, Greenlight Re and Viridis Re are incorporated under the laws of the Cayman Islands, and GRIL is incorporated under the laws of Ireland. These entities intend to operate in a manner that will not cause us to be treated as engaging in a trade or business within the United States and will not cause us to be subject to current United States federal income taxation on Greenlight Capital Re’s, Greenlight Re’s, Viridis Re’s and/or GRIL’s net income. However, because there are no definitive standards provided by the Internal Revenue Code, regulations or court decisions as to the specific activities that constitute being engaged in the conduct of a trade or business within the United States, and as any such determination is essentially factual in nature, we cannot provide assurance that the United States Internal Revenue Service (the “IRS”), will not successfully assert that Greenlight Capital Re, Greenlight Re, Viridis Re and/or GRIL are engaged in a trade or business within the United States. If the IRS were to successfully assert that Greenlight Capital Re, Greenlight Re, Viridis Re and/or GRIL have been engaged in a trade or business within the United States in any taxable year, various adverse tax consequences could result, including the following: Greenlight Capital Re, Greenlight Re, Viridis Re and/or GRIL may become subject to current United States federal income taxation on its net income from sources within the United States; Greenlight Capital Re, Greenlight Re, Viridis Re and/or GRIL may be subject to United States federal income tax on a portion of its net investment income, regardless of its source; and Greenlight Capital Re, Greenlight Re, Viridis Re and/or GRIL may be subject to United States branch profits tax on profits deemed to have been distributed out of the United States.

United States persons who own ordinary shares may be subject to United States federal income taxation on our undistributed earnings and may recognize ordinary income upon disposition of ordinary shares.

Passive Foreign Investment Company. Potential adverse United States federal income tax consequences, including certain reporting requirements, generally apply to any United States person who owns shares in a passive foreign investment company, or a “PFIC”. We believe that based upon implementation of our business plan, none of Greenlight Capital Re, Greenlight Re, Viridis Re or GRIL will be, or should be, a PFIC for the current taxable year or for any foreseeable future years.

In general, any of Greenlight Capital Re, Greenlight Re, Viridis Re or GRIL would be a PFIC for a taxable year if either (i) 75% or more of its income constitutes “passive income” or (ii) 50% or more of its assets produce “passive income”, or are held for the production of passive income. Passive income generally includes interest, dividends and other investment income. However, under an “active insurance” exception, income is not treated as passive if it is derived in the active conduct of an insurance business by a qualifying insurance corporation. A qualifying insurance corporation is an insurance company which has applicable insurance liabilities, as reported on its annual financial statement, exceeding 25% of its total assets. Applicable insurance liabilities means, with respect to our property and casualty reinsurance business, reserves for loss and loss adjustment expenses, and excluding unearned premium reserves.

The exception for insurance companies is intended to ensure that a qualifying insurance entity’s income is not treated as passive income, except to the extent such income is attributable to financial reserves in excess of the reasonable needs of the insurance business. We intend to operate our business with financial reserves and

Return to table of contents

applicable insurance liabilities at levels that should not cause us to be deemed PFICs, although we cannot provide definitive assurance that we will be successful in structuring our operations to meet such levels nor can we ensure that the IRS will not successfully challenge our status. If we are unable to underwrite sufficient amount of risks and maintain a sufficient amount of applicable insurance liabilities, any of Greenlight Capital Re, Greenlight Re, Viridis Re or GRIL may become a PFIC.

In addition, sufficient risk must be transferred under an insurance entity’s contracts with its insureds in order to qualify for the insurance exception. Whether our insurance contracts possess adequate risk transfer for purposes of determining whether income under our contracts is insurance income, and whether we are predominantly engaged in an insurance business, are subjective in nature and there is little authoritative tax guidance on these issues. We cannot provide assurance that the IRS will not successfully challenge our interpretation of the scope of the active insurance company exception and our qualification for the exception. Further, the IRS may issue regulatory or other guidance that causes us to fail to qualify for the active insurance company exception on a prospective or retroactive basis. Therefore, we cannot provide definitive assurance that we will satisfy the exception for insurance companies and will not be treated as PFICs currently or in the future.

Controlled Foreign Corporation (“CFC”). United States persons who, directly or indirectly or through attribution rules, own 10% or more of the total combined voting power or value of our shares, which we refer to as United States 10% shareholders, may be subject to the controlled foreign corporation, or CFC, rules. Under the CFC rules, each United States 10% shareholder must annually include their pro-rata share of the CFC’s “subpart F income” and “global intangible low-tax income” in their gross income in the year earned by the CFC, even if no distributions are made. This income inclusion rule does not apply to United States persons that are partnerships. In general, a foreign insurance company will be treated as a CFC only if during the taxable year United States 10% shareholders collectively own more than 25% of the total combined voting power or total value of the entity’s shares. We believe that the dispersion of our ordinary shares among holders and the restrictions placed on transfer, issuance or repurchase of our ordinary shares, will in most cases prevent shareholders who acquire ordinary shares from being United States 10% shareholders. We cannot provide assurance, however, that these rules will not apply to you if you are or become a United States 10% shareholder. In particular, recent changes to the definition of a United States 10% Shareholder, whereby both vote and value are tested, and recent changes to the constructive ownership rules, whereby shares owned by non-United States persons can be attributed to United States persons, may increase the likelihood of these rules applying. If you are a United States person, we strongly urge you to consult your own tax advisor concerning the CFC rules.

Related Person Insurance Income. If:


			●			our gross income attributable to insurance or reinsurance policies where the direct or indirect insureds are our direct or indirect United States shareholders or persons related to such United States shareholders equals or exceeds 20% of our gross insurance income in any taxable year; and
			●			direct or indirect insureds and persons related to such insureds owned directly or indirectly 20% or more of the voting power or value of our stock.

a United States person (other than a partnership) who owns ordinary shares directly or indirectly on the last day of the taxable year would most likely be required to include their pro-rata share of our related person insurance income for the taxable year in their income. This amount would be determined as if such related person insurance income were distributed proportionally to the United States persons at that date. We do not expect that we will knowingly enter into reinsurance agreements in which, in the aggregate, the direct or indirect insureds are, or are related to, owners of 20% or more of the ordinary shares. We do not believe that the 20% gross insurance income threshold will be met. However, we cannot provide assurance that this is or will continue to be the case. Consequently, we cannot provide assurance that a person who is a direct or indirect United States shareholder will not be required to include amounts in its income in respect of related person insurance income in any taxable year.

If a United States shareholder is treated as disposing of shares in a foreign insurance corporation that has related person insurance income and in which United States persons own 25% or more of the voting power or value of the entity’s shares, any gain from the disposition will generally be treated as a dividend to the extent of the United States shareholder’s portion of the corporation’s undistributed earnings and profits that were accumulated during the period that the United States shareholder owned the shares. In addition, the shareholder will be required to comply with certain reporting requirements, regardless of the amount of shares owned by the direct or indirect United States shareholder. Although not free from doubt, we believe these rules should not apply to dispositions of ordinary shares because Greenlight Capital Re is not directly engaged in the insurance business and because proposed United States Treasury regulations applicable to this situation appear to apply only in the case of shares

Return to table of contents

of corporations that are directly engaged in the insurance business. We cannot provide assurance, however, that the IRS will interpret the proposed regulations in this manner or that the proposed regulations will not be promulgated in final form in a manner that would cause these rules to apply to dispositions of ordinary shares.

United States tax-exempt organizations who own ordinary shares may recognize unrelated business taxable income.

If you are a United States tax-exempt organization you may recognize unrelated business taxable income if a portion of our subpart F insurance income is allocated to you. In general, subpart F insurance income will be allocated to you if we are a CFC as discussed above and you are a United States 10% shareholder or there is related person insurance income and certain exceptions do not apply. Although we do not believe that any United States persons will be allocated subpart F insurance income, we cannot provide assurance that this will be the case. If you are a United States tax-exempt organization, we advise you to consult your own tax advisor regarding the risk of recognizing unrelated business taxable income.

The Tax Cuts and Jobs Act (“TCJA”) may cause us to undertake changes to the manner in which we conduct our business and could subject United States persons who own ordinary shares to United States income taxation on our undistributed earnings.

On December 22, 2017, the TCJA was signed into law. The TCJA provides a bright-line test that a non-U.S. insurance company only will receive the benefit, for passive foreign investment company purposes, of being engaged in the active conduct of an insurance business if its applicable insurance liabilities constitute more than 25% of its total assets. For this purpose, the term “applicable insurance liabilities” does not include unearned premium reserves. One of the TCJA’s potential impacts is that this limitation could result in the treatment of offshore insurers or reinsurers that write business on a low frequency/high severity basis, such as property catastrophe companies and financial guaranty companies, as PFICs, as significant reserves for losses may not be recorded until a catastrophic event actually occurs. Accordingly, subject to any future corrections or clarifications that may be made to the TCJA, or any additional regulations that may be promulgated thereunder, the Company will be treated as a PFIC for any taxable year in which it does not meet the bright-line applicable insurance liabilities requirement of the TCJA.

At December 31, 2025, we met the bright-line applicable insurance liabilities test. However, there is still substantial uncertainty regarding the application of the test. We cannot guarantee that we will continue to meet the bright-line applicable insurance liabilities test in future periods. In the event that we cannot meet this test, shareholders that are United States persons will be subject to United States income taxation on our undistributed earnings.

Further changes in United States tax regulations and laws including the rules regarding passive foreign investment companies could have a material impact on our ability to qualify for the insurance company exemption and/or change our status for United States persons who own ordinary shares.

A non-U.S. corporation will generally be considered a passive foreign investment company (“PFIC”), for U.S. federal income tax purposes, in any taxable year if either (i) at least 75% of its gross income for such year is passive income or (ii) at least 50% of the value of its assets is attributable to assets that produce or are held for the production of passive income.

Based on our past and current projections of our income and assets, we do not expect the Company to be a PFIC for the 2025 taxable year or for the foreseeable future. However, since our projections may differ from our actual business results and our market capitalization and value of our assets may fluctuate, we cannot definitively assure you that we will not be or become a PFIC in the current taxable year or any future taxable year.

We are monitoring developments with respect to both the applicable insurance liabilities test and the IRS regulations. At this time, we cannot predict whether or what, if any, additional regulations will be adopted or additional legislation will be enacted. If regulations are adopted or legislation enacted that cause us to fail to meet the requirements of the insurance company exception, or if we fail to meet the applicable insurance liabilities test such failure could have a material adverse effect on the taxation of our shareholders who are U.S. persons. In that event we may undertake further changes to the manner in which we conduct our business, which also could have a material effect on our results of operations.

The tax laws and interpretations regarding whether an entity is engaged in a United States trade or business, is a CFC, has related party insurance income or is a PFIC are subject to change, possibly on a retroactive basis. New

Return to table of contents

regulations or pronouncements interpreting or clarifying such rules may be forthcoming from the IRS. We are not able to predict if, when or in what form such guidance will be provided and whether such guidance will have a retroactive effect.

The TCJA may have a detrimental effect on the Company and its assets.

The regulatory and tax environment globally is evolving, and changes in the regulation or taxation of the Company and its assets may materially adversely shareholders. The TCJA among other things, made significant changes to the rules applicable to the taxation of the Company and its assets, such as changing the rules applicable to active insurance income for passive foreign investment company purposes (discussed above), changing rules applicable to controlled foreign investment company purposes, new base erosion rules, changing the general corporate tax rate to a flat 21% rate, modifying the rules regarding limitations on certain deductions, introducing a capital investment deduction in certain circumstances, placing certain limitations on the interest deduction, modifying the rules regarding the usability of certain net operating losses, and the migration from a worldwide system of taxation to a modified territorial system. At this time the ultimate outcome of the legislation on the Company and its shareholders is uncertain and could be adverse. Shareholders should consult their own tax advisors regarding potential changes in tax laws.

If investments held by GRIL are determined not to be integral to the reinsurance business carried on by GRIL, additional Irish tax could be imposed and our business and financial results could be materially adversely affected.

Based on administrative practice, taxable income derived from investments made by GRIL is generally taxed in Ireland at the rate of 12.5% on the grounds that such investments either form part of the permanent capital required by regulatory authorities, or are otherwise integral to the reinsurance business carried on by GRIL. GRIL intends to operate in such a manner so that the level of investments held by GRIL does not exceed the amount that is integral to the reinsurance businesses carried on by GRIL. If, however, investment income earned by GRIL exceeds these thresholds or if the administrative practice of the Irish Revenue Commissioners changes, Irish corporation tax could apply to such investment income at a higher rate (currently 25%) instead of the general 12.5% rate, and our results of operations could be materially adversely affected.

The impact of the initiative of the OECD and the EU to eliminate harmful tax practices is uncertain and could adversely affect our tax status in the Cayman Islands where we are exempt from income taxes.

The OECD has published reports and launched a global dialogue among member and non-member countries on measures to limit harmful tax competition. These measures are largely directed at counteracting the effects of tax neutral jurisdictions and preferential tax regimes in countries around the world. The Cayman Islands was removed from the EU’s list of non-cooperative jurisdictions for tax purposes in October 2020 following the introduction of economic substance and private funds legislation and it is considered to be a country which co-operates with the EU with no pending commitments. While the Cayman Islands is currently on the list of co-operative jurisdictions, we are not able to predict if additional requirements will be imposed, and if so, whether changes arising from such additional requirements will subject us to additional taxes. The Cayman Islands’ economic substance legislation was evaluated in June 2019 by the OECD’s Forum on Harmful Tax Practices as “not harmful”, which is the highest rating possible. There are no immediate regulatory, tax, trade or other legal impacts to the Company, but we are not able to predict any future EU actions.

On October 8, 2021, the OECD announced an accord endorsing and providing an implementation plan for a global minimum tax rate of at least 15% for large multinational corporations on a jurisdiction-by-jurisdiction basis, known as “Pillar Two.” While the Company is not currently aware of any definitive actions being taken in the Cayman Islands to implement a minimum tax, Ireland and the United Kingdom have enacted legislation implementing Pillar Two, including an “undertaxed profit rule” that came into effect in both countries in 2025. If the Cayman Islands does not adopt a minimum tax, the undertaxed profits rule may allow Irish or United Kingdom tax authorities to collect more tax from our Irish or United Kingdom companies. The global minimum tax rules implemented in different jurisdictions (including the undertaxed profit rule) would apply to overseas profits of multinational firms with annual revenue of more than €750 million. While these global minimum tax rules are not expected to apply to the Company in 2026 as currently proposed and being implemented in jurisdictions applicable to the Company’s operations, due to the Company’s revenues currently falling below the applicable revenue threshold test (that tests meeting the annual €750 million revenue threshold for at least two of the four fiscal years immediately preceding the tested fiscal year), adjustments to the threshold or continued growth of the Company’s revenues could impact the Company’s Pillar Two position in future periods beyond 2026. Further, even if the Company did eventually meet the applicable

Return to table of contents

threshold due to meeting the revenue test in at least two fiscal years within a four-year period, then given the size and structure of the Company, the Company may be eligible to meet an initial phase transitional safe harbor provided for in the model rules of the accord (and incorporated into the Irish and UK legislation), which provides relief from taxation under the undertaxed profit rule for a period of up to five additional years after the Company comes within the scope of the rules.

We may become subject to taxation in the Cayman Islands, which would negatively affect our results.

The Government of the Cayman Islands, does not, under existing legislation, impose any income, corporate or capital gains tax, estate duty, inheritance tax, gift tax or withholding tax upon Greenlight Re, GLRE or Viridis Re. Each of Greenlight Re, GLRE and Viridis Re have applied for and received an undertaking from the Governor-in-Cabinet of the Cayman Islands that, in accordance with Section 6 of the Tax Concessions Act (as revised) of the Cayman Islands, for a period of 20 years from the date of the undertaking (until December 2043 in the case of Viridis Re and until January 2045 in the case of Greenlight Re and GLRE), each company will be exempt from any law which is enacted in the Cayman Islands imposing any tax on profits, income, gains or appreciations of Greenlight Re, GLRE or Viridis Re or their operations. We cannot be assured that after the expiration of the respective certificates that we would not be subject to any such tax. As the law currently stands, upon the expiration of the current exemption, it will be possible for us to apply for another 20 year exemption for each of Greenlight Re, GLRE and Viridis Re, which we plan to do. If we were to become subject to taxation in the Cayman Islands, our financial condition and results of operations could be materially and adversely affected.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 1C. CYBERSECURITY

Cybersecurity is a complex and constantly evolving risk that we are committed to understanding and mitigating. The foundation of our information security practices is rooted in the principles set forth by the National Institute of Standards and Technology ("NIST"), ensuring a robust and comprehensive approach to safeguarding our digital assets. This program provides standards, guidelines, and best practices for improving our cybersecurity risk management. To effectively manage our cybersecurity risk, we employ a comprehensive approach encompassing risk assessment, identification, and mitigation, all aligned with the rigorous standards and principles. Cybersecurity and IT compliance risk metrics are monitored regularly to assess, identify, manage and protect our environment. Periodic audits of IT and Cybersecurity are carried out as part of internal and external audits, are performed by professionals and form a part of our overall risk management system and processes.

Our approach to third-party cybersecurity underscores a commitment to robust risk management and adherence to industry best practices. By implementing comprehensive measures in line with recognized standards, we ensure that our third-party cybersecurity protocols are aligned with rigorous standards. Regular assessments, SOC reviews, and collaborative efforts are integral components of our strategy, aimed at fostering a secure and resilient ecosystem that safeguards sensitive information and maintains the integrity of our digital infrastructure in partnership with external entities.

We have a Chief Information Security Officer ("CISO") and have an IT Steering Committee ("ITSC"). Our CISO is responsible for establishing the cybersecurity vision for the Company, determining and prioritizing cybersecurity initiatives, and keeping abreast of developing security threats. The ITSC reports to the Board and Audit Committee, is chaired by our Head of IT and Software Development (“Head of IT”), and has our CISO, CFO, COO, and Chief Accounting Officer as some of its members. Our CISO brings over three decades of expertise in the IT Industry and is a member of ISACA, showcasing a rich portfolio of industry certifications like the Certified Information Security Manager (“CISM”), Certified Data Privacy Solutions Engineer (“CPDSE”), and Microsoft Certified Systems Engineer (“MCSE”). The CISO also holds accreditations from vendors such as CISCO and Microsoft. Our Head of IT brings two decades of experience in aligning technology initiatives with business goals and managing IT strategy. With a background of over 15 years in insurance and reinsurance, the Head of IT is responsible for ensuring the implementation and adherence to governance and cybersecurity frameworks. Other members of the ITSC hold relevant qualifications and collectively, the ITSC has substantial experience and expertise in cybersecurity, risk, strategy, and management.

Return to table of contents

The ITSC meets at least quarterly to discuss and approve IT and Cybersecurity matters. The ITSC produces and approves an annual IT budget, as well as an Incident Management and Response plan through which the CISO and the ITSC are informed about cybersecurity incidents.

To assist with mitigating the risks of cybersecurity threats, periodic cybersecurity training is provided to employees, vendors, and members of the Board. Further, to mitigate risk arising from our relationships with third-parties, key vendors must be SOC 2 compliant, as determined in accordance with the framework developed by the American Institute of Certified Public Accountants, or undertake the Company’s enhanced due diligence process. Periodic testing is performed, and all material incidents are reported to the Board.

IT and cybersecurity are a standing Board agenda item, with quarterly presentations to the Board from the IT leadership quarterly. Our Audit Committee assists the Board in its oversight responsibilities regarding our systems, policies, and procedures relating to technology and cybersecurity. The Audit Committee’s charter mandates that the Audit Committee reviews our technology and cybersecurity systems, policies, and procedures (including those relating to our assessment of third-party provider cybersecurity controls) with management. The Audit Committee is further tasked with discussing with management the policies with respect to risk assessment and risk management, including those related to technology and cybersecurity. An IT and Cybersecurity presentation is made to the Audit Committee quarterly and additionally as needed, to inform it of any new or emerging cybersecurity threats or risks.

We have not identified or experienced any cybersecurity threats or incidents likely to materially affect our business strategy, results of operations, or financial conditions.

See “Item 1A. Risk Factors — Risks Relating to Our Business — Technology breaches or failures, including those resulting from a malicious ransomware or cyber-attack on us or our business partners and service providers, could disrupt or otherwise negatively impact our business.”

ITEM 2. PROPERTIES

We lease office space in Grand Cayman, Cayman Islands, where our principal executive office is located. Additionally, we lease office spaces in the United Kingdom and Ireland. We renew and enter into new leases in the ordinary course of business.

We believe that our office space is sufficient for us to conduct our operations for the foreseeable future. For further discussion of our lease commitments at December 31, 2025, refer to Note 17 “Commitments and Contingencies” of the consolidated financial statements.

ITEM 3. LEGAL PROCEEDINGS

From time to time, in the normal course of business, we may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine our rights and obligations under our reinsurance contracts and other contractual agreements. In some disputes, we may seek to enforce our rights under an agreement or to collect funds owing to us. In other matters, we may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, we do not believe that any of our existing contractual disputes, when finally resolved, will have a material adverse effect on our business, financial condition or operating results.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information and number of holders

Our ordinary shares are listed on the Nasdaq Global Select Market under the symbol “GLRE.”

Return to table of contents

On February 28, 2026, there were 69 holders of record of our ordinary shares. This figure does not include the beneficial owners of our ordinary shares held in “street name” or held through participants in depositories, such as the Depository Trust Company.

Dividends

Since inception, we have not paid any cash dividends on our ordinary shares.

Holders of ordinary shares are entitled to receive dividends when, as, and if declared by the Board of Directors in accordance with the provisions of our Articles and the Companies Law. In the event of a liquidation, dissolution, or winding-up of the Company, the holders of ordinary shares are entitled to share equally and ratably in our assets, if any remain after the payment of all of our debts and liabilities and the liquidation preference of any outstanding preferred shares.

We currently do not intend to declare and pay dividends on our ordinary shares in the foreseeable future. Our Board of Directors would only approve a dividend after taking into account our capital and liquidity position. In addition, a credit facility prohibits us from paying dividends (i) during an event of default as defined in the credit agreement, (ii) if such payment would reasonably be expected to have a material adverse effect on the Company and its subsidiaries or (iii) if we are not in compliance with certain specified financial covenants pertaining to leverage, capital requirements and minimum liquidity. Our future dividend policy will also depend on the requirements of any future financing agreements to which we may be a party and other factors considered relevant by our Board of Directors, such as our results of operations and cash flows, our financial position, and capital requirements, general business conditions, rating agency guidelines, legal, tax, regulatory and any contractual restrictions on the payment of dividends. Further, any future declaration and payment of dividends are discretionary, and our Board of Directors may, at any time, modify or revoke our dividend policy on our ordinary shares. Finally, our ability to pay dividends also depends on the ability of our subsidiaries to pay dividends to us. Although Greenlight Capital Re is not subject to any significant legal prohibitions on the payment of dividends, Greenlight Re and GRIL are subject to regulatory constraints that affect their ability to pay dividends and include minimum net worth requirements. At December 31, 2025, Greenlight Re and GRIL both exceeded the minimum statutory capital requirements. Any dividends we pay will be declared and paid in U.S. dollars.

Performance Graph

Presented below is a line graph comparing the yearly change in the cumulative total shareholder return on our ordinary shares for the five year period commencing December 31, 2020 through December 31, 2025 against the total return index for the Russell 2000 Index, or RUT, and the S&P 500 Property & Casualty Insurance Index, or S&P Insurance Index, for the same period. The performance graph assumes $100 invested on December 31, 2020 in the ordinary shares of Greenlight Capital Re, the RUT and the S&P Insurance Index. The performance graph also assumes that all dividends are reinvested.

Return to table of contents

The performance reflected in the graph above is not necessarily indicative of future performance.

This graph and related information presented is not “soliciting material,” is not deemed filed with the SEC, is not subject to Regulation 14A or 14C or to the liabilities of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference in any filing by us under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

Refer to Note 11 “Share Capital” of the consolidated financial statements for a summary of our share repurchase plan (the “Plan”). We had the following share repurchases during the quarter ended December 31, 2025.


Shares Purchased Under Publicly Announced Repurchase Program
Period	Number of Shares Purchased	Average Price per Share		Maximum Dollar Amount Still Available Under Share Repurchase Plan
Beginning balance				$	23,000,012
October 1 - 31, 2025	—	$	—	23,000,012
November 1 - 30, 2025	—	$	—	23,000,012
December 1 - 31, 2025	201,517	$	14.02	20,175,382
Total	201,517	$	14.02

Return to table of contents

During Q4 2025, we repurchased 201,517 ordinary shares at an average price of $14.02 per share, for a total of $2.8 million.

ITEM 6. [RESERVED]

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following is management’s discussion and analysis (“MD&A”) of the financial condition and results of operations for the years ended December 31, 2025, and 2024. Comparisons between 2024 and 2023 have been omitted from this Annual Report, but may be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC. Accordingly, this information is incorporated by reference.

This discussion and analysis should be read in conjunction with our audited consolidated financial statements and notes thereto presented in “Part II, Item 8. Financial Statements and Supplementary Data” of this Annual Report. Unless otherwise noted, tabular dollars are in thousands, except per share amounts. Amounts may not reconcile due to rounding differences.

Page


Overview			55
Business Overview			55
Outlook and Trends			55
Revenues and Expenses			55
Key Financial Measures and Non-GAAP Measures			56
Consolidated Results of Operations			58
Segment Results			60
Open Market Segment			60
Innovations Segment			63
Other Corporate			65
Runoff Underwriting Business			65
Income from Investment in Solasglas			66
Financial Condition			66
Liquidity and Capital Resources			69
Liquidity			69
Capital Resources			70
Contractual Obligations and Commitments			71
Critical Accounting Estimates			71
Premium Recognition			71
Loss and LAE Reserves			73
Investments Valuation			75

Return to table of contents

Overview

Business Overview

We are a global specialty property and casualty reinsurer headquartered in the Cayman Islands, with an underwriting and investment strategy that we believe differentiates us from most of our competitors. Our goal is to build long-term shareholder value by providing risk management solutions to the insurance, reinsurance, and other risk marketplaces. Refer to “Part 1, Item 1. Business” for additional information.

We earned a net income of $74.8 million for the year ended December 31, 2025, an increase of $32.0 million, or 74.8% compared to the prior year, predominantly due to strong underwriting results and favorable foreign exchange movement in 2025, partially offset by lower net investment income from Innovations and lower yields on restricted cash and cash equivalents.

The following is a summary of our financial performance for the year ended December 31, 2025, compared to the prior year:

•Gross premiums written was $773.3 million, an increase of 10.7%;

•Net premiums earned was $661.1 million, an increase of 6.6%;

•Net underwriting income was $35.7 million, compared to net underwriting loss of $8.2 million;

•Total investment income was $60.2 million, a decrease of 24.4%;

•Foreign exchange gains were $8.5 million, compared to foreign exchange losses of $5.6 million;

•Diluted EPS was $2.17, compared to $1.24, an increase of 75.0%; and

•Fully diluted book value per share was $20.43, an increase of $2.48, or 13.8%.

Outlook and Trends

Reinsurance market conditions

At the January 1, 2026 renewals, we experienced greater opportunities owing to our stronger balance sheet and the upgrade of our A.M. Best Rating to A (Excellent), but we also faced a more competitive market. Rate changes for Open Market business varied significantly by line of business: property and specialty rates experienced downward pressure, whereas casualty rates increased. Attachment points and other terms and conditions mostly held firm.

Although January 1st, is not historically a significant renewal date for our Innovations portfolio, we observed more opportunities with rate holding up well. In the current market conditions, we see increasing opportunities to leverage retrocession coverage, and we will take advantage of these opportunities where they enhance our economics and risk profile.

General economic conditions

There are many factors contributing to an uncertain global economic outlook, and in particular, we believe that inflationary trends of recent years could persist. We continue to consider the potential impact of relevant economic factors on our underwriting portfolio. On the investment side, DME Advisors regularly monitors and re-positions Solasglas’ investment portfolio to manage the impact of inflation on its underlying investments and holds macro positions to benefit from a rising inflationary environment. DME Advisors remains conservatively positioned as it believes the equity markets are very expensive.

We believe trade policies will continue to cause uncertainty and volatility. In February 2026, the U.S. Supreme Court struck down the Administration’s tariffs enacted under the International Emergency Economic Powers Act (IEEPA) of 1977, but the Administration stated it will enact new tariffs under several other legislative acts.

Revenues and Expenses

Revenues

We derive our revenues from two principal sources:

•premiums from reinsurance on property and casualty business assumed (net of any premiums ceded) - see “Critical Accounting Estimates” section of this MD&A; and

•income from investments, including:

Return to table of contents

•income (or loss) generated from our investment in Solasglas, net of management fee and performance compensation;

•gains (or losses) from our other investments, including Innovations-related investments; and

•interest income on our cash and cash equivalents, fixed maturities investment portfolio and FAL.

In addition, we may from time to time derive other income from foreign exchange gains (or losses) relating to underwriting balances, net investment income from Lloyd’s syndicates, fees generated from advisory services, and fees relating to overrides, profit commissions, and fees due upon the early termination of contracts.

Expenses

Our expenses consist primarily of the following:


			●			underwriting losses and LAE;
			●			acquisition costs;
			●			underwriting expenses;
			●			corporate and other expenses (also referred as “G&A”);
			●			interest expense on deposit-accounted contracts and debt;
			●			income taxes.

The extent of our net losses and LAE incurred is a function of the amount and type of reinsurance contracts we write and the loss experience of the underlying coverage. Refer to “Critical Accounting Estimates” section of this MD&A.

Acquisition costs consist primarily of brokerage fees, ceding commissions, premium taxes, profit commissions, letters of credit and trust fees, and federal excise taxes. We amortize deferred acquisition costs relating to successfully bound reinsurance contracts over the related contract term.

Underwriting expenses consist primarily of compensation costs related to our underwriting activities, in addition to an allocation of corporate overhead costs.

Corporate and other expenses consist primarily of compensation costs related to non-underwriting activities, including Innovations related investments and corporate personnel. Additionally, these also include professional fees (non-claim related), director compensation, travel and entertainment, information technology, rent, and other general operating costs, net of an allocation to underwriting expenses.

Deposit interest expense relates to the accretion costs for deposit-accounted contracts that did not meet the risk transfer condition for reinsurance accounting under U.S. GAAP.

Interest expense consists of interest paid and accrued on our debt and the amortization of the related deferred financing costs.

Key Financial Measures and Non-GAAP Measures

Management uses certain key financial measures, some of which are not prescribed under U.S. GAAP rules and standards (“non-GAAP financial measures”), to evaluate our financial performance, financial position, and the change in shareholder value. Generally, a non-GAAP financial measure, as defined in SEC Regulation G, is a numerical measure of a company’s historical or future financial performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented under U.S. GAAP. We believe that these measures, which may be calculated or defined differently by other companies, provide consistent and comparable metrics of our business performance to help shareholders understand performance trends and facilitate a more thorough understanding of the Company’s business. Non-GAAP financial measures should not be viewed as substitutes for those determined under U.S. GAAP.

We use the following non-GAAP financial measure in this Annual Report.

Return to table of contents

Fully Diluted Book Value Per Share

Our primary financial goal is to increase fully diluted book value per share over the long term. We use fully diluted book value as a financial measure in our incentive compensation plan.

We believe that long-term growth in fully diluted book value per share is the most relevant measure of our financial performance because it provides management and investors a yardstick to monitor the shareholder value generated. Fully diluted book value per share may also help our investors, shareholders, and other interested parties form a basis of comparison with other companies within the property and casualty reinsurance industry. Fully diluted book value per share should not be viewed as a substitute for the most comparable U.S. GAAP measure, which in our view is the basic book value per share.

We calculate basic book value per share as (a) ending shareholders' equity, divided by (b) the total ordinary shares issued and outstanding, as reported in the consolidated financial statements.

Fully diluted book value per share represents basic book value per share combined with any dilutive impact of in-the-money stock options and all outstanding restricted stock units, or “RSUs”. We believe these adjustments better reflect the ultimate dilution to our shareholders.

The following table presents a reconciliation of the fully diluted book value per share to basic book value per share (the most directly comparable U.S. GAAP financial measure):


At December 31,	2025			2024
Numerator for basic and fully diluted book value per share:
Total equity as reported under U.S. GAAP	$	707,977		$	635,879

Denominator for basic and fully diluted book value per share:
Ordinary shares issued and outstanding as reported and denominator for basic book value per share	33,897,709			34,831,324
Add: In-the-money stock options (1) and all outstanding RSUs	755,997			590,001
Denominator for fully diluted book value per share	34,653,706			35,421,325

Basic book value per share	$	20.89		$	18.26
Increase in basic book value per share	$	2.63		$	1.39
Increase in basic book value per share	14.4		%	8.2		%

Fully diluted book value per share	$	20.43		$	17.95
Increase in fully diluted book value per share	$	2.48		$	1.21
Increase in fully diluted book value per share	13.8		%	7.2		%

(1) Assuming net exercise by the grantee.

Return to table of contents

Consolidated Results of Operations

The table below summarizes our consolidated operating results.


	2025			2024			Change
Underwriting results:
Gross premiums written	$	773,261		$	698,335		$	74,926
Net premiums written	$	691,409		$	621,265		$	70,144
Net premiums earned	$	661,144		$	619,954		$	41,190
Net loss and LAE incurred:
Current year	(399,200)			(406,465)			7,265
Prior year (1)	(12,392)			(20,804)			8,412
Net loss and LAE incurred	(411,592)			(427,269)			15,677
Acquisition costs	(184,853)			(176,775)			(8,078)
Underwriting expenses	(28,627)			(22,857)			(5,770)
Deposit interest expense	(421)			(1,228)			807
Net underwriting income (loss)	35,651			(8,175)			43,826

Investment results:
Income from investment in Solasglas	35,711			33,605			2,106
Net investment income	24,457			45,954			(21,497)
Total investment income	60,168			79,559			(19,391)

Corporate and other expenses	(21,607)			(16,377)			(5,230)
Foreign exchange gains (losses)	8,465			(5,606)			14,071

Interest expense	(4,366)			(5,836)			1,470
Income tax expense	(3,479)			(749)			(2,730)
Net income	$	74,832		$	42,816		$	32,016
Diluted earnings per share	$	2.17		$	1.24		$	0.93

Underwriting ratios:							% Point Change
Attritional loss ratio	53.4		%	56.3		%	(2.9)
Large event loss ratio	3.0		%	1.8		%	1.2
CAT event loss ratio	4.0		%	7.5		%	(3.5)
Current year loss ratio	60.4		%	65.6		%	(5.2)
Prior year reserve development ratio	1.9		%	3.4		%	(1.5)
Loss ratio	62.3		%	69.0		%	(6.7)
Acquisition cost ratio	28.0		%	28.5		%	(0.5)
Composite ratio	90.2		%	97.5		%	(7.2)
Underwriting expense ratio	4.4		%	3.9		%	0.5
Combined ratio	94.6		%	101.4		%	(6.8)

1 The net financial impact associated with changes in the estimate of losses incurred in prior years, which incorporates earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs, and deposit interest income and expense, was a loss of $11.4 million in 2025 (2024: $21.8 million).

Return to table of contents

Consolidated Results of Operations for 2025 compared to 2024

Basic book value per share increased by $2.63 per share, or 14.4%, to $20.89 per share from $18.26 per share at December 31, 2024. Fully diluted book value per share increased by $2.48 per share, or 13.8%, to $20.43 per share from $17.95 per share at December 31, 2024.

For the year ended December 31, 2025, net income increased by $32.0 million to $74.8 million, driven mainly by the following:

•Underwriting income: Increased by $43.8 million due to 6.8 percentage points improvement in our combined ratio, driven predominantly by improved current year loss ratio and lower adverse prior year reserve development ratio. The lower attritional loss and CAT event loss ratios contributed to the lower current year loss ratio; partially offset by an increase in large event loss ratio. Refer to the “Results by Segment” section of the MD&A for further discussion and analysis.

•Solasglas investment: Solasglas returned 7.5% in 2025, compared to 9.8% in 2024. However, income from our Solasglas investment was $2.1 million higher in 2025 versus 2024, due to the growth in the Investment Portfolio.

•Foreign exchange gains (losses): $8.5 million foreign exchange gains for 2025, compared to $5.6 million foreign exchange losses for 2024, driven mainly by a stronger pound sterling movement against the U.S. dollar in 2025.

•Interest expense: Decreased by $1.5 million predominantly driven by a decrease in the average outstanding debt balance in 2025 as a result of debt repayment due strong cash flows generated from operations.

Offset partially by:

•Investment income: Decreased by $19.4 million primarily driven by lower investment income on cash and cash equivalents mainly due to lower yields, losses on Innovations investments, and lower returns on funds withheld by third party Lloyd’s syndicates. The Lloyd’s syndicates invest a portion of these funds in fixed maturity securities, equities, and investment funds. We record our share of the investment income and fair value adjustments on these securities when the syndicates report them to us, generally on a quarter in arrears. See Note 14 “Net Investment Income” of the consolidated financial financial statements for further details.

•Corporate and other expenses: Increased by $5.2 million predominantly driven by an increase in non-underwriting personnel costs, including higher incentive compensation expense as a result of strong underwriting results in 2025.

•Income tax expense: Increased by $2.7 million due to increased taxable income from our operations in Ireland and U.K.

Return to table of contents

Segment Results

We have two operating segments: Open Market and Innovations. The following is a discussion and analysis for each reporting segment for the years ended December 31, 2025 and 2024.

Open Market Segment

Results for the Open Market segment were as follows:


	Year ended December 31
		2025			2024			% Change
Gross premiums written		$	652,229		$	603,798		8	%
Net premiums written		$	601,690		$	541,446		11	%
Net premiums earned		$	576,032		$	511,922		13	%
Net loss and LAE incurred		(358,396)			(341,586)
Acquisition costs		(158,465)			(144,852)
Other underwriting expenses		(21,114)			(19,175)
Deposit interest expense, net		(421)			(1,228)
Underwriting income		37,636			5,081
Net investment income		32,036			42,629			(25)	%
Income before income taxes		$	69,672		$	47,710

Underwriting ratios:		2025			2024			% Point Change
Loss ratio		62.2		%	66.7		%	(4.5)
Acquisition cost ratio		27.5		%	28.3		%	(0.8)
Composite ratio		89.7		%	95.0		%	(5.3)
Underwriting expenses ratio		3.7		%	4.0		%	(0.3)
Combined ratio		93.4		%	99.0		%	(5.6)

Gross Premiums Written

Gross premiums written by line of business were as follows:


	Year ended December 31
		2025	2024				Change
Casualty			$	66,210	10	%	$	92,471	15	%	$	(26,261)
Financial			77,461		12	%	63,679		11	%	13,782
Health			230		—	%	217		—	%	13
Multiline			252,265		39	%	181,140		30	%	71,125
Property			82,537		13	%	87,922		15	%	(5,385)
Specialty			173,526		27	%	178,369		30	%	(4,843)
Total			$	652,229	100	%	$	603,798	100	%	$	48,431

Gross premiums written within our Open Market segment in 2025 increased by $48.4 million or 8%, compared to 2024. The increase was predominantly attributable to the following lines of business:

•Multiline:The $71.1 million, or 39%, increase was driven mostly by growth in our FAL business bound in 2025, coupled with growth from new construction and engineering business bound in 2025. This was partially offset by non-renewal of commercial auto business.

Return to table of contents

•Financial: The $13.8 million, or 22%, increase was mainly due to the reporting of additional premiums from previous treaty years in our mortgage business, coupled with rate and exposure growth in our transactional liability business and new surety business bound in 2025.

The above was partially offset by the decrease in our casualty, property and specialty lines of business. The significant decrease in casualty business is predominantly a result of our decision to reduce our casualty exposure through non-renewal of certain general liability and workers’ compensation programs.

Net Premiums Written

Ceded premiums written in 2025 was $50.5 million, resulting in net premiums written of $601.7 million, compared to $62.4 million and $541.4 million, respectively, in 2024. The decrease in ceded premiums written of 19% was driven by reduced quota share retrocessional activity within our property business due to lower inward premiums. Additionally in 2024, we reinstated certain retrocession excess of loss treaties in which the full coverage was deemed exhausted due to the Baltimore Bridge loss. This was partially offset mainly by additional excess of loss retrocessional coverage within our specialty business in 2025 to manage our overall exposure to aviation, marine and energy risks.

Net Premiums Earned

For our Open Market segment, net premiums earned by line of business were as follows:


	Year ended December 31
		2025	2024				Change
Casualty			$	87,279	15	%	$	89,213	15	%	$	(1,934)
Financial			63,470		11	%	56,903		9	%	6,567
Health			221		—	%	217		—	%	4
Multiline			216,673		38	%	191,849		32	%	24,824
Property			61,065		11	%	49,262		8	%	11,803
Specialty			147,324		26	%	124,478		21	%	22,846
Total			$	576,032	100	%	$	511,922	100	%	$	64,110

Net premiums earned in 2025 increased by $64.1 million, or 13%, compared to 2024. The change is influenced by the amount and timing of net premiums written during the current year and prior years, coupled with the business mix written in the form of excess of loss versus proportional contracts. Additionally, within the financial line and certain specialty line classes, the gross premiums written for some treaties are earned over multiple years, corresponding with the anticipated risk coverage period. Similarly, the impact of scaling back our casualty business was partially reflected during 2025, and will mostly impact our casualty earned premiums in 2026.

Loss ratio

The components of the loss ratio for our Open Market segment were as follows:


	Year ended December 31
		2025		2024		% Point Change
Current year:
Attritional loss ratio		52.8	%	56.8	%	(4.0)
Large event loss ratio		3.1	%	2.2	%	0.9
CAT event loss ratio		4.6	%	4.8	%	(0.2)
Current year loss ratio		60.5	%	63.8	%	(3.3)
Prior year reserve development ratio		1.8	%	2.9	%	(1.1)
Loss ratio		62.2	%	66.7	%	(4.4)

Return to table of contents

Current Year Loss Ratio

The current year loss ratio in 2025 decreased by 3.3 percentage points to 60.5%, compared to 2024, predominantly due to improved attritional loss ratio, offset partially by a higher volume of large event losses. The CAT losses during 2025 primarily related to the California wildfire losses.

Prior Year Reserve Development Ratio

The Open Market segment’s prior year reserve development ratio improved by 1.1 percentage points in 2025 compared to 2024. Refer to Note 8 Loss and LAE Reserves to the consolidated financial statements for further details on the lines of business and prior year development.

Acquisition cost ratio

The acquisition cost ratio decreased by 0.8 percentage points in 2025 compared to 2024, due to the change in business mix, coupled with improved acquisition cost ratios for our multiline and financial lines of business. This was partially offset by an increase in acquisition cost ratio for our specialty line, mainly due to growth in quota share reinsurance treaties at higher acquisition cost ratio than for excess of loss treaties.

The key drivers for the improved acquisition cost ratio relating to the financial and multiline business were:

•Financial: Driven by our transactional liability business due to lower profit commission costs as a result of adverse loss reserve development in 2025. Additionally, the acquisition cost ratio for the mortgage business was higher in 2024 due to an increase in profit commission costs on prior years’ treaties.

•Multiline: Driven predominantly from lower acquisition cost ratio for our FAL business, in part due to higher net premiums earned base to absorb fixed brokerage and commissions for new Syndicate 3456 programs.

Underwriting expense ratio

The underwriting expense ratio decreased marginally by 0.3 percentage points to 3.7% in 2025 compared to 2024, mainly due to net premiums earned growing more than our underwriting expenses which included higher incentive compensation due to stronger underwriting performance in 2025. A lower deposit interest expense also contributed to the lower expense ratio for 2025.

Net investment income

Net investment income decreased by 25% to $32.0 million in 2025 compared to 2024, predominantly driven by lower yields on collateralized cash balances and lower returns on funds withheld by third party Lloyd’s syndicates.

Income before income taxes

Income before income taxes for the Open Market segment was $69.7 million for 2025, compared to $47.7 million in 2024, driven predominantly by strong underwriting profits; partially offset by lower net investment income.

Return to table of contents

Innovations Segment

Results for the Innovations segment were as follows:


	Year ended December 31
		2025			2024			% Change
Gross premiums written		$	121,598		$	94,725		28	%
Net premiums written		$	90,233		$	80,016		13	%
Net premiums earned		$	85,626		$	86,352		(1)	%
Net loss and LAE incurred		(51,472)			(51,939)
Acquisition costs		(26,818)			(27,151)
Other underwriting expenses		(7,513)			(3,682)
Underwriting income (loss)		(177)			3,580
Net investment income		(10,064)			702
Corporate and other expenses		(2,703)			(2,445)			11	%
Income (loss) before income taxes		$	(12,944)		$	1,837

Underwriting ratios:		2025			2024			% Point Change
Loss ratio		60.1		%	60.1		%	—
Acquisition cost ratio		31.3		%	31.4		%	(0.1)
Composite ratio		91.4		%	91.5		%	(0.1)
Underwriting expenses ratio		8.8		%	4.3		%	4.5
Combined ratio		100.2		%	95.8		%	4.4

Gross Premiums Written

Gross premiums written by line of business within our Innovations segment were as follows:


	Year ended December 31
		2025	2024				Change
Casualty			$	31,378	26	%	$	24,843	26	%	$	6,535
Financial			9,781		8	%	7,800		8	%	1,981
Health			9,087		7	%	4,631		5	%	4,456
Multiline			58,733		48	%	47,311		50	%	11,422
Specialty			12,619		10	%	10,140		11	%	2,479
Total			$	121,598	100	%	$	94,725	100	%	$	26,873

Gross premiums written in 2025 increased by $26.9 million, or 28%, compared to 2024. All lines of business contributed to the premium growth, particularly our multiline business due to organic premium growth and new business from Syndicate 3456.

Net Premiums Written

For the Innovations segment, ceded premiums written in 2025 was $31.4 million, resulting in net premiums written of $90.2 million, compared to $14.7 million and $80.0 million, respectively, in 2024. The increase in ceded premiums written was predominantly driven by the new whole-account retrocession program in which we have ceded 28% of Innovations-related programs incepting Q4 2024 onwards.

Return to table of contents

Net Premiums Earned

Net premiums earned by line of business within the Innovations segment were as follows:


	Year ended December 31
		2025	2024			Change
Casualty			24,615	29	%	18,705	22	%	$	5,910
Financial			9,428	11	%	5,499	6	%	3,929
Health			3,456	4	%	2,144	2	%	1,312
Multiline			45,053	53	%	51,669	60	%	(6,616)
Specialty			3,074	4	%	8,335	10	%	(5,261)
Total			85,626	100	%	86,352	100	%	$	(726)

Despite the significant growth in net premiums written in 2025, the net premiums earned was relatively consistent with 2024. This is influenced by the amount and timing of net premiums written during the current year and prior years, coupled with the business mix written in the form of excess of loss versus proportional contracts. Additionally, as previously noted, the whole-account retrocession program for Innovations incepted from the fourth quarter of 2024; whereas this retro program was in place for the full year in 2025. The ceded premium on the whole-account retro program is included in the multiline business in the above table.

Loss ratio

The components of the loss ratio within the Innovations segment were as follows:


	Year ended December 31
		2025		2024		% Point Change
Current year:
Attritional loss ratio		57.5	%	60.5	%	(3.0)
Large event loss ratio		2.5	%	—	%	2.5
CAT event loss ratio		—	%	—	%	—
Current year loss ratio		59.9	%	60.5	%	(0.5)
Prior year reserve development ratio		0.2	%	(0.3)	%	0.5
Loss ratio		60.1	%	60.1	%	—

Current Year Loss Ratio

The current year loss ratio in 2025 decreased by 0.5 percentage points, compared to 2024 driven mainly by improved attritional loss ratio for all lines of business, offset partially by a large event loss relating to financial line of business.

The Innovations segment was not impacted by any CAT events for the years presented in the above table.

Prior Year Reserve Development Ratio

The change in prior year reserve development was unfavorable by 0.5 ratio points. Refer to Note 8 Loss and LAE Reserves to the consolidated financial statements for further details on the lines of business and prior year development.

Acquisition cost ratio

While the acquisition cost ratio for the Innovations segment remained relatively consistent with 2024, there was variability within the lines of the business. The increase in acquisition cost ratio, mostly from our financial line, was offset predominantly by the decrease in the specialty business.

Return to table of contents

The increase in acquisition costs in the financial line was driven mainly by premium growth from one program at higher acquisition cost; whereas the decrease in acquisition costs in the specialty business was driven mainly by non-renewal of certain quota share reinsurance business that had higher acquisition costs.

Underwriting expense ratio

The underwriting expense ratio increased by 4.5 percentage points to 8.8% in 2025 compared to 2024, as we invested in additional underwriters and infrastructure to drive the Innovations business growth. The increase in personnel costs also included higher incentive compensation driven by the overall company’s underwriting performance in 2025.

Net investment income (loss)

The Innovations segment reported a net investment loss of $10.1 million in 2025, compared to net investment income of $0.7 million in 2024. The investment performance in 2025 was predominantly driven by our Innovations private equity portfolio, primarily due to:

•$22.3 million reversal of previously recognized unrealized gains (impairment charges) on two of our private equity holdings based on new financing rounds at a reduced enterprise value, coupled with fully impaired holdings due to financial distress and a partial debt impairment.

For impairment charges based on reduced enterprise value, we calculated the fair value using valuation models incorporating significant unobservable inputs. These include discounted cash flow analyses and option pricing models. The key inputs and assumptions used in these models include, but are not limited to, projected cash flows provided by the investee’s management, discount rates, growth rates, volatility assumptions, and current market multiples.

Partially offsetting the above impairment charges, we had the following unrealized and realized gains in 2025:

•$8.0 million of unrealized gains from six holdings as a result of latest closed financing rounds by the respective investees, for which the fair value was based on observable price changes in orderly transactions; and

•$2.1 million of realized gain on partial sales relating to two holdings.

We also earned $1.7 million of interest income on cash collateral in 2025, compared to $1.7 million in 2024. While the yield declined in 2025, the average outstanding cash collateral was higher in 2025 compared to 2024.

Income before income taxes

The loss before income taxes for the Innovations segment was $12.9 million in 2025 compared to income before income taxes of $1.8 million in 2024. The performance in 2025 was predominantly driven by net investment loss and, to a lesser extent, an increase in underwriting expenses.

Other Corporate

Runoff Underwriting Business

In late 2023, we made the decision to not renew a property business due to significant CAT losses relating to unprecedented severe convective storms in the U.S. On the quota share reinsurance treaty bound in 2023, we continued to earn premiums in 2024 and incurred additional CAT losses from severe convective storms that occurred in 2024. For the years ended December 31, 2025, and 2024, we incurred an underwriting loss of $1.8 million, and $16.8 million respectively, including prior year adverse development of $2.0 million and $6.2 million, respectively. This was partially offset by investment income of $1.0 million and $1.4 million, respectively, relating to this runoff business.

We have reported the results of the above property runoff business as part of Corporate in Note 18 Segment Reporting in the consolidated financial statements.

Return to table of contents

Income from Investment in Solasglas

Our share of Solasglas’ net income increased by $2.1 million to $35.7 million in 2025, compared to 2024. This increase was driven by a higher investment portfolio balance during 2025, offset partially by a lower net investment return. For the year ended December 31, 2025, Solasglas reported a net investment return of 7.5%, compared to 9.8% for 2024.

The following table provides a breakdown of the gross and net investment return for Solasglas:


	2025		2024
Long portfolio gains	2.8	%	10.3	%
Short portfolio losses	(8.1)	%	(2.3)	%
Macro gains	14.9	%	4.4	%
Other income and expenses(1)	(1.2)	%	(1.6)	%
Gross investment return	8.4	%	10.8	%
Net investment return(1)	7.5	%	9.8	%

1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts. For further information about management fees and performance compensation, refer to Note 16 “Related Party Transactions” of the consolidated financial statements.

For the year ended December 31, 2025, the significant contributors to Solasglas’ investment return were long positions in gold, Brighthouse Financial Inc. (BHF) and Teva Pharmaceutical Industries (TEVA). The largest detractors were a long position in Lanxess AG (LXS GY) and two single-name short positions.

For the year ended December 31, 2024, the significant contributors to Solasglas’ investment return were long positions in gold, Kyndryl Holdings (KD) and Green Brick Partners (GRBK). The largest detractors were three single-name short positions.

Each month, we post on our website (www.greenlightre.com) the returns from our investment in Solasglas.

Financial Condition

Investments

The following table provides a breakdown of our total investments:


At December 31,	2025				2024
Investment in Solasglas	$	504,555	79.7	%	$	387,144	84.1	%
Fixed maturities	65,609		10.4	%	—		—	%
Other investments	62,911		9.9	%	73,160		15.9	%
Total investments	$	633,075	100.0	%	$	460,304	100.0	%

At December 31, 2025, our total investments increased by $172.8 million, or 37.5%, to $633.1 million from December 31, 2024..

Investment in Solasglas

Our investment in Solasglas increased by $117.4 million to $504.6 million at December 31, 2025. This was predominantly driven by $81.7 million of net contributions into Solasglas, coupled with the 7.5% net investment return in 2025. The contributions were funded partially from cash flows from operations and from the partial release of restricted cash and FAL.

DME Advisors reports the composition of Solasglas’ portfolio on a delta-adjusted basis, which it believes is the appropriate manner to assess the exposure and profile of investments and reflects how it manages the portfolio. An option’s delta is the option price’s sensitivity to the underlying stock (or commodity) price. The delta-adjusted basis is the number of shares or contracts underlying the option multiplied by the delta and the underlying stock (or commodity) price.

Return to table of contents

The following table represents the composition of Solasglas’ investments as a percentage of the investment portfolio:


At December 31,	2025				2024
	Long %		Short %		Long %		Short %
Equities and related derivatives	91.0		(53.3)		73.9		(43.3)
Private and unlisted equity securities	1.9		—		2.1		—
Debt instruments	0.1		—		0.1		—
Total	93.0	%	(53.3)	%	76.1	%	(43.3)	%

The above exposure analysis does not include cash (U.S. dollar and foreign currencies), gold and other commodities, credit default swaps, sovereign debt, foreign currency derivatives, interest rate derivatives, inflation swaps and other macro positions. Under this methodology, a total return swap’s exposure is reported at its full notional amount and options are reported at their delta-adjusted basis. At December 31, 2025, Solasglas’ exposure to gold on a delta-adjusted basis was 11.9% (2024: 10.1%).

At December 31, 2025, 94.7% of Solasglas’ portfolio was valued based on quoted prices in actively traded markets (Level 1), 4.1% was composed of instruments valued based on observable inputs other than quoted prices (Level 2), and no instruments were valued based on non-observable inputs (Level 3). At December 31, 2025, 1.2% of Solasglas’ portfolio consisted of private equity funds valued using the funds’ net asset values as a practical expedient.

Fixed Maturities

In late 2025, we began investing funds held in certain regulatory trusts for U.S. cedents in a managed fixed maturity portfolio as well as cash held by Syndicate 3456 in a Lloyd’s approved liquidity fund to generate higher yields on these assets.

The following table provides the credit quality distribution of our fixed maturity portfolio at December 31, 2025.


				Credit Rating
		Fair Value		AAA		AA- to AA+		A to A+		Not Subject to Credit Rating
Fixed Maturities:
	U.S. government and agencies	$	17,979	$	—	$	17,979	$	—	$	—
	Agency RMBS	18,258		—		18,258		—		—
	Corporate bonds	9,769				2,638		7,131		—
	ABS	5,565		5,565		—		—		—

	Non-agency RMBS	600		600

	Municipal bonds	857		—		857		—		—
	Total fixed maturity portfolio	53,028		6,165		39,732		7,131		—
Liquidity fund		12,581		—		—		—		12,581
Total fixed maturity investments		$	65,609	$	6,165	$	39,732	$	7,131	$	12,581

Our methodology for assigning credit ratings to fixed maturity securities utilizes a rules-based methodology, typically employing the middle rating of Standard & Poor’s (“S&P”), Moody’s, and Fitch ratings. When ratings from only two of these three agencies are available, the lower rating is used. When only one agency rates a security, that rating is used.

At December 31, 2025, the fixed maturity portfolio had a weighted average credit rating of AA+, a book yield of 3.8%, and an average duration of 1.3 years. See Notes 4 “Fixed Maturities” and Note 7 “Fair Value Measureme nts” for further details.

Return to table of contents

Other Investments

The other investment holdings relate to private investments made by Innovations. At December 31, 2025, other investments decreased by $10.2 million to $62.9 million, from $73.2 million at December 31, 2024. The decrease was driven mainly by net investment losses, coupled with the partial sale of two holdings during 2025. This was partially offset by $4.1 million of new investments in 2025.

While we manage a diversified Innovations-related investment portfolio, our top five holdings accounted for 53% (2024: 70%) of the total carrying value. For further information, see Note 5 “Other Investments” of the consolidated financial statements.

Restricted cash and cash equivalents

We use our restricted cash and cash equivalents primarily for funding trusts and letters of credit issued to our ceding insurers. Our restricted cash decreased by $52.4 million, or 9.0%, to $532.0 million since December 31, 2024, primarily due to transferring funds held in certain regulatory trusts for U.S. cedents into a managed fixed maturity portfolio.

Reinsurance balances receivable

Our reinsurance balances receivable decreased by $40.1 million, or 5.7%, to $664.4 million since December 31, 2024. This decrease was driven primarily by $25.8 million net reduction in funds held by cedents and $69.1 million net release of FAL; partially offset by $58.0 million increase in premiums held by Lloyd’s syndicates. The net release of FAL was as a result of substituting it with a £45 million LC in favor of Lloyd’s (see 10 “Debt and Credit Facilities”).

Loss and LAE Reserves; Loss and LAE Recoverable

Our total gross loss and LAE reserves increased by $107.0 million, or 12.4%, to $968.0 million since December 31, 2024. See Note 8 “Loss and Loss Adjustment Expense Reserves” of the consolidated financial statements for a summary of changes in outstanding loss and LAE reserves, current year CAT losses, prior period reserve development, and analysis of our incurred and paid claims development and claims duration for each of our reporting segments. In addition, refer to “Critical Accounting Estimates - Loss and LAE Reserves” within this MD&A for information on the reserving techniques, assumptions and processes we follow to estimate our loss and LAE reserves.

Our total loss and LAE recoverable decreased by $4.4 million, or 5.1%, to $81.4 million since December 31, 2024, mainly due to updated estimate for loss recoveries from prior years. Virtually all the outstanding balance is based on estimated recoveries not yet due. See Note 9 “Retrocession” of the consolidated financial statements for a description of the credit risk associated with our retrocessionaires.

Catastrophe Loss Exposure

Most of our contracts have defined limits of liability that cap our risk exposure. Once these limits are reached, we are not liable for further losses. However, some contracts, especially quota share contracts covering first-dollar exposure, lack aggregate limits.

Our property and Lloyd’s business, and to a lesser extent our casualty and other business, in the Open Market segment include contracts with natural peril loss exposure. We monitor our catastrophe loss exposure using PML (net of retrocession and reinstatement premiums), which can vary based on simulated losses and our in-force business composition.

We track natural peril PMLs globally, focusing on peak peril regions and subdividing large geographic areas into individual peril zones. For natural catastrophe PMLs, we use catastrophe models at the 1-in-250-year return period, indicating a 0.4% probability of exceeding the estimated losses in any given year.

PMLs are best estimates based on available modeled data, and actual events may differ significantly from these models. Our PML estimates cover all significant exposures from our reinsurance operations, including property, marine and energy, motor, and catastrophe workers’ compensation.

Return to table of contents

At January 1, 2026, our estimated largest PML at a 1-in-250-year return period for a single event and in aggregate was $138.8 million and $151.2 million, respectively, both relating to the peril of North Atlantic Hurricane, compared to $116.3 million and $129.1 million, respectively, at January 1, 2025. Our PMLs increased as we grew our clients and accessed new business that met our profitability requirements.

The below table contains the expected modeled loss for each of our peak peril regions and sub-regions for both a single event loss and aggregate loss measures at the 1-in-250-year return period.


	January 1, 2026
	Net 1-in-250 Year Return Period
Peril	Single Event Loss		Aggregate Loss
North Atlantic Hurricane	$	138,805	$	151,247
Florida Hurricane	97,857		101,080
Southeast Hurricane (excluding Florida)	114,122		117,190
Gulf of Mexico Hurricane	70,841		71,377
Northeast Hurricane	86,217		89,067
North America Earthquake
California Earthquake	112,384		113,921
Pacific Northwest Earthquake	34,856		34,866
New Madrid Earthquake	17,924		17,924
Japan Earthquake	34,681		35,294
Japan Windstorm	19,612		20,386
Europe Windstorm	71,630		75,716

Liquidity and Capital Resources

Liquidity

Liquidity is a measure of a company’s ability to generate sufficient cash flows to meet the short-term and long-term cash requirements of its business operations. We manage liquidity at the holding company and operating subsidiary level.

Holding Company

Greenlight Capital Re is a holding company with no operations of its own and its assets consist primarily of investments in its subsidiaries. Accordingly, Greenlight Capital Re’s future cash flows depend on the availability of dividends or other statutorily permissible distributions, such as returns of capital, from its subsidiaries. The ability to pay dividends and/or distributions is limited by:

•the applicable laws and regulations of the countries in which Greenlight Capital Re’s subsidiaries operate (see Note 19 “Statutory Requirements” to the consolidated financial statements);

•the need to maintain adequate capital levels to support our reinsurance operations; and

•the need to preserve our current “A (Excellent)” rating by A.M. Best.

As a holding company, Greenlight Capital Re has minimal continuing cash needs, most of which are related to the payment of corporate and general administrative expenses and interest expenses. Our current policy is to retain earnings to support the growth of our business. We currently do not expect to pay dividends on our ordinary shares.

We anticipate positive cash flows from operations (underwriting activities and investment income) to be sufficient to cover cash outflows under most loss scenarios in the near term. Based on expected cash flows from operations, financing arrangements and redemptions from related party investment fund as needed (subject to three day’s notice to the general partner), we believe we have sufficient liquidity to cover our working capital requirements and other contractual obligations and commitments through the foreseeable future.

Operating Subsidiaries

Our sources of funds from operating subsidiaries consist primarily of premium receipts (net of brokerage and ceding commissions), investment income, and other income. We use cash from our operations to pay losses and loss

Return to table of contents

adjustment expenses, profit commissions, interest, and G&A expenses. Our reinsurance business inherently provides liquidity as premiums are received in advance of the time claims are paid. However, the amount of cash required to fund loss payments can fluctuate significantly from period to period due to the low frequency / high severity nature of certain types of reinsurance business we write.

The following table summarizes our sources and uses of funds:


	2025		2024
Total cash provided by (used in):
Operating activities	$	210,212	$	111,504
Investing activities	(149,170)		(96,562)
Financing activities	(65,138)		(21,240)
Effect of currency exchange on cash(1)	(1,259)		(345)
Net cash outflows	(5,355)		(6,643)
Cash, beginning of period	649,087		655,730
Cash, end of period	$	643,732	$	649,087

(1) Cash includes unrestricted and restricted cash and cash equivalents - see Note 6 “Restricted Cash and Cash Equivalents” of the consolidated financial statements.

Cash provided by operating activities

The $98.7 million increase in cash provided by operating activities in 2025 compared to 2024 was driven mainly by the release of FAL and higher net income. We expect cash from operations to ebb and flow with our underwriting activities. Cash inflows from underwriting activities generally include premiums, net of acquisition costs, and reinsurance recoverables. Cash outflows principally include payments of losses and LAE, payments of retrocession premiums, and operating expenses. Cash provided by operating activities may vary significantly from period to period due to the timing of these inflows and outflows.

Cash used in investing activities

The $52.6 million increase in cash used for investing activities was driven predominantly by the new fixed maturity investments transferred from restricted cash; offset partially by a lower net contribution to Solasglas in 2025.

Cash used in financing activities

Financing cash outflows in 2025 were driven mainly by the $9.8 million of share repurchases and $55.3 million of debt repayments. In 2024, we had $7.5 million of share repurchases and $13.8 million of debt repayments.

Capital Resources

The following table summarizes our debt and capital structure:


	2025			2024
Debt - outstanding principal	$	5,000		$	60,313
Shareholders’ equity	707,977			635,879
Total capital	$	712,977		$	696,192

Ratio of debt to shareholders’ equity	0.7		%	9.5		%

The ratio of debt to shareholders’ equity provides an indication of our leverage and capital structure, along with some insights into our financial strength. In addition to the above capital, we also have LOC facilities to support our reinsurance business operations where we are not licensed or admitted as a reinsurer (see Note 10 “Debt and Credit Facilities” of the consolidated financial statements for further information).

Debt

As a result of strong operating cash flows and a new Revolving Credit Facility, we repaid the Term loans in 2025. At December 31, 2025, we had $5.0 million of outstanding debt under the Revolving Credit Facility.

Return to table of contents

Total shareholders’ equity

Total shareholders’ equity increased by $72.1 million to $708.0 million since December 31, 2024. The increase was primarily due to the net income of $74.8 million reported for the year, coupled with $7.1 million of share-based compensation adjustment to additional paid-in capital. This was partially offset by $9.8 million of share repurchases in the open market at an average price of $13.76 per share.

At December 31, 2025, there were 33,897,709 outstanding ordinary shares, a decrease of 933,615 since December 31, 2024, mainly due to 714,044 shares repurchased and 376,686 forfeited restricted shares, offset partially by issuance of restricted shares and ordinary shares for vested RSUs.

We expect that the existing capital base and internally generated funds will be sufficient to implement our business strategy for the foreseeable future. However, to provide us with flexibility and timely access to public capital markets should we require additional capital for working capital, capital expenditures, acquisitions, or other general corporate purposes, we have a $200.0 million shelf registration (Form S-3 registration statement) filed with the SEC, which became effective on July 5, 2024, and will expire on July 1, 2027.

Contractual Obligations and Commitments

At December 31, 2025, our contractual obligations and commitments by period due were as follows:


	Less than 1 year		1-3 years		3-5 years		More than 5 years		Total
Operating activities
Loss and loss adjustment expense reserves (1)	$	391,056	$	353,305	$	126,803	$	96,796	$	967,960
Operating lease obligations (2)	698		1,252		1,213		—		3,163
Financing activities
Debt (principal payments) (3)	—		—		5,000		—		5,000
Total	$	391,754	$	354,557	$	133,016	$	96,796	$	976,123

(1) Due to the nature of our reinsurance operations, the actual amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain. We have not taken into account corresponding reinsurance recoverable on unpaid amounts that would be due to us.

(2) See Note 17 “Commitments and Contingencies” of the consolidated financial statements.

(3) See Note 10 “Debt and Credit Facilities” of the consolidated financial statements.

Critical Accounting Estimates

Our consolidated financial statements contain certain amounts that are inherently subjective and have required management to make assumptions and best estimates to determine reported values. If certain factors, including those described in “Part I, Item IA. — Risk Factors,” cause actual events or results to differ materially from our underlying assumptions or estimates. In that case, there could be a material adverse effect on our results of operations, financial condition, or liquidity.

We believe the following are the critical accounting estimates used to prepare our consolidated financial statements:

•Premium recognition

•Loss and LAE reserves

•Investments valuation

The following provides a summary of our accounting policies for the above critical accounting estimates.

Premium Recognition

Gross Premiums Written

We record our property and casualty reinsurance premiums as premiums written based on our best estimate of the ultimate premiums for the contract period. Our estimates are based on actuarial pricing models, information

Return to table of contents

received from ceding companies, and from Lloyd’s syndicates (for FAL business). Further, we record reinsurance premiums so long as they meet the risk transfer criteria under U.S. GAAP (see “Deposit Contracts” below).

The recognition of gross premiums written will vary based on the type of the reinsurance contract as follows:

•Excess of loss contracts: typically the contracts state premiums as a percentage of the subject premiums written by the client, subject to a minimum deposit premium. The minimum deposit premium is generally based on an estimate of subject premiums expected to be written by the client during the contract term. At the inception of the contract, we record the total contractual minimum deposit premium, which is subsequently adjusted when the actual subject premium is known. Generally, the adjustment to actual is not material on an aggregate basis.

•Quota share (also known as proportional) contracts: we record our participation share of the estimated ultimate premiums in the same periods in which the underlying insurance contracts are written. For example, for a 12-month quota share reinsurance contract, we will recognize the estimated gross premiums written over 12 months, generally on a linear basis.

•For multi-year contracts: we record reinsurance premiums at the inception of the contract based on our best estimate of total premiums to be received. Premiums are recognized on an annual basis for multi-year contracts where the cedants have the ability to unilaterally commute or cancel coverage within the term of the contract.

We write mostly quota share reinsurance treaties. The following table provides a summary of our estimated gross premiums written for quota share reinsurance contracts incepting during the year:


	2025		2024		2023
Open Market segment	$	439,982	$	402,666	$	358,230
Innovations segment	58,219		45,494		44,133
Property runoff	—		—		42,744
Total quota share estimated premiums	498,201		448,160		445,107
Consolidated gross premiums written	773,261		698,335		636,8

GREENLIGHT CAPITAL RE, LTD. 10-K